<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microorganisms</journal-id><journal-id journal-id-type="iso-abbrev">Microorganisms</journal-id><journal-id journal-id-type="publisher-id">microorganisms</journal-id><journal-title-group><journal-title>Microorganisms</journal-title></journal-title-group><issn pub-type="epub">2076-2607</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10456854</article-id><article-id pub-id-type="doi">10.3390/microorganisms11081899</article-id><article-id pub-id-type="publisher-id">microorganisms-11-01899</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Bioprospecting the Skin Microbiome: Advances in Therapeutics and Personal Care Products</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nicholas-Haizelden</surname><given-names>Keir</given-names></name><xref rid="af1-microorganisms-11-01899" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2305-5875</contrib-id><name><surname>Murphy</surname><given-names>Barry</given-names></name><xref rid="af2-microorganisms-11-01899" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4437-6221</contrib-id><name><surname>Hoptroff</surname><given-names>Michael</given-names></name><xref rid="af2-microorganisms-11-01899" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Horsburgh</surname><given-names>Malcolm J.</given-names></name><xref rid="af1-microorganisms-11-01899" ref-type="aff">1</xref><xref rid="c1-microorganisms-11-01899" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Br&#x000fc;ggemann</surname><given-names>Holger</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Lood</surname><given-names>Rolf</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-microorganisms-11-01899"><label>1</label>Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3BX, UK; <email>hlknicho@liverpool.ac.uk</email></aff><aff id="af2-microorganisms-11-01899"><label>2</label>Unilever Research &#x00026; Development, Port Sunlight, Wirral CH63 3JW, UK; <email>barry.murphy@unilever.com</email> (B.M.); <email>michael.hoptroff@unilever.com</email> (M.H.)</aff><author-notes><corresp id="c1-microorganisms-11-01899"><label>*</label>Correspondence: <email>m.j.horsburgh@liverpool.ac.uk</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2023</year></pub-date><volume>11</volume><issue>8</issue><elocation-id>1899</elocation-id><history><date date-type="received"><day>20</day><month>6</month><year>2023</year></date><date date-type="rev-recd"><day>20</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>25</day><month>7</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 by the authors.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Bioprospecting is the discovery and exploration of biological diversity found within organisms, genetic elements or produced compounds with prospective commercial or therapeutic applications. The human skin is an ecological niche which harbours a rich and compositional diversity microbiome stemming from the multifactorial interactions between the host and microbiota facilitated by exploitable effector compounds. Advances in the understanding of microbial colonisation mechanisms alongside species and strain interactions have revealed a novel chemical and biological understanding which displays applicative potential. Studies elucidating the organismal interfaces and concomitant understanding of the central processes of skin biology have begun to unravel a potential wealth of molecules which can exploited for their proposed functions. A variety of skin-microbiome-derived compounds display prospective therapeutic applications, ranging from antioncogenic agents relevant in skin cancer therapy to treatment strategies for antimicrobial-resistant bacterial and fungal infections. Considerable opportunities have emerged for the translation to personal care products, such as topical agents to mitigate various skin conditions such as acne and eczema. Adjacent compound developments have focused on cosmetic applications such as reducing skin ageing and its associated changes to skin properties and the microbiome. The skin microbiome contains a wealth of prospective compounds with therapeutic and commercial applications; however, considerable work is required for the translation of in vitro findings to relevant in vivo models to ensure translatability. </p></abstract><kwd-group><kwd>skin microbiome</kwd><kwd>therapeutics</kwd><kwd>bioprospecting</kwd><kwd>personal care</kwd><kwd>ageing</kwd><kwd>lipid</kwd></kwd-group><funding-group><award-group><funding-source>BBSRC Collaborative Training Partnership</funding-source><award-id>BB/X511481/1</award-id></award-group><funding-statement>K.N.-H. is funded by BBSRC Collaborative Training Partnership grant BB/X511481/1.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-microorganisms-11-01899"><title>1. Introduction</title><p>Despite perceptions of being an arid wasteland, the human skin is a habitat occupied by a diverse array of microorganisms. Human skin microbiome diversity stems from microenvironment variations between body sites ranging from the <italic toggle="yes">Cutibacterium</italic>-dominated sebaceous regions, rich in lipids, to the halotolerant <italic toggle="yes">Staphylococcus</italic> that are abundant in sweat-rich areas [<xref rid="B1-microorganisms-11-01899" ref-type="bibr">1</xref>,<xref rid="B2-microorganisms-11-01899" ref-type="bibr">2</xref>]. The complement of these microorganisms, the microbiota, utilises host compounds as nutrient sources whilst conveying benefits to their host, such as pathogenic colonisation resistance, local immune system priming and the maintenance of lipid barriers [<xref rid="B3-microorganisms-11-01899" ref-type="bibr">3</xref>]. Akin to macroecological biomes, the skin microbiota community structure consists of organisms specialised to corresponding niches that are susceptible to invasion by foreign species displacing resident organisms [<xref rid="B2-microorganisms-11-01899" ref-type="bibr">2</xref>]. The composition and stability of the skin microbiome are constrained by physical factors that include pH, oxygen concentration, nutrient availability and competition, plus host symbiotic and commensal relationships [<xref rid="B4-microorganisms-11-01899" ref-type="bibr">4</xref>]. Interactions between host microbiota are largely mediated by secreted biological effector compounds, such as digestive enzymes, antimicrobials and quorum sensing compounds [<xref rid="B5-microorganisms-11-01899" ref-type="bibr">5</xref>]. The diversity of skin microbiota and associated effector compounds represent an underappreciated source of effectors potentially relevant to the treatment of a variety of diseases and conditions. </p><p>Bioprospecting is the discovery and exploration of the biological diversity of organisms, genetic components or compounds with potential commercial or therapeutic applications. The utility of beneficial biologically derived compounds is highlighted by the discovery of antibiotics, which has revolutionised modern healthcare and drastically increased global lifespan [<xref rid="B6-microorganisms-11-01899" ref-type="bibr">6</xref>]. Novel drug discovery remains necessary for improving the financial viability of therapeutic and commercial compound pipelines and healthcare outcomes [<xref rid="B7-microorganisms-11-01899" ref-type="bibr">7</xref>]. There is an overwhelming need for novel treatments for bacterial infections in a contemporary world where antimicrobial resistant (AMR) pathogens are an increasing concern, with over 1 million deaths in 2019 associated with such infections [<xref rid="B8-microorganisms-11-01899" ref-type="bibr">8</xref>]. Several alternative treatment strategies are in development to combat AMR infections, such as bacteriophage therapy that has recently gained momentum in Western countries [<xref rid="B9-microorganisms-11-01899" ref-type="bibr">9</xref>].</p><p>The skin microbiome provides a vast resource for the development of novel treatment strategies towards the control of AMR infections. Understanding the biochemistry at the interface between host and microbiota will unravel hitherto unknown biology. The coevolution of the human skin with pathogens has resulted in control mechanisms, such as sapienic acid and psoriasin capable of the growth inhibition of AMR <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Escherichia coli</italic>, respectively [<xref rid="B8-microorganisms-11-01899" ref-type="bibr">8</xref>,<xref rid="B10-microorganisms-11-01899" ref-type="bibr">10</xref>,<xref rid="B11-microorganisms-11-01899" ref-type="bibr">11</xref>]. The comparable gut microbiome has revealed a plethora of novel compounds with treatment potential for diseases such as chronic infection, cancer and obesity [<xref rid="B12-microorganisms-11-01899" ref-type="bibr">12</xref>]. Whilst skin microbiota potentially harbours a greater species richness than the gut, its potential abundance of therapeutic compounds and their translational benefits are yet to be mined [<xref rid="B3-microorganisms-11-01899" ref-type="bibr">3</xref>].</p><p>Advances in high-throughput genomic technologies have revealed a wealth of microbiome data, facilitating a conceptual shift whereby multicellular organisms&#x02019; functions are intrinsically linked to their microbiota [<xref rid="B13-microorganisms-11-01899" ref-type="bibr">13</xref>]. Classically, microbiological investigations relied upon the direct culturing of isolates utilising historic techniques to infer organism identity. The true picture of microbiota diversity was confounded by fastidious organisms lacking the necessary growth conditions provided in vivo, such as complex metabolic interdependences [<xref rid="B14-microorganisms-11-01899" ref-type="bibr">14</xref>,<xref rid="B15-microorganisms-11-01899" ref-type="bibr">15</xref>]. Metagenomic techniques have facilitated more interrogative analyses of the total genomic material present within the skin, which continue to reveal ever more diversity within the skin microbiota [<xref rid="B16-microorganisms-11-01899" ref-type="bibr">16</xref>,<xref rid="B17-microorganisms-11-01899" ref-type="bibr">17</xref>,<xref rid="B18-microorganisms-11-01899" ref-type="bibr">18</xref>,<xref rid="B19-microorganisms-11-01899" ref-type="bibr">19</xref>]. Further development of artificial intelligence technologies has enabled a sophisticated analysis of metagenomic and physical data, allowing for inferences in the causal linkage of skin hydration, age and smoking status to microbiome composition and interpersonal variation [<xref rid="B16-microorganisms-11-01899" ref-type="bibr">16</xref>]. </p><p>Investigations utilising next-generation omics technologies have revealed a multitude of mechanisms and concepts from the skin microbiome. The human skin microbiome is a complex and dynamic field with varied applications, and many organisms and associated compounds have feasibly exploitable properties [<xref rid="B3-microorganisms-11-01899" ref-type="bibr">3</xref>,<xref rid="B4-microorganisms-11-01899" ref-type="bibr">4</xref>,<xref rid="B17-microorganisms-11-01899" ref-type="bibr">17</xref>,<xref rid="B18-microorganisms-11-01899" ref-type="bibr">18</xref>]</p><p>This review is distinct through a focus on the breadth and recent advances in the therapeutic and commercial application of biological molecules gained from bioprospecting the human skin microbiome. We further explore the viability of prospective compounds for their translational capacity in human application.</p></sec><sec id="sec2-microorganisms-11-01899"><title>2. Skin Environment</title><p>The external skin represents a surface functioning primarily to minimise transepidermal evaporative water loss whilst simultaneously providing a physical barrier to extrinsic biological and environmental agents and regulating body temperature [<xref rid="B19-microorganisms-11-01899" ref-type="bibr">19</xref>]. Structurally, skin is comprised of three layers: the innermost hypodermis which stores adipose fat for physical protection and energy, the connective dermis, containing blood and nerve vessels, and the external epidermis [<xref rid="B20-microorganisms-11-01899" ref-type="bibr">20</xref>]. The epidermis is composed of a stratified network of keratinocytes which originate from lower levels and migrate through the epidermis eventually forming the outer stratum corneum of dead anucleate corneocytes [<xref rid="B19-microorganisms-11-01899" ref-type="bibr">19</xref>]. Eventually, corneocytes desquamate and are released from the keratin and lipid matrix, facilitating skin renewal whilst providing nutrition for resident skin microorganisms (<xref rid="microorganisms-11-01899-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B4-microorganisms-11-01899" ref-type="bibr">4</xref>,<xref rid="B21-microorganisms-11-01899" ref-type="bibr">21</xref>].</p><p>Human skin displays localised variability in secretion content, local topography and thickness. Oily skin areas, such as the forehead, contain an increased abundance of sebaceous glands which release sebum onto the skin through the hair follicle canal and holocrine secretions [<xref rid="B22-microorganisms-11-01899" ref-type="bibr">22</xref>,<xref rid="B23-microorganisms-11-01899" ref-type="bibr">23</xref>]. Sebum is composed of a mixture of nonpolar lipids, such as wax esters, squalene and triglycerides, with the latter lipolysed into free fatty acids by resident microbiota [<xref rid="B24-microorganisms-11-01899" ref-type="bibr">24</xref>,<xref rid="B25-microorganisms-11-01899" ref-type="bibr">25</xref>,<xref rid="B26-microorganisms-11-01899" ref-type="bibr">26</xref>,<xref rid="B27-microorganisms-11-01899" ref-type="bibr">27</xref>,<xref rid="B28-microorganisms-11-01899" ref-type="bibr">28</xref>,<xref rid="B29-microorganisms-11-01899" ref-type="bibr">29</xref>,<xref rid="B30-microorganisms-11-01899" ref-type="bibr">30</xref>]. Sebum-derived fatty acids including sapienic acid maintain skin pH and exert a broad-spectrum antimicrobial action modulating skin microbiota composition. Community structure disruption is linked to inflammatory skin conditions like atopic dermatitis [<xref rid="B31-microorganisms-11-01899" ref-type="bibr">31</xref>,<xref rid="B32-microorganisms-11-01899" ref-type="bibr">32</xref>,<xref rid="B33-microorganisms-11-01899" ref-type="bibr">33</xref>]. Epidermal lipids secreted directly by keratinocytes filling in areas between squamous corneocytes act directly to minimise transepidermal evaporative water loss [<xref rid="B34-microorganisms-11-01899" ref-type="bibr">34</xref>]. </p><p>Perspiration occurs across nearly all bodily regions via sweat glands secreting saline-rich liquid onto the skin to facilitate evaporative thermoregulation [<xref rid="B35-microorganisms-11-01899" ref-type="bibr">35</xref>,<xref rid="B36-microorganisms-11-01899" ref-type="bibr">36</xref>]. The regional variation in human skin sites is further evidenced through variations in thickness, invaginations, moisture content and hair follicle density, among other factors (<xref rid="microorganisms-11-01899-f001" ref-type="fig">Figure 1</xref>), [<xref rid="B2-microorganisms-11-01899" ref-type="bibr">2</xref>].</p><fig position="anchor" id="microorganisms-11-01899-f001"><label>Figure 1</label><caption><p>Structure and microbial diversity of healthy human skin at distinct body areas. The microhabitats of the scalp, axilla (armpit), forearm and plantar heel are related to distinct secretion profiles associated with epidermal lipids, sebum and sweat. Lipid- and sebum-rich sites are associated with an increased proportion of lipophilic microorganism genera, namely, <italic toggle="yes">Cutibacterium</italic> and <italic toggle="yes">Malassezia.</italic> Sweat-rich regions display an abundance of halotolerant genera such as <italic toggle="yes">Staphylococcus</italic> and <italic toggle="yes">Corynebacterium</italic> [<xref rid="B1-microorganisms-11-01899" ref-type="bibr">1</xref>,<xref rid="B37-microorganisms-11-01899" ref-type="bibr">37</xref>]. Pie charts represent the abundance of bacterial and fungal genera at corresponding body sites adapted from several studies. Additionally, sites such as the plantar heel display a high degree of diversity across individuals [<xref rid="B2-microorganisms-11-01899" ref-type="bibr">2</xref>,<xref rid="B38-microorganisms-11-01899" ref-type="bibr">38</xref>,<xref rid="B39-microorganisms-11-01899" ref-type="bibr">39</xref>]. Created with <uri xlink:href="www.BioRender.com">www.BioRender.com</uri> (accessed on 4 April 2023).</p></caption><graphic xlink:href="microorganisms-11-01899-g001" position="float"/></fig></sec><sec id="sec3-microorganisms-11-01899"><title>3. Drivers of Skin Microbiome Community Structure</title><p>The human skin microbiome is governed by fundamental ecological principles relating to habitat, species interaction and community disruption. The skin environment contains an abundance of biological niches that vary in factors, including topography, lipid content, pH, salinity and moisture content alongside temporal changes from ageing and gender [<xref rid="B16-microorganisms-11-01899" ref-type="bibr">16</xref>,<xref rid="B40-microorganisms-11-01899" ref-type="bibr">40</xref>,<xref rid="B41-microorganisms-11-01899" ref-type="bibr">41</xref>]. Human skin is occupied by very diverse populations of bacteria, archaea, fungi, viruses and protists, with colonisation requiring specialisation and adaptation due to niche-specific microenvironments [<xref rid="B42-microorganisms-11-01899" ref-type="bibr">42</xref>,<xref rid="B43-microorganisms-11-01899" ref-type="bibr">43</xref>]. Resident skin microorganisms coevolved with competitors and their hosts, producing complex nutritional interdependencies and behavioural characteristics such as diverse antimicrobial biosynthesis [<xref rid="B2-microorganisms-11-01899" ref-type="bibr">2</xref>,<xref rid="B4-microorganisms-11-01899" ref-type="bibr">4</xref>,<xref rid="B44-microorganisms-11-01899" ref-type="bibr">44</xref>]. Given the range and variation in skin environments alongside differences in external factors, microorganisms are under a variety of abiotic and biotic selective pressures driving variation in stable community structures (<xref rid="microorganisms-11-01899-f002" ref-type="fig">Figure 2</xref>), [<xref rid="B3-microorganisms-11-01899" ref-type="bibr">3</xref>].</p></sec><sec id="sec4-microorganisms-11-01899"><title>4. Pathogenic Invasion and Community Disruption </title><p>The skin microbiome is susceptible to invasion by foreign organisms capable of disrupting the community equilibrium. Many human skin pathogens are generally considered commensal, with their opportunistic pathogenic behaviour evident when introduced into a new subsurface niche through environmental disturbance, such as a laceration [<xref rid="B46-microorganisms-11-01899" ref-type="bibr">46</xref>]. Commensals such as <italic toggle="yes">Staphylococcus epidermidis</italic> and <italic toggle="yes">Cutibacterium acnes</italic> provide host benefit through nutritional competition with pathogens, stimulating host antimicrobial peptide secretion and dampening nonpathogenic local immune system activation [<xref rid="B47-microorganisms-11-01899" ref-type="bibr">47</xref>,<xref rid="B48-microorganisms-11-01899" ref-type="bibr">48</xref>,<xref rid="B49-microorganisms-11-01899" ref-type="bibr">49</xref>]. Yet <italic toggle="yes">S. epidermidis</italic> and <italic toggle="yes">C. acnes</italic> represent common aetiological agents of nosocomial infections of immunocompromised patients, generally following medical device implantation and prosthetic joint surgery [<xref rid="B4-microorganisms-11-01899" ref-type="bibr">4</xref>,<xref rid="B50-microorganisms-11-01899" ref-type="bibr">50</xref>]. <italic toggle="yes">Staphylococcus aureus</italic> asymptomatic colonisation of the anterior nares is often causative of future systemic infection, a threat compounded by the feasibility of AMR strains competing with susceptible strains for dominance [<xref rid="B51-microorganisms-11-01899" ref-type="bibr">51</xref>]. The wide range of skin-relevant pathogens has been discussed in detail elsewhere [<xref rid="B52-microorganisms-11-01899" ref-type="bibr">52</xref>,<xref rid="B53-microorganisms-11-01899" ref-type="bibr">53</xref>,<xref rid="B54-microorganisms-11-01899" ref-type="bibr">54</xref>]. Current antibiotic treatment strategies are often ineffective given the recalcitrant nature of skin-pathogen-associated biofilms alongside the prevalence and continued dissemination of multiple antibiotic resistance elements [<xref rid="B55-microorganisms-11-01899" ref-type="bibr">55</xref>,<xref rid="B56-microorganisms-11-01899" ref-type="bibr">56</xref>,<xref rid="B57-microorganisms-11-01899" ref-type="bibr">57</xref>]. Mechanisms by which microorganisms interact directly influence the microbiota community structure, hence these mechanisms can be manipulated as a source of therapeutically and commercially relevant compounds.</p></sec><sec id="sec5-microorganisms-11-01899"><title>5. Therapeutically Relevant Skin-Microbiome-Derived Compounds</title><sec id="sec5dot1-microorganisms-11-01899"><title>5.1. Bacteriocins </title><p>Bacteriocins are a range of bacterial-derived peptides and proteins capable of exerting bacteriostatic and bactericidal activity. Bacteriocins act as competitive factors to inhibit the growth of adjacent organisms, akin to antibiotics, yet are associated with distinct resistance mechanisms and thus therapeutically relevant [<xref rid="B58-microorganisms-11-01899" ref-type="bibr">58</xref>]. Diversity in the structure of bacteriocins has evolved with variations in their molecular targets and breadth of host range [<xref rid="B59-microorganisms-11-01899" ref-type="bibr">59</xref>,<xref rid="B60-microorganisms-11-01899" ref-type="bibr">60</xref>,<xref rid="B61-microorganisms-11-01899" ref-type="bibr">61</xref>].</p><p>In contrast to broad-spectrum antibiotics, bacteriocin-based treatments could be tailored to the clearance of specific pathogenic organisms with minimal disruption to natural flora [<xref rid="B62-microorganisms-11-01899" ref-type="bibr">62</xref>,<xref rid="B63-microorganisms-11-01899" ref-type="bibr">63</xref>,<xref rid="B64-microorganisms-11-01899" ref-type="bibr">64</xref>,<xref rid="B65-microorganisms-11-01899" ref-type="bibr">65</xref>]. Hence, they are relevant in the treatment of nosocomial infections which are linked to unstable patient microbiomes and increased colonisation by reservoirs of highly antimicrobial-resistant pathogenic bacteria in the healthcare environment [<xref rid="B65-microorganisms-11-01899" ref-type="bibr">65</xref>,<xref rid="B66-microorganisms-11-01899" ref-type="bibr">66</xref>].</p><p>Bacteriocins have been identified as effector agents of bacterial antagonism, directing research to exploit their commercial and therapeutic activity [<xref rid="B67-microorganisms-11-01899" ref-type="bibr">67</xref>]. Commercial applications of bacteriocins have focused primarily on the preservation of meat, vegetables and dairy products through the prevention of the bacterial degradation of food [<xref rid="B68-microorganisms-11-01899" ref-type="bibr">68</xref>]. To date, Nisin derived from the dairy fermentative lactic acid bacterium <italic toggle="yes">Lactococcus lactis</italic> remains the sole Food and Drug Administration-approved bacteriocin with licensing in food preservation [<xref rid="B69-microorganisms-11-01899" ref-type="bibr">69</xref>]. The scope for the therapeutic use of bacteriocins is broad, ranging from infection treatments to oral hygiene products and spermicidal compounds. The therapeutic bacteriocin field has yet to fully target the potential of skin microbiome diversity, with studies needed to further the elucidation of the biosynthetic pathways, mechanisms of action and cost of production alongside tolerance in clinical trials [<xref rid="B70-microorganisms-11-01899" ref-type="bibr">70</xref>,<xref rid="B71-microorganisms-11-01899" ref-type="bibr">71</xref>,<xref rid="B72-microorganisms-11-01899" ref-type="bibr">72</xref>].</p><p>Studies of the nasal microbiome identified that coagulase-negative commensal staphylococci produce bacteriocins active against niche competitors [<xref rid="B73-microorganisms-11-01899" ref-type="bibr">73</xref>]. The skin and nasopharynx commensal <italic toggle="yes">S. lugdunensis</italic> synthesises lugdunin, which represents the first nonribosomal-produced antimicrobial identified within the human skin microbiome. Classified as a novel class of thiazolidine cyclic peptide bacteriocin termed fibupeptides, lugdunin inhibits the growth of several Gram-positive bacteria, including methicillin-resistant <italic toggle="yes">S. aureus</italic> (MRSA) [<xref rid="B74-microorganisms-11-01899" ref-type="bibr">74</xref>,<xref rid="B75-microorganisms-11-01899" ref-type="bibr">75</xref>,<xref rid="B76-microorganisms-11-01899" ref-type="bibr">76</xref>]. Lugdunin is proposed to exert antimicrobial activity through the disruption of the transmembrane pH gradient likely leading to intracellular protein denaturation and reduced proton motive force, directly inhibiting respiration [<xref rid="B74-microorganisms-11-01899" ref-type="bibr">74</xref>,<xref rid="B77-microorganisms-11-01899" ref-type="bibr">77</xref>,<xref rid="B78-microorganisms-11-01899" ref-type="bibr">78</xref>]. Lugdunin is further evidenced to increase the gene expression of several cutaneous antimicrobial peptides and induce the phagocytic recruitment of neutrophils and monocytes [<xref rid="B75-microorganisms-11-01899" ref-type="bibr">75</xref>]. A key driver of lugdunin research is the low propensity for resistance development in exposed bacteria, with one study identifying <italic toggle="yes">S. aureus</italic> as not developing resistance after several subinhibitory passages [<xref rid="B76-microorganisms-11-01899" ref-type="bibr">76</xref>].</p><p>The therapeutic translation of purified bacteriocins remains difficult due to several factors, such as serum half-life and immunogenicity. Protein engineering represents a promising area for redesigning bacteriocins towards their human use. An example comes from a study of the domesticated ruminant commensal <italic toggle="yes">Staphylococcus simulans</italic> that is associated with rare opportunistic infections in humans, such as endocarditis and erythema [<xref rid="B79-microorganisms-11-01899" ref-type="bibr">79</xref>,<xref rid="B80-microorganisms-11-01899" ref-type="bibr">80</xref>,<xref rid="B81-microorganisms-11-01899" ref-type="bibr">81</xref>]. <italic toggle="yes">S. simulans</italic> secretes the bacteriocin lysostaphin, an endopeptidase enzyme capable of pentaglycine bridge cleavage within the peptidoglycan of staphylococci. Lysostaphin exerts anti-<italic toggle="yes">S. aureus</italic> bactericidal activity regardless of planktonic, quiescent and biofilm-associated lifestyles [<xref rid="B82-microorganisms-11-01899" ref-type="bibr">82</xref>]. Lysostaphin immunogenicity represents a major barrier to clinical application. Protein engineering reduced lysostaphin immunogenicity through T-cell epitope removal alongside an increased serum half-life through polyethylene glycol and albumin conjugation [<xref rid="B83-microorganisms-11-01899" ref-type="bibr">83</xref>,<xref rid="B84-microorganisms-11-01899" ref-type="bibr">84</xref>,<xref rid="B85-microorganisms-11-01899" ref-type="bibr">85</xref>]. Various lysostaphin application vehicles have been effective versus <italic toggle="yes">S. aureus</italic> in vivo via intravaginal dissolvable tablets, emulsion-based topical gels and intravenous injection.</p><p>The viricidal, virostatic and food-preservative applications of certain bacteriocins have further been reported. For example, the gut commensal and rare skin pathogen <italic toggle="yes">Enterococcus faecium</italic> produces the bacteriocin CRL35, capable of the considerable inhibition of herpes simplex virus (HSV) 1/2 through late-stage protein-synthesis retardation in vitro [<xref rid="B86-microorganisms-11-01899" ref-type="bibr">86</xref>,<xref rid="B87-microorganisms-11-01899" ref-type="bibr">87</xref>,<xref rid="B88-microorganisms-11-01899" ref-type="bibr">88</xref>]. Antimicrobial properties of CRL35 have been demonstrated in vivo and been explored for use as a dairy food preservative via chitosan microencapsulation with a retainment of bactericidal activity [<xref rid="B89-microorganisms-11-01899" ref-type="bibr">89</xref>]. <italic toggle="yes">Bacillus subtilis</italic> can be found on skin and its bacteriocin subtilosin, a macrocyclic lantibiotic, is capable of the inhibition of both HSV-1 and 2 late-stage replication in addition to several bacteria associated with urinary tract infections [<xref rid="B90-microorganisms-11-01899" ref-type="bibr">90</xref>,<xref rid="B91-microorganisms-11-01899" ref-type="bibr">91</xref>,<xref rid="B92-microorganisms-11-01899" ref-type="bibr">92</xref>]. Further nonskin-bacteria-derived bacteriocins have potent antiviral activity, which highlights the scope for further investigation of the skin microbiome in this area [<xref rid="B90-microorganisms-11-01899" ref-type="bibr">90</xref>].</p><p>Most skin-relevant bacteriocins remain to be explored in preclinical development stages to assess pharmacological benefits. Several considerations must be addressed prior to the therapeutic and commercial applications of bacteriocins, including toxicity, biological half-life and the capacity for resistance development [<xref rid="B58-microorganisms-11-01899" ref-type="bibr">58</xref>]. Indeed, given the range of susceptibility spectrums for bacteriocins, there is a need to collect temporal data as a means to disfavour those with the potential to disrupt the skin microbiota community, where it may exacerbate or perpetuate inflammatory disorders [<xref rid="B67-microorganisms-11-01899" ref-type="bibr">67</xref>].</p></sec><sec id="sec5dot2-microorganisms-11-01899"><title>5.2. Bacteriophages</title><p>The virome remains an underappreciated area of the skin microbiome, with attention mostly limited to bacteriophages. In natural environments, bacteriophages are considered to modulate bacterial communities through the proliferation inhibition of dominant species, thereby maintaining diversity via predator&#x02013;prey coevolution [<xref rid="B93-microorganisms-11-01899" ref-type="bibr">93</xref>]. Research of the species-rich gut virome has revealed 10<sup>10</sup> bacteriophages per gram of faecal material, with variations indicating complex ecological interactions [<xref rid="B94-microorganisms-11-01899" ref-type="bibr">94</xref>,<xref rid="B95-microorganisms-11-01899" ref-type="bibr">95</xref>]. Skin metagenome analyses have highlighted the breadth of phages associated with the predominant skin bacterial genera <italic toggle="yes">Staphylococcus, Cutibacterium</italic> and <italic toggle="yes">Streptococcus</italic> [<xref rid="B96-microorganisms-11-01899" ref-type="bibr">96</xref>,<xref rid="B97-microorganisms-11-01899" ref-type="bibr">97</xref>]. This repertoire represents a rich source of potentially therapeutic bacteriophages.</p><p>A principal translational pathway for the therapeutic use of lytic bacteriophages is to clear pathogens from infected tissue [<xref rid="B98-microorganisms-11-01899" ref-type="bibr">98</xref>]. Phages exert bactericidal activity with typical strain specificity for infection through the interaction with bacterial cell surface structures, such as lipopolysaccharide or teichoic acid [<xref rid="B99-microorganisms-11-01899" ref-type="bibr">99</xref>,<xref rid="B100-microorganisms-11-01899" ref-type="bibr">100</xref>]. The genetic manipulation of phage&#x02013;bacteria determinant regions has been extensively studied, thereby improving the effectiveness of this strategy for the treatment of AMR infections [<xref rid="B101-microorganisms-11-01899" ref-type="bibr">101</xref>,<xref rid="B102-microorganisms-11-01899" ref-type="bibr">102</xref>,<xref rid="B103-microorganisms-11-01899" ref-type="bibr">103</xref>].</p><p>Multiple bacteriophages are reportedly being explored for phage therapy for various manifestations of skin-associated pathogens. Support for clinical research comes from phage therapy success for skin infections of <italic toggle="yes">Mycobacterium chelonae</italic> and multiple-drug resistant (MDR) <italic toggle="yes">Pseudomonas aeruginosa</italic> [<xref rid="B104-microorganisms-11-01899" ref-type="bibr">104</xref>,<xref rid="B105-microorganisms-11-01899" ref-type="bibr">105</xref>]. Topical bacteriophage therapy targeting <italic toggle="yes">C. acnes</italic> has advanced to phase I clinical trials after displaying efficacy in reducing <italic toggle="yes">C. acnes</italic> abundance without significant safety concerns [<xref rid="B106-microorganisms-11-01899" ref-type="bibr">106</xref>]. Screening studies isolated seven distinct bacteriophages effective against <italic toggle="yes">S. epidermidis</italic> albeit with highly variable strain-specific resistance profiles [<xref rid="B107-microorganisms-11-01899" ref-type="bibr">107</xref>]. Combinations of <italic toggle="yes">S. epidermidis</italic> with <italic toggle="yes">S. aureus</italic>-specific phages were demonstrated to suppress phage-resistant mutants of <italic toggle="yes">S. aureus</italic> in a skin model of atopic dermatitis [<xref rid="B108-microorganisms-11-01899" ref-type="bibr">108</xref>].</p><p>More than 10 clinical trials were in various stages of completion by early 2023 investigating the efficacy of bacteriophage therapy for the treatment of musculoskeletal, skin and soft tissue infections [<xref rid="B109-microorganisms-11-01899" ref-type="bibr">109</xref>]. Previous trials supported the high safety of phage therapy with varying efficacy arising from delivery mechanisms and phage stability [<xref rid="B110-microorganisms-11-01899" ref-type="bibr">110</xref>]. For example, PhagoBurn is a phage-treated wound dressing found safe yet ineffective in phase I/II clinical trials at reducing <italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">Pseudomonas aeruginosa</italic> burdens, likely through insufficient dosing. The foundation is established, however, for future phage-mediated skin infection trials using phage lysins, liposome-encapsulated phage cocktails and antibiotic phage combinatorial therapy [<xref rid="B111-microorganisms-11-01899" ref-type="bibr">111</xref>].</p><p>A topical bacteriophage cocktail therapy for acne, BX001, demonstrated significant <italic toggle="yes">C. acnes</italic> abundance reduction in phase I cosmetic clinical trials. The evidence implicates the IA-1 <italic toggle="yes">C. acnes</italic> phylotype as an opportunistic pathogen of the pilosebaceous unit by stimulating a localised proinflammatory response leading to acne lesions, meaning such treatment has utility [<xref rid="B112-microorganisms-11-01899" ref-type="bibr">112</xref>]. Direct modulation of skin microbiome composition through targeted phage therapy may yield novel skin treatment strategies from wound healing to eczema [<xref rid="B108-microorganisms-11-01899" ref-type="bibr">108</xref>,<xref rid="B113-microorganisms-11-01899" ref-type="bibr">113</xref>,<xref rid="B114-microorganisms-11-01899" ref-type="bibr">114</xref>,<xref rid="B115-microorganisms-11-01899" ref-type="bibr">115</xref>]. A sufficient knowledge of multiple phages with distinct cellular targets is required to mitigate the capacity for phage resistance alongside a physiochemical knowledge of product formulations slowing product development [<xref rid="B116-microorganisms-11-01899" ref-type="bibr">116</xref>].</p><p>An appreciation of safety concerns is necessary for the responsible translation of bacteriophages into clinical use. Wildtype phages are classified in relation to their infection cycles, with temperate phages associated with prophage genomic integration and maintenance, whilst obligate lytic phages are associated with direct cellular lysis following infection [<xref rid="B117-microorganisms-11-01899" ref-type="bibr">117</xref>,<xref rid="B118-microorganisms-11-01899" ref-type="bibr">118</xref>]. Phage therapy focuses on obligate lytic phages to circumvent toxin production, integration and insertional mutagenesis [<xref rid="B119-microorganisms-11-01899" ref-type="bibr">119</xref>]. Temperate phage insertions are experimentally evidenced in some cases to facilitate the mobilisation of pathogenicity islands and associated antibiotic resistance and superantigen genes in <italic toggle="yes">S. aureus</italic>, thereby limiting their translation by promoting virulence and treatment resistance [<xref rid="B120-microorganisms-11-01899" ref-type="bibr">120</xref>,<xref rid="B121-microorganisms-11-01899" ref-type="bibr">121</xref>]. Strategies to circumvent inherent phage limitations include the modification of phage DNA to encode CRISPR-Cas9 systems that resensitise resistant bacteria to antibiotic treatments or bactericidal toxins [<xref rid="B122-microorganisms-11-01899" ref-type="bibr">122</xref>]. Bacteriophage endolysins targeting specific cell wall lysis are a promising alternative to hindrances associated with bacteriophage therapy by removing the replicative cycle of phages, albeit with higher production costs [<xref rid="B123-microorganisms-11-01899" ref-type="bibr">123</xref>]. Endolysins available commercially include the eczema treatment Gladskin Micreobalance<sup>&#x000ae;</sup> with considerable mitigation of <italic toggle="yes">S. aureus</italic>-associated atopic dermatitis [<xref rid="B124-microorganisms-11-01899" ref-type="bibr">124</xref>].</p></sec><sec id="sec5dot3-microorganisms-11-01899"><title>5.3. Cutaneous Lipids</title><p>Cutaneous fatty acids impart multiple functions for the host, namely, microbial growth inhibition through a reduction in skin pH alongside direct antimicrobial activity, whilst simultaneously promoting commensal adherence [<xref rid="B2-microorganisms-11-01899" ref-type="bibr">2</xref>]. Skin fatty acids are produced through the hydrolysis of epidermal and sebaceous triglycerides, with activity predominantly facilitated through the extracellular lipase secretion of commensals, such as <italic toggle="yes">Cutibacterium</italic> spp. and <italic toggle="yes">Staphylococcus</italic> spp. [<xref rid="B125-microorganisms-11-01899" ref-type="bibr">125</xref>,<xref rid="B126-microorganisms-11-01899" ref-type="bibr">126</xref>,<xref rid="B127-microorganisms-11-01899" ref-type="bibr">127</xref>]. Fatty acids further function as signalling molecules capable of diminishing proinflammatory cytokine induction in keratinocytes associated with allergic dermis reactions through free fatty acid receptor 1 activation [<xref rid="B128-microorganisms-11-01899" ref-type="bibr">128</xref>]. Triglyceride degradation liberates glycerol, a potent humectant that supports corneocyte desquamation from corneodesosome cleavage, thereby stimulating the recovery of irritated skin [<xref rid="B26-microorganisms-11-01899" ref-type="bibr">26</xref>,<xref rid="B129-microorganisms-11-01899" ref-type="bibr">129</xref>,<xref rid="B130-microorganisms-11-01899" ref-type="bibr">130</xref>]. The microbial fermentation of glycerol with the production of fatty acids, namely lactic acid, promotes an acidic pH and the upregulated gene expression of essential skin barrier proteins in keratinocytes [<xref rid="B131-microorganisms-11-01899" ref-type="bibr">131</xref>]. Topical formulations of certain skin lipids have the potential for therapeutic use due to their range of activity and antimicrobial activity. Sphingosine and sapienic acid show potent activity towards staphylococci [<xref rid="B11-microorganisms-11-01899" ref-type="bibr">11</xref>,<xref rid="B31-microorganisms-11-01899" ref-type="bibr">31</xref>,<xref rid="B132-microorganisms-11-01899" ref-type="bibr">132</xref>]. Skin lipids represent an avenue for therapeutic application, and studies indicate a potential use for sapienic acid as a stable antimicrobial in cosmetic products [<xref rid="B31-microorganisms-11-01899" ref-type="bibr">31</xref>,<xref rid="B132-microorganisms-11-01899" ref-type="bibr">132</xref>,<xref rid="B133-microorganisms-11-01899" ref-type="bibr">133</xref>].</p></sec><sec id="sec5dot4-microorganisms-11-01899"><title>5.4. Biofilm Inhibitors</title><p>Microorganisms aggregate into biofilms through the secretion of matrix proteins, polysaccharides and DNA, with the structures considered a dominant growth mechanism by members of the skin microbiome [<xref rid="B134-microorganisms-11-01899" ref-type="bibr">134</xref>,<xref rid="B135-microorganisms-11-01899" ref-type="bibr">135</xref>]. Biofilms convey many benefits to their community with decreases in both immune system stimulation and antimicrobial uptake through metabolic dormancy [<xref rid="B136-microorganisms-11-01899" ref-type="bibr">136</xref>]. Many opportunistic skin pathogens form monomicrobial biofilms, e.g., <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">C. acnes</italic> and <italic toggle="yes">S. epidermidis</italic>. Notably, <italic toggle="yes">S. aureus</italic> biofilms are prevalent in atopic dermatitis, with a correlation between abundance and disease severity [<xref rid="B137-microorganisms-11-01899" ref-type="bibr">137</xref>]. <italic toggle="yes">C. acnes</italic> and <italic toggle="yes">S. epidermidis</italic> biofilms are associated with medical-implant-associated infection, often leading to systemic bacteraemia in immunocompromised individuals [<xref rid="B138-microorganisms-11-01899" ref-type="bibr">138</xref>,<xref rid="B139-microorganisms-11-01899" ref-type="bibr">139</xref>,<xref rid="B140-microorganisms-11-01899" ref-type="bibr">140</xref>]. Given the clinical relevance of biofilm-associated infection, novel therapeutics are necessary to circumvent the treatment resistance of these bacterial aggregates.</p><p>Resident skin flora exerts antagonistic interactions to limit biofilm formation and integrity through the production of antibiofilm agents. <italic toggle="yes">S. epidermidis</italic> secretes a serine protease, Esp, evidenced to disassemble MRSA biofilms by degrading several proteins for cell wall and biofilm formation. Esp can degrade human receptors utilised by <italic toggle="yes">S. aureus</italic> for adherence, such as fibronectin to convey colonisation resistance [<xref rid="B141-microorganisms-11-01899" ref-type="bibr">141</xref>,<xref rid="B142-microorganisms-11-01899" ref-type="bibr">142</xref>,<xref rid="B143-microorganisms-11-01899" ref-type="bibr">143</xref>]. Moreover, a <italic toggle="yes">S. epidermidis</italic> protease-independent biofilm inhibitor is effective against a range of MRSA and methicillin-susceptible <italic toggle="yes">S. aureus</italic> (MSSA) without reducing cell viability. This uncharacterised biofilm inhibitor was proposed to be a phenol-soluble modulin (PSM) likely functioning through the inhibition of the polysaccharide adhesion operon [<xref rid="B144-microorganisms-11-01899" ref-type="bibr">144</xref>,<xref rid="B145-microorganisms-11-01899" ref-type="bibr">145</xref>,<xref rid="B146-microorganisms-11-01899" ref-type="bibr">146</xref>].</p><p>The lipophilic, aerotolerant commensal <italic toggle="yes">Cutibacterium acnes</italic> can reside in pilosebaceous units, and its secreted lipases hydrolyse triglycerides, releasing short-chain fatty acids (SCFAs) resulting in local pH reduction and the inhibition of competing bacteria, stabilising niche occupation [<xref rid="B147-microorganisms-11-01899" ref-type="bibr">147</xref>]. Additional beneficial functions of <italic toggle="yes">C. acnes</italic> include the secretion of antioxidant enzymes and in vivo antitumoral properties [<xref rid="B49-microorganisms-11-01899" ref-type="bibr">49</xref>,<xref rid="B148-microorganisms-11-01899" ref-type="bibr">148</xref>]. However, sebum-derived SCFAs may also induce proinflammatory gene expression in keratinocytes and sebocytes within the pilosebaceous unit that likely drive acne vulgaris manifestations [<xref rid="B149-microorganisms-11-01899" ref-type="bibr">149</xref>,<xref rid="B150-microorganisms-11-01899" ref-type="bibr">150</xref>]. SCFAs further inhibit the polysaccharide biofilm formation of <italic toggle="yes">S. epidermidis</italic> at physiological concentrations whilst simultaneously increasing susceptibility to both ampicillin and doxycycline [<xref rid="B151-microorganisms-11-01899" ref-type="bibr">151</xref>]. SCFAs are being explored within the gut microbiome given their significant potential for inflammatory and immune diseases, with a likely relevance to cutaneous homeostasis [<xref rid="B152-microorganisms-11-01899" ref-type="bibr">152</xref>,<xref rid="B153-microorganisms-11-01899" ref-type="bibr">153</xref>,<xref rid="B154-microorganisms-11-01899" ref-type="bibr">154</xref>].</p></sec><sec id="sec5dot5-microorganisms-11-01899"><title>5.5. Quorum Sensing Modulators</title><p>The survival of bacterial communities requires constant environmental adaptation to selective pressures [<xref rid="B155-microorganisms-11-01899" ref-type="bibr">155</xref>]. Quorum sensing (QS) systems mediate cell-to-cell communication to bring about a coordinated change in gene expression producing a community beneficial behaviour [<xref rid="B156-microorganisms-11-01899" ref-type="bibr">156</xref>]. QS relies upon the secretion of autoinducer compounds at subthreshold levels that diffuse into the extracellular environment where the autoinducer concentration is linked with bacterial population density. The post-threshold autoinducer activates signal transduction to a transcription factor(s) that drive(s) regulon expression [<xref rid="B157-microorganisms-11-01899" ref-type="bibr">157</xref>,<xref rid="B158-microorganisms-11-01899" ref-type="bibr">158</xref>,<xref rid="B159-microorganisms-11-01899" ref-type="bibr">159</xref>,<xref rid="B160-microorganisms-11-01899" ref-type="bibr">160</xref>].</p><p>QS products such as extracellular proteases have a metabolic expense but provide community level fitness benefits, hence collaborative production acts to limit individual cost [<xref rid="B161-microorganisms-11-01899" ref-type="bibr">161</xref>]. Many QS-mediated products are virulence factors that facilitate processes such as biofilm formation, integrity promotion and dispersal associated with systemic disease progression [<xref rid="B160-microorganisms-11-01899" ref-type="bibr">160</xref>,<xref rid="B162-microorganisms-11-01899" ref-type="bibr">162</xref>]. In recent years, analogous quorum-sensing-like systems were identified in fungi and bacteriophages, highlighting the significance of microbial communication in microbiota present on the skin [<xref rid="B163-microorganisms-11-01899" ref-type="bibr">163</xref>,<xref rid="B164-microorganisms-11-01899" ref-type="bibr">164</xref>]. </p><p>The secretion of QS inhibitors represents a form of antagonism common within the skin microbiome that has potential therapeutic translatability. Various commensal staphylococci, including <italic toggle="yes">S. epidermidis</italic>, <italic toggle="yes">S. hominis</italic> and <italic toggle="yes">S. simulans</italic>, secrete inhibitors of the <italic toggle="yes">S. aureus</italic> accessory gene regulator (agr) that interfere with colonisation and virulence [<xref rid="B165-microorganisms-11-01899" ref-type="bibr">165</xref>,<xref rid="B166-microorganisms-11-01899" ref-type="bibr">166</xref>]. <italic toggle="yes">S. hominis</italic> autoinducer peptides (AIPs) were shown to quench accessory gene regulatory (agr) QS systems of MRSA, with AIP-2 providing protection from <italic toggle="yes">S. aureus</italic> necrosis and skin damage [<xref rid="B167-microorganisms-11-01899" ref-type="bibr">167</xref>]. <italic toggle="yes">Staphylococcus warneri</italic> produces AIP-1 and AIP-2 capable of the dose-dependent inhibition of <italic toggle="yes">S. epidermidis</italic> agr-1 and all agr of <italic toggle="yes">S. aureus</italic>, reducing virulence factor production and providing protection against associated skin barrier damage [<xref rid="B168-microorganisms-11-01899" ref-type="bibr">168</xref>].</p><p>Since pathogenic bacteria often utilise QS to stimulate biofilm formation, many QS inhibitors have a translational application in the treatment of recalcitrant biofilm infections derived from the human skin [<xref rid="B169-microorganisms-11-01899" ref-type="bibr">169</xref>,<xref rid="B170-microorganisms-11-01899" ref-type="bibr">170</xref>]. The skin commensal <italic toggle="yes">Staphylococcus xylosus</italic> expresses an RNAIII-inhibiting peptide (RIP) that inhibits QS-associated signal transduction pathways. RIP is a potent inhibitor of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">S. epidermidis</italic> biofilm formation proteins [<xref rid="B171-microorganisms-11-01899" ref-type="bibr">171</xref>,<xref rid="B172-microorganisms-11-01899" ref-type="bibr">172</xref>,<xref rid="B173-microorganisms-11-01899" ref-type="bibr">173</xref>]. Moreover, RIP treatment displayed both an in vitro inhibition of <italic toggle="yes">S. aureus</italic> adhesion and efficacy in the treatment of <italic toggle="yes">S. aureus</italic> murine infection models [<xref rid="B173-microorganisms-11-01899" ref-type="bibr">173</xref>,<xref rid="B174-microorganisms-11-01899" ref-type="bibr">174</xref>].</p></sec><sec id="sec5dot6-microorganisms-11-01899"><title>5.6. Fungicidal Compounds</title><p>The cutaneous mycobiome is less well studied as the fungal component that colonises human skin. The mycobiome becomes established following birth with compositional changes associated with extrinsic and intrinsic factors comparable with the microbiome as a whole. Skin fungal dysbiosis correlates with common cutaneous disorders, such as dandruff, atopic dermatitis and pityriasis versicolor [<xref rid="B175-microorganisms-11-01899" ref-type="bibr">175</xref>,<xref rid="B176-microorganisms-11-01899" ref-type="bibr">176</xref>,<xref rid="B177-microorganisms-11-01899" ref-type="bibr">177</xref>]. Fungal pathogen emergence is underrecognised in contrast to the antimicrobial resistance of bacterial pathogens and viral pathogen resurgence [<xref rid="B178-microorganisms-11-01899" ref-type="bibr">178</xref>,<xref rid="B179-microorganisms-11-01899" ref-type="bibr">179</xref>]. Problematically, fungal infection treatment is generally limited to just four classes of compounds, which can often be unsuccessful due to resistance development that highlights the necessity of novel antifungal compounds [<xref rid="B180-microorganisms-11-01899" ref-type="bibr">180</xref>,<xref rid="B181-microorganisms-11-01899" ref-type="bibr">181</xref>].</p><p>The predominant genus of the human cutaneous mycobiome is <italic toggle="yes">Malassezia</italic>, which was recently identified to have a greater breadth of species from metagenomic studies, albeit species that remain uncultured [<xref rid="B182-microorganisms-11-01899" ref-type="bibr">182</xref>]. <italic toggle="yes">Malassezia</italic> can produce indole compounds for nitrogen acquisition through tryptophan metabolism [<xref rid="B183-microorganisms-11-01899" ref-type="bibr">183</xref>]. <italic toggle="yes">Malassezia</italic> indoles display broad-spectrum fungicidal properties, effective against pathogenic yeasts and moulds at skin-relevant concentrations in vitro [<xref rid="B184-microorganisms-11-01899" ref-type="bibr">184</xref>]. <italic toggle="yes">Malassezia furfur</italic> produces several indoles, such as indolo [<xref rid="B2-microorganisms-11-01899" ref-type="bibr">2</xref>,<xref rid="B3-microorganisms-11-01899" ref-type="bibr">3</xref>] carbazole, which inhibits <italic toggle="yes">Candida</italic> spp. and other <italic toggle="yes">Malassezia</italic> spp. at concentrations less than 6 ug/mL [<xref rid="B184-microorganisms-11-01899" ref-type="bibr">184</xref>,<xref rid="B185-microorganisms-11-01899" ref-type="bibr">185</xref>]. Known ligands of aryl hydrocarbon receptors, these indoles can result in the induction of proinflammatory responses, drastically limiting their therapeutic prospects [<xref rid="B186-microorganisms-11-01899" ref-type="bibr">186</xref>].</p><p>Several commensal bacteria inhibit <italic toggle="yes">Candida albicans</italic> colonisation within the cutaneous environment. <italic toggle="yes">S. epidermidis</italic> stimulates the production of specific CD8+ T cells via localised dendritic cell activation, resulting in an improved protection against <italic toggle="yes">Candida albicans</italic> infection through enhanced innate defence systems [<xref rid="B187-microorganisms-11-01899" ref-type="bibr">187</xref>]. <italic toggle="yes">S. epidermidis</italic> stimulates the primary keratinocyte production of human antimicrobial peptides beta defensin 1&#x02013;3 in a Toll-like receptor-2-associated manner [<xref rid="B177-microorganisms-11-01899" ref-type="bibr">177</xref>,<xref rid="B188-microorganisms-11-01899" ref-type="bibr">188</xref>]. <italic toggle="yes">Lactobacillus</italic> spp. that are abundant within the vaginal microbiome produce lactic acid and SCFA resulting in vaginal acidification that inhibits the <italic toggle="yes">C. albicans</italic> yeast&#x02013;hyphae transition [<xref rid="B189-microorganisms-11-01899" ref-type="bibr">189</xref>]. Such hyphal transition represents a key virulence strategy of <italic toggle="yes">C. albicans</italic> required for mucosal invasion and systemic dissemination [<xref rid="B190-microorganisms-11-01899" ref-type="bibr">190</xref>]. Several postulated antifungal benefits of vaginal lactobacilli are related to colonisation resistance through strong adhesion and biofilm formation upon mucosal membranes and free-radical secretion increasing mucus cohesion [<xref rid="B191-microorganisms-11-01899" ref-type="bibr">191</xref>]. Indeed, vaginal probiotics are commercialised with <italic toggle="yes">Lactobacillus</italic>-based Canesten Canesflor<sup>&#x000ae;</sup>, demonstrating the potential of developing probiotics for fungal infections. The antifungal potential of <italic toggle="yes">Saccharomyces cerevisiae</italic> and <italic toggle="yes">Candida</italic> spp. was demonstrated in vitro to inhibit biofilm formation and hyphal transition in <italic toggle="yes">C. albicans</italic>, highlighting the need for future probiotic research [<xref rid="B192-microorganisms-11-01899" ref-type="bibr">192</xref>]. </p></sec><sec id="sec5dot7-microorganisms-11-01899"><title>5.7. Skin Cancer Treatments</title><p>The development of novel cancer treatments represents an unequivocally imperative task for modern health science. The significance of cancer is highlighted through the rapid growth in global morbidity and mortality, representing a leading cause of premature deaths in an estimated 60% of countries as of 2021 [<xref rid="B193-microorganisms-11-01899" ref-type="bibr">193</xref>,<xref rid="B194-microorganisms-11-01899" ref-type="bibr">194</xref>].</p><p>Within cancerous tumours exists a distinct microenvironment, and the microbiome can alter both progression and treatment resistance. Multiple associations were identified between the prevalence of individual skin microbiome members and specific skin cancers, such as <italic toggle="yes">S. aureus</italic> within squamous cell carcinoma skin biopsies [<xref rid="B195-microorganisms-11-01899" ref-type="bibr">195</xref>]. A causative relationship between skin microbiome members and skin cancers is proposed to occur through the induction of proinflammatory responses, which links to an apparent increased risk of skin cancer with skin-microbiome-associated disorders [<xref rid="B196-microorganisms-11-01899" ref-type="bibr">196</xref>,<xref rid="B197-microorganisms-11-01899" ref-type="bibr">197</xref>,<xref rid="B198-microorganisms-11-01899" ref-type="bibr">198</xref>,<xref rid="B199-microorganisms-11-01899" ref-type="bibr">199</xref>]. There is a necessity to investigate the intentional modification of skin tumour microbiomes to mitigate the risks associated with skin cancer development given the previously described rich source of bactericidal products [<xref rid="B195-microorganisms-11-01899" ref-type="bibr">195</xref>]. The characterisation of the skin microbiome has so far revealed several compounds displaying potential antioncogenic activity capable of increasing the available therapies to clinical professionals.</p><p>The metabolic analysis of <italic toggle="yes">S. epidermidis</italic> skin isolates revealed the trait variable production of 6-N-hydroxyaminopurine (6-HAP), a hydroxylamine adenine analogue with mutagenic and teratogenic activity [<xref rid="B200-microorganisms-11-01899" ref-type="bibr">200</xref>,<xref rid="B201-microorganisms-11-01899" ref-type="bibr">201</xref>]. 6-HAP displayed an in vitro selective inhibition of lymphoma and melanoma tumour cell line proliferation whilst exerting relatively little effect on an epidermal keratinocyte cell line. <italic toggle="yes">S. epidermidis</italic>-producing 6-HAP is prevalent in the human skin microbiome, and these strains exerted a significant inhibition of ultraviolet-associated neoplasia generation in vivo [<xref rid="B202-microorganisms-11-01899" ref-type="bibr">202</xref>]. The antioncogenic properties of 6-HAP have been questioned based on the characterisation of commercially sourced versus commensal-produced 6-HAP [<xref rid="B203-microorganisms-11-01899" ref-type="bibr">203</xref>,<xref rid="B204-microorganisms-11-01899" ref-type="bibr">204</xref>]. The therapeutic potential of 6-HAP is contingent on the further translation to in vivo models alongside the elucidation of its mechanism of action, prior to its application in cancer treatment and prevention.</p><p>Commensal <italic toggle="yes">Malassezia</italic> spp. synthesise indirubin, a compound capable of potent aryl hydrocarbon receptor (AHR) agonism, with a proposed competitive inhibition of cyclin-dependent kinases associated with cell cycle modulation, resulting in cell cycle arrest [<xref rid="B205-microorganisms-11-01899" ref-type="bibr">205</xref>]. Further antioncogenic mechanisms of indirubin have been discussed in detail elsewhere [<xref rid="B206-microorganisms-11-01899" ref-type="bibr">206</xref>]. Despite the apparent commensality of <italic toggle="yes">Malassezia</italic> spp., opportunistic pathogenesis is associated with several conditions, such as dermatitis, supporting the application of topical probiotic formulations, i.e., for treatment of skin cancers [<xref rid="B207-microorganisms-11-01899" ref-type="bibr">207</xref>].</p><p>Bacteriocins represent an attractive source of antioncogenic compounds arising from their specificity, nontoxicity and abundance within the skin microbiome [<xref rid="B208-microorganisms-11-01899" ref-type="bibr">208</xref>]. Pyocins (bacteriocins produced by the genus <italic toggle="yes">Pseudomonas</italic>) of the transient opportunistic pathogen <italic toggle="yes">Pseudomonas aeruginosa</italic> selectively inhibit the proliferation of human hepatoma, B lymphocyte and murine fibroblast cell lines [<xref rid="B209-microorganisms-11-01899" ref-type="bibr">209</xref>,<xref rid="B210-microorganisms-11-01899" ref-type="bibr">210</xref>]. The antioncogenic activity of bacteriocins produced by skin-relevant pathogens has been described, such as <italic toggle="yes">Klebsiella pneumoniae</italic>-derived microcin E492; however, the therapeutic potential of skin-microbiome-derived bacteriocins remains unexplored [<xref rid="B208-microorganisms-11-01899" ref-type="bibr">208</xref>]. Moreover, investigations of the antioncogenic activity of bacteriocins are largely limited to in vitro cell lines, illustrating the necessity for in vivo studies and considerations of the reported limitations of the therapeutic utilisation of bacteriocins.</p><p>Many anticancer therapeutic compounds are limited by the development of resistance in target cells alongside nonselective cell targeting, resulting in multiple adverse side effects. The selective and distinct functional mechanisms of bacteriocins highlight their therapeutic application potential [<xref rid="B209-microorganisms-11-01899" ref-type="bibr">209</xref>]. Several methods were discussed to feasibly increase bacteriocin therapeutic activity, for example, the conjugation to nanoparticles for synergistic drug delivery facilitating a lower therapeutic dosage [<xref rid="B211-microorganisms-11-01899" ref-type="bibr">211</xref>]. Additionally, many common oral probiotic compounds are associated with the production of bacteriocins with considerable anticancer activity, highlighting the need for parallel investigations with topical probiotics or purified compounds [<xref rid="B209-microorganisms-11-01899" ref-type="bibr">209</xref>].</p></sec></sec><sec id="sec6-microorganisms-11-01899"><title>6. Skin Microbiome Applications in Personal Care Products</title><p>Personal care products represent a considerable proportion of the global economy, with a total estimated market valuation of over USD 500 billion in 2022 and a predicted annual growth rate of over 6% [<xref rid="B212-microorganisms-11-01899" ref-type="bibr">212</xref>]. Within this growth potential, the skin microbiome has many demonstratable applications for personal care product development and many areas for future investigations.</p><p>The composition and stability of an individual&#x02019;s skin microbiota is paramount for the maintenance of cutaneous homeostasis through functions such as pathogenic colonisation resistance [<xref rid="B2-microorganisms-11-01899" ref-type="bibr">2</xref>]. A growing body of evidence correlates skin microbiota composition with biophysical skin properties alongside the perpetuation and onset of skin conditions [<xref rid="B16-microorganisms-11-01899" ref-type="bibr">16</xref>,<xref rid="B40-microorganisms-11-01899" ref-type="bibr">40</xref>,<xref rid="B213-microorganisms-11-01899" ref-type="bibr">213</xref>,<xref rid="B214-microorganisms-11-01899" ref-type="bibr">214</xref>,<xref rid="B215-microorganisms-11-01899" ref-type="bibr">215</xref>,<xref rid="B216-microorganisms-11-01899" ref-type="bibr">216</xref>,<xref rid="B217-microorganisms-11-01899" ref-type="bibr">217</xref>]. Hence, the reshaping of the skin microbiota community structure and utilisation of isolated effector compounds represent a significant area for commercial product development [<xref rid="B218-microorganisms-11-01899" ref-type="bibr">218</xref>]. The viability of such products is shown by the prevalence of novel topical probiotics in the personal care market alongside the renowned success of parallel gut probiotics.</p><sec id="sec6dot1-microorganisms-11-01899"><title>6.1. Acne Vulgaris</title><p>The key microbial component of acne pathophysiology is linked to the obstruction of the sebaceous gland leading to sebum accumulation, resulting in <italic toggle="yes">C. acnes</italic> extracellular lipases creating proinflammatory SCFAs [<xref rid="B219-microorganisms-11-01899" ref-type="bibr">219</xref>,<xref rid="B220-microorganisms-11-01899" ref-type="bibr">220</xref>,<xref rid="B221-microorganisms-11-01899" ref-type="bibr">221</xref>]. Several clinical trials have demonstrated probiotics cause <italic toggle="yes">C. acnes</italic> inhibition leading to reduced acne severity. A topical mixture of <italic toggle="yes">E. faecalis</italic> and <italic toggle="yes">Lactobacillus</italic> sp. applied bidaily resulted in reductions in acne lesions, proposedly resultant of <italic toggle="yes">C. acnes</italic> inhibition and reduced proinflammatory factor production. Similarly, trials utilising aqueous <italic toggle="yes">Lactobacillus plantarum</italic> probiotics demonstrated dosage-dependent reductions in lesion size [<xref rid="B222-microorganisms-11-01899" ref-type="bibr">222</xref>]. To date, these trials have had a small cohort of less than 100 people, inviting larger studies to support the confidence and reliability of such products [<xref rid="B223-microorganisms-11-01899" ref-type="bibr">223</xref>,<xref rid="B224-microorganisms-11-01899" ref-type="bibr">224</xref>]. Skin probiotics capable of reducing acne manifestations include products recently released to the market, such as those from Yun probiotherapy, indicating the growth of such probiotic markets [<xref rid="B225-microorganisms-11-01899" ref-type="bibr">225</xref>].</p></sec><sec id="sec6dot2-microorganisms-11-01899"><title>6.2. Atopic Dermatitis</title><p>Atopic dermatitis (AD) is the most common inflammatory skin disorder globally and is associated with pruritic and desiccated inflamed lesions, arising from various inheritable mutations in skin barrier proteins and allergen-specific immunological defects [<xref rid="B226-microorganisms-11-01899" ref-type="bibr">226</xref>,<xref rid="B227-microorganisms-11-01899" ref-type="bibr">227</xref>]. AD cutaneous dysbiosis is characterised by an increased abundance of staphylococci such as <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Malassezia</italic> spp. which perpetuates AD manifestation and its severity through the secretion of virulence factors (e.g., toxins) and cytokine-inducing nanovesicles, respectively [<xref rid="B228-microorganisms-11-01899" ref-type="bibr">228</xref>,<xref rid="B229-microorganisms-11-01899" ref-type="bibr">229</xref>,<xref rid="B230-microorganisms-11-01899" ref-type="bibr">230</xref>]. Nakatsuji et al. identified that in a small cohort study, the transplantation of specific antimicrobial peptide-producing <italic toggle="yes">S. epidermidis</italic> and <italic toggle="yes">S. hominis</italic> strains yielded considerable reductions in <italic toggle="yes">S. aureus</italic> abundance in AD patients [<xref rid="B228-microorganisms-11-01899" ref-type="bibr">228</xref>]. Such promise means further investigations with a larger cohort size and an understanding of the longer-term persistence of transplanted strains with the effect of repeat applications is necessary to further unlock their clear potential. The effects of bacterial extracts of <italic toggle="yes">Vitreoscilla filiformis</italic>, <italic toggle="yes">Streptococcus thermophilus</italic> and <italic toggle="yes">Lactobacillus johnsonii</italic> have yielded a promising mitigation of AD severity, likely through an antagonistic action upon <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Malassezia</italic> [<xref rid="B231-microorganisms-11-01899" ref-type="bibr">231</xref>].</p></sec><sec id="sec6dot3-microorganisms-11-01899"><title>6.3. Anti-Ageing</title><p>Skin ageing corresponds with physiological changes altering elasticity, thickness and moisture. These changes are linked to multiple biological processes, including mutation accumulation, cellular senescence and microbiome dysbiosis [<xref rid="B232-microorganisms-11-01899" ref-type="bibr">232</xref>]. Physiological manifestations of cutaneous ageing are accelerated by environmental factors, such as UV-mediated photodamage [<xref rid="B233-microorganisms-11-01899" ref-type="bibr">233</xref>]. The composition of the skin microbiome varies throughout life, with aged skin having increased overall diversity. Ageing is further correlated to increased antimicrobial production and physiological reductions in the production of cutaneous factors, notably reduced collagen and sebum [<xref rid="B40-microorganisms-11-01899" ref-type="bibr">40</xref>,<xref rid="B234-microorganisms-11-01899" ref-type="bibr">234</xref>].</p><p>Correlations between ageing and cutaneous skin microbiome changes are well established. Elderly skin microbiomes are associated with consistently reduced <italic toggle="yes">Cutibacterium</italic> spp. and <italic toggle="yes">Lactobacillus</italic> spp. across multiple bodily sites. [<xref rid="B40-microorganisms-11-01899" ref-type="bibr">40</xref>,<xref rid="B235-microorganisms-11-01899" ref-type="bibr">235</xref>]. A conjectural association with reduced <italic toggle="yes">C. acnes</italic> abundance is reduced glycerol, fatty acids and antioxidant production perpetuating physiological changes associated with cutaneous ageing [<xref rid="B131-microorganisms-11-01899" ref-type="bibr">131</xref>,<xref rid="B236-microorganisms-11-01899" ref-type="bibr">236</xref>]. <italic toggle="yes">Streptococcus</italic> spp. abundance increases until puberty and correlates with younger biophysical properties, such as high elasticity [<xref rid="B235-microorganisms-11-01899" ref-type="bibr">235</xref>]. The exogenous treatment of human fibroblasts with a supernatant from facial-skin-swab-derived strains of <italic toggle="yes">Streptococcus</italic> sp. resulted in an increased gene expression of collagen, filaggrin and lipid synthesis proteins [<xref rid="B237-microorganisms-11-01899" ref-type="bibr">237</xref>]. The causative compound within <italic toggle="yes">Streptococcus</italic> supernatants is accepted to be spermidine, a polyamine capable of inducing cytoprotective autophagy associated with an increased turnover of cells, proteins and organelles. Spermidine is further associated with chemotherapy potentiation and tumorigenesis suppression in murine models [<xref rid="B238-microorganisms-11-01899" ref-type="bibr">238</xref>,<xref rid="B239-microorganisms-11-01899" ref-type="bibr">239</xref>]. Moreover, spermidine levels are shown to decrease with biological ageing, further supporting its role in ageing, and this polyamine displays low toxicity in mice and humans [<xref rid="B240-microorganisms-11-01899" ref-type="bibr">240</xref>]. The supplementation of spermidine or the promotion of producing streptococci in naturally deficient older humans may provide improved phenotypes associated with biological ageing and warrant further investigation. </p><p>Wide-ranging prospects of personal care treatments aimed to mitigate physiological alterations associated with ageing are feasible. For example, <italic toggle="yes">Lactobacillus</italic> spp. correlate with reduced photo-ageing through an ultraviolet protective effect, thus reducing collagen degradation [<xref rid="B17-microorganisms-11-01899" ref-type="bibr">17</xref>]. Further, <italic toggle="yes">C. acnes</italic> RoxP is a free-radical oxygenase capable of potent antioxidant activity relevant for the mitigation of cutaneous ageing processes in purified or pre- and probiotic formulations [<xref rid="B236-microorganisms-11-01899" ref-type="bibr">236</xref>,<xref rid="B241-microorganisms-11-01899" ref-type="bibr">241</xref>,<xref rid="B242-microorganisms-11-01899" ref-type="bibr">242</xref>].</p></sec><sec id="sec6dot4-microorganisms-11-01899"><title>6.4. Skin Rejuvenation</title><p>Topical probiotics produced with the aim of establishing stable communities of beneficial microorganisms represent a key direction for skin-microbiome-derived development. <italic toggle="yes">S. epidermidis</italic> may contribute to the production of ceramide on human skin through sphingomyelinase production leading to the digestion of antimicrobial amino alcohol sphingosines [<xref rid="B132-microorganisms-11-01899" ref-type="bibr">132</xref>,<xref rid="B243-microorganisms-11-01899" ref-type="bibr">243</xref>] <italic toggle="yes">S. epidermidis</italic> sphingomyelinase is sufficient to significantly increase murine ceramide content on skin and conveys no apparent pathology associated with keratinocyte cytolysis or biofilm formation [<xref rid="B244-microorganisms-11-01899" ref-type="bibr">244</xref>]. Ceramides provide a diverse and vital range of functions through forming a major component of the lipid barrier to the regulation of keratinocyte proliferation and the modulation of localised immune responses [<xref rid="B244-microorganisms-11-01899" ref-type="bibr">244</xref>,<xref rid="B245-microorganisms-11-01899" ref-type="bibr">245</xref>]. The further potential of streptococci producing hyaluronic acid and streptococcal lysates increasing skin ceramide production highlights potential avenues that might direct skin care product development [<xref rid="B246-microorganisms-11-01899" ref-type="bibr">246</xref>,<xref rid="B247-microorganisms-11-01899" ref-type="bibr">247</xref>,<xref rid="B248-microorganisms-11-01899" ref-type="bibr">248</xref>]. Sphingomyelinase expression appears to provide growth advantages for <italic toggle="yes">S. epidermidis</italic> by facilitating colonisation through nutrient acquisition and lipid osmoprotection [<xref rid="B249-microorganisms-11-01899" ref-type="bibr">249</xref>]. Indeed, a correlative relationship was reported with reduced spingomyelinase activity in atopic dermatitis, highlighting a further direction for product development [<xref rid="B250-microorganisms-11-01899" ref-type="bibr">250</xref>]. The exploration into the commercial viability of products utilising purified sphingomyelinase, lysate or probiotic formulations derived from strains with optimal activity is warranted.</p><p><italic toggle="yes">Lactobacillus</italic> spp. were explored as topical cutaneous probiotics [<xref rid="B225-microorganisms-11-01899" ref-type="bibr">225</xref>,<xref rid="B251-microorganisms-11-01899" ref-type="bibr">251</xref>]. Lactobacilli are evidenced in primary human keratinocytes to aid skin rejuvenation through stimulating the expression of skin-junction proteins via Toll-like receptor 2 activation, thus promoting the integrity of the lipid barrier. Similarly, <italic toggle="yes">Lactobacillus</italic> ferment lysate stimulated keratinocyte migration leading to increased skin repair; however, the direct effector compounds are unknown [<xref rid="B252-microorganisms-11-01899" ref-type="bibr">252</xref>].</p></sec><sec id="sec6dot5-microorganisms-11-01899"><title>6.5. Moisturisers</title><p>Topical moisturisers are a staple in the cosmetic industry, aiming to hydrate the skin to visually improve skin smoothness through restoration of the skin lipid barrier [<xref rid="B253-microorganisms-11-01899" ref-type="bibr">253</xref>]. Since glycerol represents a potent humectant facilitating skin moisture and hydration retention, cosmetic products that aim to increase glycerol liberation from sebaceous triglycerides are a feasible option [<xref rid="B131-microorganisms-11-01899" ref-type="bibr">131</xref>,<xref rid="B254-microorganisms-11-01899" ref-type="bibr">254</xref>]. Hence, formulations containing either commensal-derived extracellular lipases or those that promote producer growth may yield moisturising potential. Both prebiotic and postbiotic moisturisers are on the market, with one study identifying visual improvements in skin moisture and increased skin microbiome diversity over the 4-week period studied [<xref rid="B131-microorganisms-11-01899" ref-type="bibr">131</xref>,<xref rid="B213-microorganisms-11-01899" ref-type="bibr">213</xref>,<xref rid="B255-microorganisms-11-01899" ref-type="bibr">255</xref>]. Moisturisers containing probiotic lysates are currently commercially available containing <italic toggle="yes">Lactobacillus</italic> spp. and generally aim to stimulate the expression and production of skin barrier proteins as reported from in vivo and in vitro models [<xref rid="B217-microorganisms-11-01899" ref-type="bibr">217</xref>,<xref rid="B256-microorganisms-11-01899" ref-type="bibr">256</xref>,<xref rid="B257-microorganisms-11-01899" ref-type="bibr">257</xref>].</p></sec><sec id="sec6dot6-microorganisms-11-01899"><title>6.6. Cutaneous Hyperpigmentation </title><p>The superficial skin infection termed pityriasis versicolor is caused by several <italic toggle="yes">Malassezia</italic> spp. and can result in hypopigmented and hyperpigmented macules [<xref rid="B258-microorganisms-11-01899" ref-type="bibr">258</xref>]. Notably, the <italic toggle="yes">Malassezia</italic> sp.-produced indole derivative compound malassezin can induce melanocyte apoptosis through aryl hydrocarbon receptor agonist activity [<xref rid="B259-microorganisms-11-01899" ref-type="bibr">259</xref>,<xref rid="B260-microorganisms-11-01899" ref-type="bibr">260</xref>,<xref rid="B261-microorganisms-11-01899" ref-type="bibr">261</xref>,<xref rid="B262-microorganisms-11-01899" ref-type="bibr">262</xref>]. This activity means malassezin was explored as a novel cosmetic treatment for facial hyperpigmentation and produces clear decreases in melanin and visible skin lightening within two to four weeks following oil&#x02013;water emulsion skin treatment [<xref rid="B261-microorganisms-11-01899" ref-type="bibr">261</xref>,<xref rid="B263-microorganisms-11-01899" ref-type="bibr">263</xref>].</p></sec><sec id="sec6dot7-microorganisms-11-01899"><title>6.7. Rosacea</title><p>The chronic inflammatory skin disorder rosacea is characterised by persistent facial flushing, sensitive dry skin and inflamed cutaneous plaques and is associated with genetic, neurological and immune system dysregulation. Correlations between rosacea and microbial dysbiosis were identified with an overgrowth of <italic toggle="yes">S. epidermidis</italic>, <italic toggle="yes">Bacillus oleronius</italic> and reduced <italic toggle="yes">C. acnes</italic> growth [<xref rid="B217-microorganisms-11-01899" ref-type="bibr">217</xref>]. However, only one known study with one participant has utilised a topical probiotic and low-dose doxycycline combinatory therapy, albeit with apparent effective results 6 months post treatment [<xref rid="B264-microorganisms-11-01899" ref-type="bibr">264</xref>]; the study signposts a future scope for treatment.</p></sec></sec><sec id="sec7-microorganisms-11-01899"><title>7. Future Perspectives </title><p>The human skin microbiome contains a wealth of compounds that can be exploited for therapeutic and personal care applications. Further research by both the public and private sectors will bring skin-microbiome-derived products to the market and importantly elucidate mechanisms of action, efficacy and safety. Simultaneously, improvements to known compounds through protein engineering that aid translation represent another promising avenue for the application of skin-microbiome-derived compounds. Such products have the capability to improve healthcare outcomes for a variety of disorders as well as improve the quality of life for a significant portion of the population.</p><p>A wealth of knowledge exists pertaining to the skin microbiome representing an incredibly well-characterised human&#x02013;microbiome association. There is a plethora of commercial and therapeutic compounds evidenced to modulate the skin microbiome to provide holistic benefits. Yet many investigations of the skin microbiome are reliant on correlative studies and deductions from in vitro investigations on bacterial isolates. Hence, many microbiome investigations are only able to reveal rudimentary relationships between a limited number of species, which may not be translatable in vivo [<xref rid="B265-microorganisms-11-01899" ref-type="bibr">265</xref>]. There is a necessity for the development of models more closely reflecting the natural skin environment and the diversity associated with physiological factors. Several skin models have been developed, such as stem-cell-derived reconstructed human epidermis, skin explants and NativeSkin<sup>&#x000ae;</sup>, albeit associated with a high cost and short-lived stability [<xref rid="B266-microorganisms-11-01899" ref-type="bibr">266</xref>].</p><p>The advent of next-generation sequencing technologies has unequivocally transformed microbiome research. Robust metagenomic pipelines have proved pivotal for the untargeted creation of detailed compositional maps of the microbiome, facilitating procedures such as nosocomial MDR pathogen surveillance [<xref rid="B267-microorganisms-11-01899" ref-type="bibr">267</xref>]. Metagenomics provides only a limited picture of the microbiome, with investigations unable to confidently identify rare species or nonviable cells [<xref rid="B16-microorganisms-11-01899" ref-type="bibr">16</xref>]. Indeed, microbiome investigations are increasingly reliant on multiomics approaches facilitating revelations of nuanced microbial behaviours with potential human translatability [<xref rid="B268-microorganisms-11-01899" ref-type="bibr">268</xref>].</p></sec><sec sec-type="conclusions" id="sec8-microorganisms-11-01899"><title>8. Conclusions </title><p>The rapid growth in the development of therapeutic and commercial skin-microbiome-derived and probiotic products illustrates the enormous potential of the field. The skin microbiome contains a vast source of cosmetic or therapeutically relevant compounds which have been shown to be translatable for the treatment of many diseases from antimicrobial-resistant pathogen infections to cancers. Many applications further exist for commercial exploitation in the personal care sector, with the potential for the development of novel cosmetic drug formulations. Similarly, the intentional modulation of the native skin flora composition through topical pre and probiotics may alleviate symptoms of many skin disorders through the promotion of microorganisms associated with healthy individuals. Skin microbiome research has recently displayed a surge in interest, yet considerable developments in areas such as in vivo modelling are required to ensure coherency and translatability to the human skin environment.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Jordan Thomas for the critical review of the manuscript.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>K.N.-H. writing and original draft preparation, visualisation; B.M., writing, review and editing; M.H., writing, review and editing; M.J.H. conceptualisation, writing, review and editing; All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>BM and MH are employed by Unilever Plc.</p></notes><ref-list><title>References</title><ref id="B1-microorganisms-11-01899"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carmona-Cruz</surname><given-names>S.</given-names></name>
<name><surname>Orozco-Covarrubias</surname><given-names>L.</given-names></name>
<name><surname>S&#x000e1;ez-de-Ocariz</surname><given-names>M.</given-names></name>
</person-group><article-title>The Human Skin Microbiome in Selected Cutaneous Diseases</article-title><source>Front. Cell Infect. Microbiol.</source><year>2022</year><volume>12</volume><fpage>834135</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2022.834135</pub-id><?supplied-pmid 35321316?><pub-id pub-id-type="pmid">35321316</pub-id></element-citation></ref><ref id="B2-microorganisms-11-01899"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Byrd</surname><given-names>A.L.</given-names></name>
<name><surname>Belkaid</surname><given-names>Y.</given-names></name>
<name><surname>Segre</surname><given-names>J.A.</given-names></name>
</person-group><article-title>The Human Skin Microbiome</article-title><source>Nat. Rev. Microbiol.</source><year>2018</year><volume>16</volume><fpage>143</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2017.157</pub-id><pub-id pub-id-type="pmid">29332945</pub-id></element-citation></ref><ref id="B3-microorganisms-11-01899"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boxberger</surname><given-names>M.</given-names></name>
<name><surname>Cenizo</surname><given-names>V.</given-names></name>
<name><surname>Cassir</surname><given-names>N.</given-names></name>
<name><surname>La Scola</surname><given-names>B.</given-names></name>
</person-group><article-title>Challenges in Exploring and Manipulating the Human Skin Microbiome</article-title><source>Microbiome</source><year>2021</year><volume>9</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/s40168-021-01062-5</pub-id><pub-id pub-id-type="pmid">33388088</pub-id></element-citation></ref><ref id="B4-microorganisms-11-01899"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Swaney</surname><given-names>M.H.</given-names></name>
<name><surname>Kalan</surname><given-names>L.R.</given-names></name>
</person-group><article-title>Living in Your Skin: Microbes, Molecules, and Mechanisms</article-title><source>Infect. Immun.</source><year>2021</year><volume>89</volume><fpage>e00695-20</fpage><pub-id pub-id-type="doi">10.1128/IAI.00695-20</pub-id><?supplied-pmid 33468585?><pub-id pub-id-type="pmid">33468585</pub-id></element-citation></ref><ref id="B5-microorganisms-11-01899"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gorter</surname><given-names>F.A.</given-names></name>
<name><surname>Manhart</surname><given-names>M.</given-names></name>
<name><surname>Ackermann</surname><given-names>M.</given-names></name>
</person-group><article-title>Understanding the Evolution of Interspecies Interactions in Microbial Communities</article-title><source>Philos. Trans. R. Soc. B</source><year>2020</year><volume>375</volume><fpage>20190256</fpage><pub-id pub-id-type="doi">10.1098/rstb.2019.0256</pub-id></element-citation></ref><ref id="B6-microorganisms-11-01899"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hutchings</surname><given-names>M.</given-names></name>
<name><surname>Truman</surname><given-names>A.</given-names></name>
<name><surname>Wilkinson</surname><given-names>B.</given-names></name>
</person-group><article-title>Antibiotics: Past, Present and Future</article-title><source>Curr. Opin. Microbiol.</source><year>2019</year><volume>51</volume><fpage>72</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2019.10.008</pub-id><?supplied-pmid 31733401?><pub-id pub-id-type="pmid">31733401</pub-id></element-citation></ref><ref id="B7-microorganisms-11-01899"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohs</surname><given-names>R.C.</given-names></name>
<name><surname>Greig</surname><given-names>N.H.</given-names></name>
</person-group><article-title>Drug Discovery and Development: Role of Basic Biological Research</article-title><source>Alzheimer&#x02019;s Dement. Transl. Res. Clin. Interv.</source><year>2017</year><volume>3</volume><fpage>651</fpage><pub-id pub-id-type="doi">10.1016/j.trci.2017.10.005</pub-id></element-citation></ref><ref id="B8-microorganisms-11-01899"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thompson</surname><given-names>T.</given-names></name>
</person-group><article-title>The Staggering Death Toll of Drug-Resistant Bacteria</article-title><source>Nature</source><year>2022</year><pub-id pub-id-type="doi">10.1038/d41586-022-00228-x</pub-id></element-citation></ref><ref id="B9-microorganisms-11-01899"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strathdee</surname><given-names>S.A.</given-names></name>
<name><surname>Hatfull</surname><given-names>G.F.</given-names></name>
<name><surname>Mutalik</surname><given-names>V.K.</given-names></name>
<name><surname>Schooley</surname><given-names>R.T.</given-names></name>
</person-group><article-title>Phage Therapy: From Biological Mechanisms to Future Directions</article-title><source>Cell</source><year>2023</year><volume>186</volume><fpage>17</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.11.017</pub-id><pub-id pub-id-type="pmid">36608652</pub-id></element-citation></ref><ref id="B10-microorganisms-11-01899"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gl&#x000e4;ser</surname><given-names>R.</given-names></name>
<name><surname>Harder</surname><given-names>J.</given-names></name>
<name><surname>Lange</surname><given-names>H.</given-names></name>
<name><surname>Bartels</surname><given-names>J.</given-names></name>
<name><surname>Christophers</surname><given-names>E.</given-names></name>
<name><surname>Schr&#x000f6;der</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Antimicrobial Psoriasin (S100A7) Protects Human Skin from <italic toggle="yes">Escherichia coli</italic> Infection</article-title><source>Nat. Immunol.</source><year>2004</year><volume>6</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/ni1142</pub-id><pub-id pub-id-type="pmid">15568027</pub-id></element-citation></ref><ref id="B11-microorganisms-11-01899"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moran</surname><given-names>J.C.</given-names></name>
<name><surname>Alorabi</surname><given-names>J.A.</given-names></name>
<name><surname>Horsburgh</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Comparative Transcriptomics Reveals Discrete Survival Responses of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">S. epidermidis</italic> to Sapienic Acid</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>33</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.00033</pub-id><?supplied-pmid 28179897?><pub-id pub-id-type="pmid">28179897</pub-id></element-citation></ref><ref id="B12-microorganisms-11-01899"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anjana</surname></name>
<name><surname>Tiwari</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota</article-title><source>Front. Cell Infect. Microbiol.</source><year>2022</year><volume>12</volume><fpage>415</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2022.851140</pub-id></element-citation></ref><ref id="B13-microorganisms-11-01899"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berg</surname><given-names>G.</given-names></name>
<name><surname>Rybakova</surname><given-names>D.</given-names></name>
<name><surname>Fischer</surname><given-names>D.</given-names></name>
<name><surname>Cernava</surname><given-names>T.</given-names></name>
<name><surname>Verg&#x000e8;s</surname><given-names>M.C.C.</given-names></name>
<name><surname>Charles</surname><given-names>T.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Cocolin</surname><given-names>L.</given-names></name>
<name><surname>Eversole</surname><given-names>K.</given-names></name>
<name><surname>Corral</surname><given-names>G.H.</given-names></name>
<etal/>
</person-group><article-title>Microbiome Definition Re-Visited: Old Concepts and New Challenges</article-title><source>Microbiome</source><year>2020</year><volume>8</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1186/s40168-020-00875-0</pub-id><pub-id pub-id-type="pmid">31901242</pub-id></element-citation></ref><ref id="B14-microorganisms-11-01899"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arnold</surname><given-names>J.W.</given-names></name>
<name><surname>Roach</surname><given-names>J.</given-names></name>
<name><surname>Azcarate-Peril</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Emerging Technologies for Gut Microbiome Research</article-title><source>Trends Microbiol.</source><year>2016</year><volume>24</volume><fpage>887</fpage><pub-id pub-id-type="doi">10.1016/j.tim.2016.06.008</pub-id><?supplied-pmid 27426971?><pub-id pub-id-type="pmid">27426971</pub-id></element-citation></ref><ref id="B15-microorganisms-11-01899"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kong</surname><given-names>H.H.</given-names></name>
<name><surname>Segre</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Skin Microbiome: Looking Back to Move Forward</article-title><source>J. Investig. Dermatol.</source><year>2012</year><volume>132</volume><fpage>933</fpage><pub-id pub-id-type="doi">10.1038/jid.2011.417</pub-id><?supplied-pmid 22189793?><pub-id pub-id-type="pmid">22189793</pub-id></element-citation></ref><ref id="B16-microorganisms-11-01899"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carrieri</surname><given-names>A.P.</given-names></name>
<name><surname>Haiminen</surname><given-names>N.</given-names></name>
<name><surname>Maudsley-Barton</surname><given-names>S.</given-names></name>
<name><surname>Gardiner</surname><given-names>L.J.</given-names></name>
<name><surname>Murphy</surname><given-names>B.</given-names></name>
<name><surname>Mayes</surname><given-names>A.E.</given-names></name>
<name><surname>Paterson</surname><given-names>S.</given-names></name>
<name><surname>Grimshaw</surname><given-names>S.</given-names></name>
<name><surname>Winn</surname><given-names>M.</given-names></name>
<name><surname>Shand</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Explainable AI Reveals Changes in Skin Microbiome Composition Linked to Phenotypic Differences</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>4565</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-83922-6</pub-id><pub-id pub-id-type="pmid">33633172</pub-id></element-citation></ref><ref id="B17-microorganisms-11-01899"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>J.</given-names></name>
<name><surname>Ma</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Cui</surname><given-names>X.</given-names></name>
<name><surname>Ding</surname><given-names>K.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Han</surname><given-names>C.</given-names></name>
</person-group><article-title>Application and Mechanism of Probiotics in Skin Care: A Review</article-title><source>J. Cosmet. Dermatol.</source><year>2022</year><volume>21</volume><fpage>886</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1111/jocd.14734</pub-id><pub-id pub-id-type="pmid">34997993</pub-id></element-citation></ref><ref id="B18-microorganisms-11-01899"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grice</surname><given-names>E.A.</given-names></name>
<name><surname>Segre</surname><given-names>J.A.</given-names></name>
</person-group><article-title>The Skin Microbiome</article-title><source>Nat. Rev. Microbiol.</source><year>2011</year><volume>9</volume><fpage>244</fpage><pub-id pub-id-type="doi">10.1038/nrmicro2537</pub-id><?supplied-pmid 21407241?><pub-id pub-id-type="pmid">21407241</pub-id></element-citation></ref><ref id="B19-microorganisms-11-01899"><label>19.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Yousef</surname><given-names>H.</given-names></name>
<name><surname>Alhajj</surname><given-names>M.</given-names></name>
<name><surname>Sharma</surname><given-names>S.</given-names></name>
</person-group><source>Anatomy, Skin (Integument), Epidermis</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2023</year><comment>Available online: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK470464/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK470464/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-06-19">(accessed on 19 June 2023)</date-in-citation></element-citation></ref><ref id="B20-microorganisms-11-01899"><label>20.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>J.Y.</given-names></name>
<name><surname>Dao</surname><given-names>H.</given-names></name>
</person-group><source>Physiology, Integument</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2023</year><comment>Available online: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK554386/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK554386/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-06-19">(accessed on 19 June 2023)</date-in-citation></element-citation></ref><ref id="B21-microorganisms-11-01899"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meisel</surname><given-names>J.S.</given-names></name>
<name><surname>Sfyroera</surname><given-names>G.</given-names></name>
<name><surname>Bartow-McKenney</surname><given-names>C.</given-names></name>
<name><surname>Gimblet</surname><given-names>C.</given-names></name>
<name><surname>Bugayev</surname><given-names>J.</given-names></name>
<name><surname>Horwinski</surname><given-names>J.</given-names></name>
<name><surname>Kim</surname><given-names>B.</given-names></name>
<name><surname>Brestoff</surname><given-names>J.R.</given-names></name>
<name><surname>Tyldsley</surname><given-names>A.S.</given-names></name>
<name><surname>Zheng</surname><given-names>Q.</given-names></name>
<etal/>
</person-group><article-title>Commensal Microbiota Modulate Gene Expression in the Skin</article-title><source>Microbiome</source><year>2018</year><volume>6</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s40168-018-0404-9</pub-id><pub-id pub-id-type="pmid">29291746</pub-id></element-citation></ref><ref id="B22-microorganisms-11-01899"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fischer</surname><given-names>H.</given-names></name>
<name><surname>Fumicz</surname><given-names>J.</given-names></name>
<name><surname>Rossiter</surname><given-names>H.</given-names></name>
<name><surname>Napirei</surname><given-names>M.</given-names></name>
<name><surname>Buchberger</surname><given-names>M.</given-names></name>
<name><surname>Tschachler</surname><given-names>E.</given-names></name>
<name><surname>Eckhart</surname><given-names>L.</given-names></name>
</person-group><article-title>Holocrine Secretion of Sebum Is a Unique DNase2-Dependent Mode of Programmed Cell Death</article-title><source>J. Investig. Dermatol.</source><year>2017</year><volume>137</volume><fpage>587</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2016.10.017</pub-id><pub-id pub-id-type="pmid">27771328</pub-id></element-citation></ref><ref id="B23-microorganisms-11-01899"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Atsugi</surname><given-names>T.</given-names></name>
<name><surname>Yokouchi</surname><given-names>M.</given-names></name>
<name><surname>Hirano</surname><given-names>T.</given-names></name>
<name><surname>Hirabayashi</surname><given-names>A.</given-names></name>
<name><surname>Nagai</surname><given-names>T.</given-names></name>
<name><surname>Ohyama</surname><given-names>M.</given-names></name>
<name><surname>Abe</surname><given-names>T.</given-names></name>
<name><surname>Kaneko</surname><given-names>M.</given-names></name>
<name><surname>Zouboulis</surname><given-names>C.C.</given-names></name>
<name><surname>Amagai</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Holocrine Secretion Occurs Outside the Tight Junction Barrier in Multicellular Glands: Lessons from Claudin-1-Deficient Mice</article-title><source>J. Investig. Dermatol.</source><year>2020</year><volume>140</volume><fpage>298</fpage><lpage>308.e5</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2019.06.150</pub-id><?supplied-pmid 31445004?><pub-id pub-id-type="pmid">31445004</pub-id></element-citation></ref><ref id="B24-microorganisms-11-01899"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Freinkel</surname><given-names>R.K.</given-names></name>
</person-group><article-title>The Origin of Free Fatty Acids in Sebum. I. Role of Coagulase Negative Staphylococci</article-title><source>J. Investig. Dermatol.</source><year>1968</year><volume>50</volume><fpage>186</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1038/jid.1968.22</pub-id><pub-id pub-id-type="pmid">5641646</pub-id></element-citation></ref><ref id="B25-microorganisms-11-01899"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lacey</surname><given-names>R.W.</given-names></name>
</person-group><article-title>Loss of the Antibacterial Action of Skin After Topical Neomycin</article-title><source>Br. J. Dermatol.</source><year>1969</year><volume>81</volume><fpage>435</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2133.1969.tb14013.x</pub-id><pub-id pub-id-type="pmid">5795777</pub-id></element-citation></ref><ref id="B26-microorganisms-11-01899"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marples</surname><given-names>R.R.</given-names></name>
<name><surname>Kligman</surname><given-names>A.M.</given-names></name>
<name><surname>Lantis</surname><given-names>L.R.</given-names></name>
<name><surname>Downing</surname><given-names>D.T.</given-names></name>
</person-group><article-title>The Role of the Aerobic Microflora in the Genesis of Fatty Acids in Human Surface Lipids</article-title><source>J. Investig. Dermatol.</source><year>1970</year><volume>55</volume><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1111/1523-1747.ep12280672</pub-id><?supplied-pmid 5466700?><pub-id pub-id-type="pmid">5466700</pub-id></element-citation></ref><ref id="B27-microorganisms-11-01899"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McGinley</surname><given-names>K.J.</given-names></name>
<name><surname>Webster</surname><given-names>G.F.</given-names></name>
<name><surname>Ruggieri</surname><given-names>M.R.</given-names></name>
<name><surname>Leyden</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Regional Variations in Density of Cutaneous Propionibacteria: Correlation of <italic toggle="yes">Propionibacterium acnes</italic> Populations with Sebaceous Secretion</article-title><source>J. Clin. Microbiol.</source><year>1980</year><volume>12</volume><fpage>672</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1128/jcm.12.5.672-675.1980</pub-id><?supplied-pmid 7276142?><pub-id pub-id-type="pmid">7276142</pub-id></element-citation></ref><ref id="B28-microorganisms-11-01899"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nicolaides</surname><given-names>N.</given-names></name>
<name><surname>Wells</surname><given-names>G.C.</given-names></name>
</person-group><article-title>On the Biogenesis of the Free Fatty Acids in Human Skin Surface Fat</article-title><source>J. Investig. Dermatol.</source><year>1957</year><volume>29</volume><fpage>423</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1038/jid.1957.118</pub-id><pub-id pub-id-type="pmid">13502598</pub-id></element-citation></ref><ref id="B29-microorganisms-11-01899"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shalita</surname><given-names>A.R.</given-names></name>
</person-group><article-title>Genesis of Free Fatty Acids</article-title><source>J. Investig. Dermatol.</source><year>1974</year><volume>62</volume><fpage>332</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1111/1523-1747.ep12724289</pub-id><?supplied-pmid 4274211?><pub-id pub-id-type="pmid">4274211</pub-id></element-citation></ref><ref id="B30-microorganisms-11-01899"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stewart</surname><given-names>M.E.</given-names></name>
<name><surname>Downing</surname><given-names>D.T.</given-names></name>
<name><surname>Pochi</surname><given-names>P.E.</given-names></name>
<name><surname>Strauss</surname><given-names>J.S.</given-names></name>
</person-group><article-title>The Fatty Acids of Human Sebaceous Gland Phosphatidylcholine</article-title><source>Biochim. Biophys. Acta (BBA)-Lipids Lipid Metab.</source><year>1978</year><volume>529</volume><fpage>380</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/0005-2760(78)90082-6</pub-id></element-citation></ref><ref id="B31-microorganisms-11-01899"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takigawa</surname><given-names>H.</given-names></name>
<name><surname>Nakagawa</surname><given-names>H.</given-names></name>
<name><surname>Kuzukawa</surname><given-names>M.</given-names></name>
<name><surname>Mori</surname><given-names>H.</given-names></name>
<name><surname>Imokawa</surname><given-names>G.</given-names></name>
</person-group><article-title>Deficient Production of Hexadecenoic Acid in the Skin Is Associated in Part with the Vulnerability of Atopic Dermatitis Patients to Colonization by <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Dermatology</source><year>2005</year><volume>211</volume><fpage>240</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1159/000087018</pub-id><pub-id pub-id-type="pmid">16205069</pub-id></element-citation></ref><ref id="B32-microorganisms-11-01899"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lov&#x000e1;szi</surname><given-names>M.</given-names></name>
<name><surname>Szegedi</surname><given-names>A.</given-names></name>
<name><surname>Zouboulis</surname><given-names>C.C.</given-names></name>
<name><surname>T&#x000f6;r&#x00151;csik</surname><given-names>D.</given-names></name>
</person-group><article-title>Sebaceous-Immunobiology Is Orchestrated by Sebum Lipids</article-title><source>Derm.-Endocrinol.</source><year>2017</year><volume>9</volume><fpage>e1375636</fpage><pub-id pub-id-type="doi">10.1080/19381980.2017.1375636</pub-id></element-citation></ref><ref id="B33-microorganisms-11-01899"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Makrantonaki</surname><given-names>E.</given-names></name>
<name><surname>Ganceviciene</surname><given-names>R.</given-names></name>
<name><surname>Zouboulis</surname><given-names>C.</given-names></name>
</person-group><article-title>An Update on the Role of the Sebaceous Gland in the Pathogenesis of Acne</article-title><source>Derm.-Endocrinol.</source><year>2011</year><volume>3</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.4161/derm.3.1.13900</pub-id></element-citation></ref><ref id="B34-microorganisms-11-01899"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vietri Rudan</surname><given-names>M.</given-names></name>
<name><surname>Watt</surname><given-names>F.M.</given-names></name>
</person-group><article-title>Mammalian Epidermis: A Compendium of Lipid Functionality</article-title><source>Front. Physiol.</source><year>2022</year><volume>12</volume><fpage>2444</fpage><pub-id pub-id-type="doi">10.3389/fphys.2021.804824</pub-id><?supplied-pmid 35095565?><pub-id pub-id-type="pmid">35095565</pub-id></element-citation></ref><ref id="B35-microorganisms-11-01899"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mark</surname><given-names>H.</given-names></name>
<name><surname>Harding</surname><given-names>C.R.</given-names></name>
</person-group><article-title>Amino Acid Composition, Including Key Derivatives of Eccrine Sweat: Potential Biomarkers of Certain Atopic Skin Conditions</article-title><source>Int. J. Cosmet. Sci.</source><year>2013</year><volume>35</volume><fpage>163</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1111/ics.12019</pub-id><?supplied-pmid 23075272?><pub-id pub-id-type="pmid">23075272</pub-id></element-citation></ref><ref id="B36-microorganisms-11-01899"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murota</surname><given-names>H.</given-names></name>
<name><surname>Matsui</surname><given-names>S.</given-names></name>
<name><surname>Ono</surname><given-names>E.</given-names></name>
<name><surname>Kijima</surname><given-names>A.</given-names></name>
<name><surname>Kikuta</surname><given-names>J.</given-names></name>
<name><surname>Ishii</surname><given-names>M.</given-names></name>
<name><surname>Katayama</surname><given-names>I.</given-names></name>
</person-group><article-title>Sweat, the Driving Force behind Normal Skin: An Emerging Perspective on Functional Biology and Regulatory Mechanisms</article-title><source>J. Dermatol. Sci.</source><year>2015</year><volume>77</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2014.08.011</pub-id><?supplied-pmid 25266651?><pub-id pub-id-type="pmid">25266651</pub-id></element-citation></ref><ref id="B37-microorganisms-11-01899"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Belvoncikova</surname><given-names>P.</given-names></name>
<name><surname>Splichalova</surname><given-names>P.</given-names></name>
<name><surname>Videnska</surname><given-names>P.</given-names></name>
<name><surname>Gardlik</surname><given-names>R.</given-names></name>
</person-group><article-title>The Human Mycobiome: Colonization, Composition and the Role in Health and Disease</article-title><source>J. Fungi</source><year>2022</year><volume>8</volume><elocation-id>1046</elocation-id><pub-id pub-id-type="doi">10.3390/jof8101046</pub-id></element-citation></ref><ref id="B38-microorganisms-11-01899"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Findley</surname><given-names>K.</given-names></name>
<name><surname>Oh</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Conlan</surname><given-names>S.</given-names></name>
<name><surname>Deming</surname><given-names>C.</given-names></name>
<name><surname>Meyer</surname><given-names>J.A.</given-names></name>
<name><surname>Schoenfeld</surname><given-names>D.</given-names></name>
<name><surname>Nomicos</surname><given-names>E.</given-names></name>
<name><surname>Park</surname><given-names>M.</given-names></name>
<name><surname>Becker</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Topographic diversity of fungal and bacterial communities in human skin</article-title><source>Nature</source><year>2013</year><volume>498</volume><fpage>367</fpage><pub-id pub-id-type="doi">10.1038/nature12171</pub-id><?supplied-pmid 23698366?><pub-id pub-id-type="pmid">23698366</pub-id></element-citation></ref><ref id="B39-microorganisms-11-01899"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>Z.</given-names></name>
<name><surname>Perez-Perez</surname><given-names>G.I.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Blaser</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Quantitation of Major Human Cutaneous Bacterial and Fungal Populations</article-title><source>J. Clin. Microbiol.</source><year>2010</year><volume>48</volume><fpage>3575</fpage><pub-id pub-id-type="doi">10.1128/JCM.00597-10</pub-id><pub-id pub-id-type="pmid">20702672</pub-id></element-citation></ref><ref id="B40-microorganisms-11-01899"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Howard</surname><given-names>B.</given-names></name>
<name><surname>Bascom</surname><given-names>C.C.</given-names></name>
<name><surname>Hu</surname><given-names>P.</given-names></name>
<name><surname>Binder</surname><given-names>R.L.</given-names></name>
<name><surname>Fadayel</surname><given-names>G.</given-names></name>
<name><surname>Huggins</surname><given-names>T.G.</given-names></name>
<name><surname>Jarrold</surname><given-names>B.B.</given-names></name>
<name><surname>Osborne</surname><given-names>R.</given-names></name>
<name><surname>Rocchetta</surname><given-names>H.L.</given-names></name>
<name><surname>Swift</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Aging-Associated Changes in the Adult Human Skin Microbiome and the Host Factors That Affect Skin Microbiome Composition</article-title><source>J. Investig. Dermatol.</source><year>2022</year><volume>142</volume><fpage>1934</fpage><lpage>1946.e21</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2021.11.029</pub-id><pub-id pub-id-type="pmid">34890626</pub-id></element-citation></ref><ref id="B41-microorganisms-11-01899"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Flowers</surname><given-names>L.</given-names></name>
<name><surname>Grice</surname><given-names>E.A.</given-names></name>
</person-group><article-title>The Skin Microbiota: Balancing Risk and Reward</article-title><source>Cell Host Microbe</source><year>2020</year><volume>28</volume><fpage>190</fpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.06.017</pub-id><pub-id pub-id-type="pmid">32791112</pub-id></element-citation></ref><ref id="B42-microorganisms-11-01899"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sanford</surname><given-names>J.A.</given-names></name>
<name><surname>Gallo</surname><given-names>R.L.</given-names></name>
</person-group><article-title>Functions of the Skin Microbiota in Health and Disease</article-title><source>Semin. Immunol.</source><year>2013</year><volume>25</volume><fpage>370</fpage><pub-id pub-id-type="doi">10.1016/j.smim.2013.09.005</pub-id><pub-id pub-id-type="pmid">24268438</pub-id></element-citation></ref><ref id="B43-microorganisms-11-01899"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kobayashi</surname><given-names>T.</given-names></name>
<name><surname>Voisin</surname><given-names>B.</given-names></name>
<name><surname>Kim</surname><given-names>D.Y.</given-names></name>
<name><surname>Kennedy</surname><given-names>E.A.</given-names></name>
<name><surname>Jo</surname><given-names>J.H.</given-names></name>
<name><surname>Shih</surname><given-names>H.Y.</given-names></name>
<name><surname>Truong</surname><given-names>A.</given-names></name>
<name><surname>Doebel</surname><given-names>T.</given-names></name>
<name><surname>Sakamoto</surname><given-names>K.</given-names></name>
<name><surname>Cui</surname><given-names>C.Y.</given-names></name>
<etal/>
</person-group><article-title>Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>982</fpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.12.031</pub-id><pub-id pub-id-type="pmid">30712873</pub-id></element-citation></ref><ref id="B44-microorganisms-11-01899"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Swaney</surname><given-names>M.H.</given-names></name>
<name><surname>Sandstrom</surname><given-names>S.</given-names></name>
<name><surname>Kalan</surname><given-names>L.R.</given-names></name>
</person-group><article-title>Cobamide Sharing Is Predicted in the Human Skin Microbiome</article-title><source>mSystems</source><year>2022</year><volume>7</volume><fpage>e00677-22</fpage><pub-id pub-id-type="doi">10.1128/msystems.00677-22</pub-id><?supplied-pmid 35968974?><pub-id pub-id-type="pmid">35968974</pub-id></element-citation></ref><ref id="B45-microorganisms-11-01899"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Skowron</surname><given-names>K.</given-names></name>
<name><surname>Bauza-kaszewska</surname><given-names>J.</given-names></name>
<name><surname>Kraszewska</surname><given-names>Z.</given-names></name>
<name><surname>Wiktorczyk-kapischke</surname><given-names>N.</given-names></name>
<name><surname>Grudlewska-buda</surname><given-names>K.</given-names></name>
<name><surname>Kwieci&#x00144;ska-pir&#x000f3;g</surname><given-names>J.</given-names></name>
<name><surname>Wa&#x00142;ecka-zacharska</surname><given-names>E.</given-names></name>
<name><surname>Radtke</surname><given-names>L.</given-names></name>
<name><surname>Gospodarek-komkowska</surname><given-names>E.</given-names></name>
</person-group><article-title>Human Skin Microbiome: Impact of Intrinsic and Extrinsic Factors on Skin Microbiota</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>543</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9030543</pub-id><?supplied-pmid 33808031?><pub-id pub-id-type="pmid">33808031</pub-id></element-citation></ref><ref id="B46-microorganisms-11-01899"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sachdeva</surname><given-names>C.</given-names></name>
<name><surname>Satyamoorthy</surname><given-names>K.</given-names></name>
<name><surname>Murali</surname><given-names>T.S.</given-names></name>
</person-group><article-title>Microbial Interplay in Skin and Chronic Wounds</article-title><source>Curr. Clin. Microbiol. Rep.</source><year>2022</year><volume>9</volume><fpage>21</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/s40588-022-00180-4</pub-id></element-citation></ref><ref id="B47-microorganisms-11-01899"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>T.H.</given-names></name>
<name><surname>Park</surname><given-names>M.D.</given-names></name>
<name><surname>Otto</surname><given-names>M.</given-names></name>
</person-group><article-title>Host Response to <italic toggle="yes">Staphylococcus epidermidis</italic> Colonization and Infections</article-title><source>Front. Cell Infect. Microbiol.</source><year>2017</year><volume>7</volume><fpage>90</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2017.00090</pub-id><?supplied-pmid 28377905?><pub-id pub-id-type="pmid">28377905</pub-id></element-citation></ref><ref id="B48-microorganisms-11-01899"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rozas</surname><given-names>M.</given-names></name>
<name><surname>de Ruijter</surname><given-names>A.H.</given-names></name>
<name><surname>Fabrega</surname><given-names>M.J.</given-names></name>
<name><surname>Zorgani</surname><given-names>A.</given-names></name>
<name><surname>Guell</surname><given-names>M.</given-names></name>
<name><surname>Paetzold</surname><given-names>B.</given-names></name>
<name><surname>Brillet</surname><given-names>F.</given-names></name>
</person-group><article-title>From Dysbiosis to Healthy Skin: Major Contributions of <italic toggle="yes">Cutibacterium acnes</italic> to Skin Homeostasis</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>628</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9030628</pub-id><?supplied-pmid 33803499?><pub-id pub-id-type="pmid">33803499</pub-id></element-citation></ref><ref id="B49-microorganisms-11-01899"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fourni&#x000e8;re</surname><given-names>M.</given-names></name>
<name><surname>Latire</surname><given-names>T.</given-names></name>
<name><surname>Souak</surname><given-names>D.</given-names></name>
<name><surname>Feuilloley</surname><given-names>M.G.J.</given-names></name>
<name><surname>Bedoux</surname><given-names>G.</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus epidermidis</italic> and <italic toggle="yes">Cutibacterium acnes</italic>: Two Major Sentinels of Skin Microbiota and the Influence of Cosmetics</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>1752</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8111752</pub-id><pub-id pub-id-type="pmid">33171837</pub-id></element-citation></ref><ref id="B50-microorganisms-11-01899"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tabaja</surname><given-names>H.</given-names></name>
<name><surname>Tai</surname><given-names>D.B.G.</given-names></name>
<name><surname>Beam</surname><given-names>E.</given-names></name>
<name><surname>Abdel</surname><given-names>M.P.</given-names></name>
<name><surname>Tande</surname><given-names>A.J.</given-names></name>
</person-group><article-title>Clinical Profile of Monomicrobial Corynebacterium Hip and Knee Periprosthetic Joint Infections</article-title><source>Open Forum Infect. Dis.</source><year>2022</year><volume>9</volume><fpage>ofac193</fpage><pub-id pub-id-type="doi">10.1093/ofid/ofac193</pub-id><pub-id pub-id-type="pmid">35873283</pub-id></element-citation></ref><ref id="B51-microorganisms-11-01899"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sakr</surname><given-names>A.</given-names></name>
<name><surname>Br&#x000e9;geon</surname><given-names>F.</given-names></name>
<name><surname>M&#x000e8;ge</surname><given-names>J.L.</given-names></name>
<name><surname>Rolain</surname><given-names>J.M.</given-names></name>
<name><surname>Blin</surname><given-names>O.</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><fpage>2419</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.02419</pub-id><pub-id pub-id-type="pmid">30349525</pub-id></element-citation></ref><ref id="B52-microorganisms-11-01899"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clebak</surname><given-names>K.T.</given-names></name>
<name><surname>Malone</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Skin Infections</article-title><source>Prim. Care</source><year>2018</year><volume>45</volume><fpage>433</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.pop.2018.05.004</pub-id><pub-id pub-id-type="pmid">30115333</pub-id></element-citation></ref><ref id="B53-microorganisms-11-01899"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gunaydin</surname><given-names>S.D.</given-names></name>
<name><surname>Arikan-Akdagli</surname><given-names>S.</given-names></name>
<name><surname>Akova</surname><given-names>M.</given-names></name>
</person-group><article-title>Fungal Infections of the Skin and Soft Tissue</article-title><source>Curr. Opin. Infect. Dis.</source><year>2020</year><volume>33</volume><fpage>130</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000630</pub-id><?supplied-pmid 31990815?><pub-id pub-id-type="pmid">31990815</pub-id></element-citation></ref><ref id="B54-microorganisms-11-01899"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marques</surname><given-names>S.A.</given-names></name>
<name><surname>Abbade</surname><given-names>L.P.F.</given-names></name>
</person-group><article-title>Severe Bacterial Skin Infections</article-title><source>An. Bras. Dermatol.</source><year>2020</year><volume>95</volume><fpage>407</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1016/j.abd.2020.04.003</pub-id><?supplied-pmid 32507327?><pub-id pub-id-type="pmid">32507327</pub-id></element-citation></ref><ref id="B55-microorganisms-11-01899"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murray</surname><given-names>C.J.</given-names></name>
<name><surname>Ikuta</surname><given-names>K.S.</given-names></name>
<name><surname>Sharara</surname><given-names>F.</given-names></name>
<name><surname>Swetschinski</surname><given-names>L.</given-names></name>
<name><surname>Robles Aguilar</surname><given-names>G.</given-names></name>
<name><surname>Gray</surname><given-names>A.</given-names></name>
<name><surname>Han</surname><given-names>C.</given-names></name>
<name><surname>Bisignano</surname><given-names>C.</given-names></name>
<name><surname>Rao</surname><given-names>P.</given-names></name>
<name><surname>Wool</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis</article-title><source>Lancet</source><year>2022</year><volume>399</volume><fpage>629</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id><?supplied-pmid 35065702?><pub-id pub-id-type="pmid">35065702</pub-id></element-citation></ref><ref id="B56-microorganisms-11-01899"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jo</surname><given-names>J.H.</given-names></name>
<name><surname>Harkins</surname><given-names>C.P.</given-names></name>
<name><surname>Schwardt</surname><given-names>N.H.</given-names></name>
<name><surname>Portillo</surname><given-names>J.A.</given-names></name>
<name><surname>Zimmerman</surname><given-names>M.D.</given-names></name>
<name><surname>Carter</surname><given-names>C.L.</given-names></name>
<name><surname>Hossen</surname><given-names>M.A.</given-names></name>
<name><surname>Peer</surname><given-names>C.J.</given-names></name>
<name><surname>Polley</surname><given-names>E.C.</given-names></name>
<name><surname>Dartois</surname><given-names>V.</given-names></name>
<etal/>
</person-group><article-title>Alterations of Human Skin Microbiome and Expansion of Antimicrobial Resistance after Systemic Antibiotics</article-title><source>Sci. Transl. Med.</source><year>2021</year><volume>13</volume><fpage>eabd8077</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.abd8077</pub-id><pub-id pub-id-type="pmid">34936382</pub-id></element-citation></ref><ref id="B57-microorganisms-11-01899"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wozniak</surname><given-names>J.M.</given-names></name>
<name><surname>Mills</surname><given-names>R.H.</given-names></name>
<name><surname>Olson</surname><given-names>J.</given-names></name>
<name><surname>Caldera</surname><given-names>J.R.</given-names></name>
<name><surname>Sepich-Poore</surname><given-names>G.D.</given-names></name>
<name><surname>Carrillo-Terrazas</surname><given-names>M.</given-names></name>
<name><surname>Tsai</surname><given-names>C.M.</given-names></name>
<name><surname>Vargas</surname><given-names>F.</given-names></name>
<name><surname>Knight</surname><given-names>R.</given-names></name>
<name><surname>Dorrestein</surname><given-names>P.C.</given-names></name>
<etal/>
</person-group><article-title>Mortality Risk Profiling of <italic toggle="yes">Staphylococcus aureus</italic> Bacteremia by Multi-Omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures</article-title><source>Cell</source><year>2020</year><volume>182</volume><fpage>1311</fpage><lpage>1327.e14</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.07.040</pub-id><pub-id pub-id-type="pmid">32888495</pub-id></element-citation></ref><ref id="B58-microorganisms-11-01899"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ben&#x000ed;tez-Chao</surname><given-names>D.F.</given-names></name>
<name><surname>Le&#x000f3;n-Buitimea</surname><given-names>A.</given-names></name>
<name><surname>Lerma-Escalera</surname><given-names>J.A.</given-names></name>
<name><surname>Morones-Ram&#x000ed;rez</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Bacteriocins: An Overview of Antimicrobial, Toxicity, and Biosafety Assessment by in Vivo Models</article-title><source>Front. Microbiol.</source><year>2021</year><volume>12</volume><fpage>677</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.630695</pub-id></element-citation></ref><ref id="B59-microorganisms-11-01899"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darbandi</surname><given-names>A.</given-names></name>
<name><surname>Asadi</surname><given-names>A.</given-names></name>
<name><surname>Mahdizade Ari</surname><given-names>M.</given-names></name>
<name><surname>Ohadi</surname><given-names>E.</given-names></name>
<name><surname>Talebi</surname><given-names>M.</given-names></name>
<name><surname>Halaj Zadeh</surname><given-names>M.</given-names></name>
<name><surname>Darb Emamie</surname><given-names>A.</given-names></name>
<name><surname>Ghanavati</surname><given-names>R.</given-names></name>
<name><surname>Kakanj</surname><given-names>M.</given-names></name>
</person-group><article-title>Bacteriocins: Properties and Potential Use as Antimicrobials</article-title><source>J. Clin. Lab. Anal.</source><year>2022</year><volume>36</volume><fpage>e24093</fpage><pub-id pub-id-type="doi">10.1002/jcla.24093</pub-id><pub-id pub-id-type="pmid">34851542</pub-id></element-citation></ref><ref id="B60-microorganisms-11-01899"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Telhig</surname><given-names>S.</given-names></name>
<name><surname>Ben Said</surname><given-names>L.</given-names></name>
<name><surname>Zirah</surname><given-names>S.</given-names></name>
<name><surname>Fliss</surname><given-names>I.</given-names></name>
<name><surname>Rebuffat</surname><given-names>S.</given-names></name>
</person-group><article-title>Bacteriocins to Thwart Bacterial Resistance in Gram Negative Bacteria</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><fpage>2807</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.586433</pub-id></element-citation></ref><ref id="B61-microorganisms-11-01899"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Acedo</surname><given-names>J.Z.</given-names></name>
<name><surname>Chiorean</surname><given-names>S.</given-names></name>
<name><surname>Vederas</surname><given-names>J.C.</given-names></name>
<name><surname>van Belkum</surname><given-names>M.J.</given-names></name>
</person-group><article-title>The Expanding Structural Variety among Bacteriocins from Gram-Positive Bacteria</article-title><source>FEMS Microbiol. Rev.</source><year>2018</year><volume>42</volume><fpage>805</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuy033</pub-id><pub-id pub-id-type="pmid">30085042</pub-id></element-citation></ref><ref id="B62-microorganisms-11-01899"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grada</surname><given-names>A.</given-names></name>
<name><surname>Bunick</surname><given-names>C.G.</given-names></name>
</person-group><article-title>Spectrum of Antibiotic Activity and Its Relevance to the Microbiome</article-title><source>JAMA Netw. Open</source><year>2021</year><volume>4</volume><fpage>e215357</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.5357</pub-id><pub-id pub-id-type="pmid">33914053</pub-id></element-citation></ref><ref id="B63-microorganisms-11-01899"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strati</surname><given-names>F.</given-names></name>
<name><surname>Pujolassos</surname><given-names>M.</given-names></name>
<name><surname>Burrello</surname><given-names>C.</given-names></name>
<name><surname>Giuffr&#x000e8;</surname><given-names>M.R.</given-names></name>
<name><surname>Lattanzi</surname><given-names>G.</given-names></name>
<name><surname>Caprioli</surname><given-names>F.</given-names></name>
<name><surname>Troisi</surname><given-names>J.</given-names></name>
<name><surname>Facciotti</surname><given-names>F.</given-names></name>
</person-group><article-title>Antibiotic-Associated Dysbiosis Affects the Ability of the Gut Microbiota to Control Intestinal Inflammation upon Fecal Microbiota Transplantation in Experimental Colitis Models</article-title><source>Microbiome</source><year>2021</year><volume>9</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s40168-020-00991-x</pub-id><?supplied-pmid 33549144?><pub-id pub-id-type="pmid">33388088</pub-id></element-citation></ref><ref id="B64-microorganisms-11-01899"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mills</surname><given-names>S.</given-names></name>
<name><surname>Ross</surname><given-names>R.P.</given-names></name>
<name><surname>Hill</surname><given-names>C.</given-names></name>
</person-group><article-title>Bacteriocins and Bacteriophage; a Narrow-Minded Approach to Food and Gut Microbiology</article-title><source>FEMS Microbiol. Rev.</source><year>2017</year><volume>41</volume><fpage>S129</fpage><lpage>S153</lpage><pub-id pub-id-type="doi">10.1093/femsre/fux022</pub-id><pub-id pub-id-type="pmid">28830091</pub-id></element-citation></ref><ref id="B65-microorganisms-11-01899"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mirande</surname><given-names>C.</given-names></name>
<name><surname>Bizine</surname><given-names>I.</given-names></name>
<name><surname>Giannetti</surname><given-names>A.</given-names></name>
<name><surname>Picot</surname><given-names>N.</given-names></name>
<name><surname>van Belkum</surname><given-names>A.</given-names></name>
</person-group><article-title>Epidemiological Aspects of Healthcare-Associated Infections and Microbial Genomics</article-title><source>Eur. J. Clin. Microbiol. Infect. Dis.</source><year>2018</year><volume>37</volume><fpage>823</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1007/s10096-017-3170-x</pub-id><pub-id pub-id-type="pmid">29340898</pub-id></element-citation></ref><ref id="B66-microorganisms-11-01899"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tozzo</surname><given-names>P.</given-names></name>
<name><surname>Delicati</surname><given-names>A.</given-names></name>
<name><surname>Caenazzo</surname><given-names>L.</given-names></name>
</person-group><article-title>Human Microbiome and Microbiota Identification for Preventing and Controlling Healthcare-Associated Infections: A Systematic Review</article-title><source>Front. Public Health</source><year>2022</year><volume>10</volume><fpage>989496</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2022.989496</pub-id><?supplied-pmid 36530685?><pub-id pub-id-type="pmid">36530685</pub-id></element-citation></ref><ref id="B67-microorganisms-11-01899"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Simons</surname><given-names>A.</given-names></name>
<name><surname>Alhanout</surname><given-names>K.</given-names></name>
<name><surname>Duval</surname><given-names>R.E.</given-names></name>
</person-group><article-title>Bacteriocins, Antimicrobial Peptides from Bacterial Origin: Overview of Their Biology and Their Impact against Multidrug-Resistant Bacteria</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>639</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8050639</pub-id><?supplied-pmid 32349409?><pub-id pub-id-type="pmid">32349409</pub-id></element-citation></ref><ref id="B68-microorganisms-11-01899"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raj</surname><given-names>T.</given-names></name>
<name><surname>Chandrasekhar</surname><given-names>K.</given-names></name>
<name><surname>Kumar</surname><given-names>A.N.</given-names></name>
<name><surname>Kim</surname><given-names>S.H.</given-names></name>
</person-group><article-title>Recent Biotechnological Trends in Lactic Acid Bacterial Fermentation for Food Processing Industries</article-title><source>Syst. Microbiol. Biomanuf.</source><year>2021</year><volume>2</volume><fpage>14</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1007/s43393-021-00044-w</pub-id></element-citation></ref><ref id="B69-microorganisms-11-01899"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lahiri</surname><given-names>D.</given-names></name>
<name><surname>Nag</surname><given-names>M.</given-names></name>
<name><surname>Dutta</surname><given-names>B.</given-names></name>
<name><surname>Sarkar</surname><given-names>T.</given-names></name>
<name><surname>Pati</surname><given-names>S.</given-names></name>
<name><surname>Basu</surname><given-names>D.</given-names></name>
<name><surname>Abdul Kari</surname><given-names>Z.</given-names></name>
<name><surname>Wei</surname><given-names>L.S.</given-names></name>
<name><surname>Smaoui</surname><given-names>S.</given-names></name>
<name><surname>Wen Goh</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Bacteriocin: A Natural Approach for Food Safety and Food Security</article-title><source>Front. Bioeng. Biotechnol.</source><year>2022</year><volume>10</volume><fpage>1978</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2022.1005918</pub-id></element-citation></ref><ref id="B70-microorganisms-11-01899"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gallo</surname><given-names>G.</given-names></name>
<name><surname>Renzone</surname><given-names>G.</given-names></name>
<name><surname>Palazzotto</surname><given-names>E.</given-names></name>
<name><surname>Monciardini</surname><given-names>P.</given-names></name>
<name><surname>Arena</surname><given-names>S.</given-names></name>
<name><surname>Faddetta</surname><given-names>T.</given-names></name>
<name><surname>Giardina</surname><given-names>A.</given-names></name>
<name><surname>Alduina</surname><given-names>R.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Sangiorgi</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Elucidating the Molecular Physiology of Lantibiotic NAI-107 Production in Microbispora ATCC-PTA-5024</article-title><source>BMC Genom.</source><year>2016</year><volume>17</volume><fpage>42</fpage><pub-id pub-id-type="doi">10.1186/s12864-016-2369-z</pub-id></element-citation></ref><ref id="B71-microorganisms-11-01899"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Sullivan</surname><given-names>J.N.</given-names></name>
<name><surname>O&#x02019;Connor</surname><given-names>P.M.</given-names></name>
<name><surname>Rea</surname><given-names>M.C.</given-names></name>
<name><surname>O&#x02019;Sullivan</surname><given-names>O.</given-names></name>
<name><surname>Walsh</surname><given-names>C.J.</given-names></name>
<name><surname>Healy</surname><given-names>B.</given-names></name>
<name><surname>Mathur</surname><given-names>H.</given-names></name>
<name><surname>Field</surname><given-names>D.</given-names></name>
<name><surname>Hill</surname><given-names>C.</given-names></name>
<name><surname>Paul Ross</surname><given-names>R.</given-names></name>
</person-group><article-title>Nisin J, a Novel Natural Nisin Variant, Is Produced by <italic toggle="yes">Staphylococcus capitis</italic> Sourced from the Human Skin Microbiota</article-title><source>J. Bacteriol.</source><year>2020</year><volume>202</volume><fpage>e00639-19</fpage><pub-id pub-id-type="doi">10.1128/JB.00639-19</pub-id><pub-id pub-id-type="pmid">31740495</pub-id></element-citation></ref><ref id="B72-microorganisms-11-01899"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Negash</surname><given-names>A.W.</given-names></name>
<name><surname>Tsehai</surname><given-names>B.A.</given-names></name>
</person-group><article-title>Current Applications of Bacteriocin</article-title><source>Int. J. Microbiol.</source><year>2020</year><volume>2020</volume><fpage>4374891</fpage><pub-id pub-id-type="doi">10.1155/2020/4374891</pub-id><pub-id pub-id-type="pmid">33488719</pub-id></element-citation></ref><ref id="B73-microorganisms-11-01899"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Janek</surname><given-names>D.</given-names></name>
<name><surname>Zipperer</surname><given-names>A.</given-names></name>
<name><surname>Kulik</surname><given-names>A.</given-names></name>
<name><surname>Krismer</surname><given-names>B.</given-names></name>
<name><surname>Peschel</surname><given-names>A.</given-names></name>
</person-group><article-title>High Frequency and Diversity of Antimicrobial Activities Produced by Nasal <italic toggle="yes">Staphylococcus</italic> Strains against Bacterial Competitors</article-title><source>PLoS Pathog.</source><year>2016</year><volume>12</volume><elocation-id>e1005812</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005812</pub-id><?supplied-pmid 27490492?><pub-id pub-id-type="pmid">27490492</pub-id></element-citation></ref><ref id="B74-microorganisms-11-01899"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barber</surname><given-names>C.C.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
</person-group><article-title>Small Molecule Natural Products in Human Nasal/Oral Microbiota</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2021</year><volume>48</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1093/jimb/kuab010</pub-id><?supplied-pmid 33945611?><pub-id pub-id-type="pmid">33945611</pub-id></element-citation></ref><ref id="B75-microorganisms-11-01899"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bitschar</surname><given-names>K.</given-names></name>
<name><surname>Sauer</surname><given-names>B.</given-names></name>
<name><surname>Focken</surname><given-names>J.</given-names></name>
<name><surname>Dehmer</surname><given-names>H.</given-names></name>
<name><surname>Moos</surname><given-names>S.</given-names></name>
<name><surname>Konnerth</surname><given-names>M.</given-names></name>
<name><surname>Schilling</surname><given-names>N.A.</given-names></name>
<name><surname>Grond</surname><given-names>S.</given-names></name>
<name><surname>Kalbacher</surname><given-names>H.</given-names></name>
<name><surname>Kurschus</surname><given-names>F.C.</given-names></name>
<etal/>
</person-group><article-title>Lugdunin Amplifies Innate Immune Responses in the Skin in Synergy with Host- and Microbiota-Derived Factors</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>2730</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-10646-7</pub-id><?supplied-pmid 31227691?><pub-id pub-id-type="pmid">31227691</pub-id></element-citation></ref><ref id="B76-microorganisms-11-01899"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krauss</surname><given-names>S.</given-names></name>
<name><surname>Zipperer</surname><given-names>A.</given-names></name>
<name><surname>Wirtz</surname><given-names>S.</given-names></name>
<name><surname>Saur</surname><given-names>J.</given-names></name>
<name><surname>Konnerth</surname><given-names>M.C.</given-names></name>
<name><surname>Heilbronner</surname><given-names>S.</given-names></name>
<name><surname>Torres Salazar</surname><given-names>B.O.</given-names></name>
<name><surname>Grond</surname><given-names>S.</given-names></name>
<name><surname>Krismer</surname><given-names>B.</given-names></name>
<name><surname>Peschel</surname><given-names>A.</given-names></name>
</person-group><article-title>Secretion of and Self-Resistance to the Novel Fibupeptide Antimicrobial Lugdunin by Distinct Abc Transporters in <italic toggle="yes">Staphylococcus lugdunensis</italic></article-title><source>Antimicrob. Agents Chemother.</source><year>2021</year><volume>65</volume><fpage>e01734-20</fpage><pub-id pub-id-type="doi">10.1128/AAC.01734-20</pub-id><?supplied-pmid 33106269?><pub-id pub-id-type="pmid">33106269</pub-id></element-citation></ref><ref id="B77-microorganisms-11-01899"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krulwich</surname><given-names>T.A.</given-names></name>
<name><surname>Sachs</surname><given-names>G.</given-names></name>
<name><surname>Padan</surname><given-names>E.</given-names></name>
</person-group><article-title>Molecular Aspects of Bacterial PH Sensing and Homeostasis</article-title><source>Nat. Rev. Microbiol.</source><year>2011</year><volume>9</volume><fpage>330</fpage><pub-id pub-id-type="doi">10.1038/nrmicro2549</pub-id><pub-id pub-id-type="pmid">21464825</pub-id></element-citation></ref><ref id="B78-microorganisms-11-01899"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farha</surname><given-names>M.A.</given-names></name>
<name><surname>Verschoor</surname><given-names>C.P.</given-names></name>
<name><surname>Bowdish</surname><given-names>D.</given-names></name>
<name><surname>Brown</surname><given-names>E.D.</given-names></name>
</person-group><article-title>Collapsing the Proton Motive Force to Identify Synergistic Combinations against <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Chem. Biol.</source><year>2013</year><volume>20</volume><fpage>1168</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2013.07.006</pub-id><pub-id pub-id-type="pmid">23972939</pub-id></element-citation></ref><ref id="B79-microorganisms-11-01899"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shields</surname><given-names>B.E.</given-names></name>
<name><surname>Tschetter</surname><given-names>A.J.</given-names></name>
<name><surname>Wanat</surname><given-names>K.A.</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus simulans</italic>: An Emerging Cutaneous Pathogen</article-title><source>JAAD Case Rep.</source><year>2016</year><volume>2</volume><fpage>428</fpage><pub-id pub-id-type="doi">10.1016/j.jdcr.2016.08.015</pub-id><pub-id pub-id-type="pmid">27957522</pub-id></element-citation></ref><ref id="B80-microorganisms-11-01899"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Power</surname><given-names>N.</given-names></name>
<name><surname>Calisti</surname><given-names>G.</given-names></name>
<name><surname>Price</surname><given-names>F.</given-names></name>
<name><surname>Watt</surname><given-names>V.</given-names></name>
<name><surname>Gamlin</surname><given-names>W.</given-names></name>
<name><surname>Dobson</surname><given-names>L.E.</given-names></name>
<name><surname>Ray</surname><given-names>S.G.</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus simulans</italic> Endocarditis of Native Aortic and Mitral Valves. Case Report and Literature Review</article-title><source>Clin. Infect. Pract.</source><year>2020</year><volume>7&#x02013;8</volume><fpage>100044</fpage><pub-id pub-id-type="doi">10.1016/j.clinpr.2020.100044</pub-id></element-citation></ref><ref id="B81-microorganisms-11-01899"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Drobeniuc</surname><given-names>A.</given-names></name>
<name><surname>Traenkner</surname><given-names>J.</given-names></name>
<name><surname>Rebolledo</surname><given-names>P.A.</given-names></name>
<name><surname>Ghazaryan</surname><given-names>V.</given-names></name>
<name><surname>Rouphael</surname><given-names>N.</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus simulans</italic>: A Rare Uropathogen</article-title><source>IDCases</source><year>2021</year><volume>25</volume><fpage>e01202</fpage><pub-id pub-id-type="doi">10.1016/j.idcr.2021.e01202</pub-id><pub-id pub-id-type="pmid">34195001</pub-id></element-citation></ref><ref id="B82-microorganisms-11-01899"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jayakumar</surname><given-names>J.</given-names></name>
<name><surname>Kumar</surname><given-names>V.A.</given-names></name>
<name><surname>Biswas</surname><given-names>L.</given-names></name>
<name><surname>Biswas</surname><given-names>R.</given-names></name>
</person-group><article-title>Therapeutic Applications of Lysostaphin against <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J. Appl. Microbiol.</source><year>2021</year><volume>131</volume><fpage>1072</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1111/jam.14985</pub-id><?supplied-pmid 33382154?><pub-id pub-id-type="pmid">33382154</pub-id></element-citation></ref><ref id="B83-microorganisms-11-01899"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<name><surname>Brooks</surname><given-names>S.A.</given-names></name>
<name><surname>Eszterhas</surname><given-names>S.</given-names></name>
<name><surname>Heim</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Xiong</surname><given-names>Y.Q.</given-names></name>
<name><surname>Fang</surname><given-names>Y.</given-names></name>
<name><surname>Kirsch</surname><given-names>J.R.</given-names></name>
<name><surname>Verma</surname><given-names>D.</given-names></name>
<name><surname>Bailey-Kellogg</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Globally Deimmunized Lysostaphin Evades Human Immune Surveillance and Enables Highly Efficacious Repeat Dosing</article-title><source>Sci. Adv.</source><year>2020</year><volume>6</volume><fpage>eabb9011</fpage><pub-id pub-id-type="doi">10.1126/sciadv.abb9011</pub-id><?supplied-pmid 32917596?><pub-id pub-id-type="pmid">32917596</pub-id></element-citation></ref><ref id="B84-microorganisms-11-01899"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blazanovic</surname><given-names>K.</given-names></name>
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<name><surname>Choi</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Salvat</surname><given-names>R.S.</given-names></name>
<name><surname>Osipovitch</surname><given-names>D.C.</given-names></name>
<name><surname>Fields</surname><given-names>J.</given-names></name>
<name><surname>Moise</surname><given-names>L.</given-names></name>
<name><surname>Berwin</surname><given-names>B.L.</given-names></name>
<name><surname>Fiering</surname><given-names>S.N.</given-names></name>
<etal/>
</person-group><article-title>Structure-Based Redesign of Lysostaphin Yields Potent Antistaphylococcal Enzymes That Evade Immune Cell Surveillance</article-title><source>Mol. Ther. Methods Clin. Dev.</source><year>2015</year><volume>2</volume><fpage>15021</fpage><pub-id pub-id-type="doi">10.1038/mtm.2015.21</pub-id><pub-id pub-id-type="pmid">26151066</pub-id></element-citation></ref><ref id="B85-microorganisms-11-01899"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tossavainen</surname><given-names>H.</given-names></name>
<name><surname>Raulinaitis</surname><given-names>V.</given-names></name>
<name><surname>Kauppinen</surname><given-names>L.</given-names></name>
<name><surname>Pentik&#x000e4;inen</surname><given-names>U.</given-names></name>
<name><surname>Maaheimo</surname><given-names>H.</given-names></name>
<name><surname>Permi</surname><given-names>P.</given-names></name>
</person-group><article-title>Structural and Functional Insights into Lysostaphin-Substrate Interaction</article-title><source>Front. Mol. Biosci.</source><year>2018</year><volume>5</volume><fpage>60</fpage><pub-id pub-id-type="doi">10.3389/fmolb.2018.00060</pub-id><?supplied-pmid 30018958?><pub-id pub-id-type="pmid">30018958</pub-id></element-citation></ref><ref id="B86-microorganisms-11-01899"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wachsman</surname><given-names>M.B.</given-names></name>
<name><surname>Castilla</surname><given-names>V.</given-names></name>
<name><surname>De Ruiz Holgado</surname><given-names>A.P.</given-names></name>
<name><surname>De Torres</surname><given-names>R.A.</given-names></name>
<name><surname>Sesma</surname><given-names>F.</given-names></name>
<name><surname>Coto</surname><given-names>C.E.</given-names></name>
</person-group><article-title>Enterocin CRL35 Inhibits Late Stages of HSV-1 and HSV-2 Replication in Vitro</article-title><source>Antivir. Res.</source><year>2003</year><volume>58</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/S0166-3542(02)00099-2</pub-id><?supplied-pmid 12719003?><pub-id pub-id-type="pmid">12719003</pub-id></element-citation></ref><ref id="B87-microorganisms-11-01899"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Medina Amado</surname><given-names>C.</given-names></name>
<name><surname>Minahk</surname><given-names>C.J.</given-names></name>
<name><surname>Cilli</surname><given-names>E.</given-names></name>
<name><surname>Oliveira</surname><given-names>R.G.</given-names></name>
<name><surname>Dupuy</surname><given-names>F.G.</given-names></name>
</person-group><article-title>Bacteriocin Enterocin CRL35 Is a Modular Peptide That Induces Non-Bilayer States in Bacterial Model Membranes</article-title><source>Biochim. Biophys. Acta (BBA)-Biomembr.</source><year>2020</year><volume>1862</volume><fpage>183135</fpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2019.183135</pub-id><?supplied-pmid 31738901?><pub-id pub-id-type="pmid">31738901</pub-id></element-citation></ref><ref id="B88-microorganisms-11-01899"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krawczyk</surname><given-names>B.</given-names></name>
<name><surname>Wityk</surname><given-names>P.</given-names></name>
<name><surname>Ga&#x00142;&#x00119;cka</surname><given-names>M.</given-names></name>
<name><surname>Michalik</surname><given-names>M.</given-names></name>
</person-group><article-title>The Many Faces of <italic toggle="yes">Enterococcus</italic> spp.&#x02014;Commensal, Probiotic and Opportunistic Pathogen</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>1900</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9091900</pub-id><pub-id pub-id-type="pmid">34576796</pub-id></element-citation></ref><ref id="B89-microorganisms-11-01899"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farizano</surname><given-names>J.V.</given-names></name>
<name><surname>D&#x000ed;az Vergara</surname><given-names>L.I.</given-names></name>
<name><surname>Masias</surname><given-names>E.</given-names></name>
<name><surname>Baillo</surname><given-names>A.A.</given-names></name>
<name><surname>Torino</surname><given-names>M.I.</given-names></name>
<name><surname>Fadda</surname><given-names>S.</given-names></name>
<name><surname>Vanden Braber</surname><given-names>N.L.</given-names></name>
<name><surname>Montenegro</surname><given-names>M.A.</given-names></name>
<name><surname>Saavedra</surname><given-names>L.</given-names></name>
<name><surname>Minahk</surname><given-names>C.</given-names></name>
</person-group><article-title>Biotechnological Use of Dairy By-Products for the Production and Microencapsulation of the Food Preservative Enterocin CRL35</article-title><source>FEMS Microbiol. Lett.</source><year>2022</year><volume>369</volume><fpage>fnac033</fpage><pub-id pub-id-type="doi">10.1093/femsle/fnac033</pub-id><pub-id pub-id-type="pmid">35325116</pub-id></element-citation></ref><ref id="B90-microorganisms-11-01899"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>F.</given-names></name>
<name><surname>Teng</surname><given-names>K.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Cao</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>T.</given-names></name>
<name><surname>Ma</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Zhong</surname><given-names>J.</given-names></name>
</person-group><article-title>Bacteriocins: Potential for Human Health</article-title><source>Oxid. Med. Cell Longev.</source><year>2021</year><volume>2021</volume><fpage>5518825</fpage><pub-id pub-id-type="doi">10.1155/2021/5518825</pub-id><pub-id pub-id-type="pmid">33936381</pub-id></element-citation></ref><ref id="B91-microorganisms-11-01899"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Quintana</surname><given-names>V.M.</given-names></name>
<name><surname>Torres</surname><given-names>N.I.</given-names></name>
<name><surname>Wachsman</surname><given-names>M.B.</given-names></name>
<name><surname>Sinko</surname><given-names>P.J.</given-names></name>
<name><surname>Castilla</surname><given-names>V.</given-names></name>
<name><surname>Chikindas</surname><given-names>M.</given-names></name>
</person-group><article-title>Anti-Herpes Simplex Virus Type 2 Activity of the Antimicrobial Peptide Subtilosin</article-title><source>J. Appl. Microbiol.</source><year>2014</year><volume>117</volume><fpage>1253</fpage><pub-id pub-id-type="doi">10.1111/jam.12618</pub-id><pub-id pub-id-type="pmid">25087911</pub-id></element-citation></ref><ref id="B92-microorganisms-11-01899"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alajlani</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Characterization of Subtilosin Gene in Wild Type <italic toggle="yes">Bacillus</italic> spp. and Possible Physiological Role</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><fpage>10521</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-13804-y</pub-id><pub-id pub-id-type="pmid">35732659</pub-id></element-citation></ref><ref id="B93-microorganisms-11-01899"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chevallereau</surname><given-names>A.</given-names></name>
<name><surname>Pons</surname><given-names>B.J.</given-names></name>
<name><surname>van Houte</surname><given-names>S.</given-names></name>
<name><surname>Westra</surname><given-names>E.R.</given-names></name>
</person-group><article-title>Interactions between Bacterial and Phage Communities in Natural Environments</article-title><source>Nat. Rev. Microbiol.</source><year>2021</year><volume>20</volume><fpage>49</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/s41579-021-00602-y</pub-id><?supplied-pmid 34373631?><pub-id pub-id-type="pmid">34373631</pub-id></element-citation></ref><ref id="B94-microorganisms-11-01899"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>Z.</given-names></name>
<name><surname>Sugimura</surname><given-names>N.</given-names></name>
<name><surname>Burgermeister</surname><given-names>E.</given-names></name>
<name><surname>Ebert</surname><given-names>M.P.</given-names></name>
<name><surname>Zuo</surname><given-names>T.</given-names></name>
<name><surname>Lan</surname><given-names>P.</given-names></name>
</person-group><article-title>The Gut Virome: A New Microbiome Component in Health and Disease</article-title><source>EBioMedicine</source><year>2022</year><volume>81</volume><fpage>104113</fpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2022.104113</pub-id><?supplied-pmid 35753153?><pub-id pub-id-type="pmid">35753153</pub-id></element-citation></ref><ref id="B95-microorganisms-11-01899"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nishijima</surname><given-names>S.</given-names></name>
<name><surname>Nagata</surname><given-names>N.</given-names></name>
<name><surname>Kiguchi</surname><given-names>Y.</given-names></name>
<name><surname>Kojima</surname><given-names>Y.</given-names></name>
<name><surname>Miyoshi-Akiyama</surname><given-names>T.</given-names></name>
<name><surname>Kimura</surname><given-names>M.</given-names></name>
<name><surname>Ohsugi</surname><given-names>M.</given-names></name>
<name><surname>Ueki</surname><given-names>K.</given-names></name>
<name><surname>Oka</surname><given-names>S.</given-names></name>
<name><surname>Mizokami</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Extensive Gut Virome Variation and Its Associations with Host and Environmental Factors in a Population-Level Cohort</article-title><source>Nat. Commun.</source><year>2022</year><volume>13</volume><fpage>5252</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-32832-w</pub-id><?supplied-pmid 36068216?><pub-id pub-id-type="pmid">36068216</pub-id></element-citation></ref><ref id="B96-microorganisms-11-01899"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oh</surname><given-names>J.</given-names></name>
<name><surname>Byrd</surname><given-names>A.L.</given-names></name>
<name><surname>Park</surname><given-names>M.</given-names></name>
<name><surname>Kong</surname><given-names>H.H.</given-names></name>
<name><surname>Segre</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Temporal Stability of the Human Skin Microbiome</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>854</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.008</pub-id><?supplied-pmid 27153496?><pub-id pub-id-type="pmid">27153496</pub-id></element-citation></ref><ref id="B97-microorganisms-11-01899"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keen</surname><given-names>E.C.</given-names></name>
</person-group><article-title>A Century of Phage Research: Bacteriophages and the Shaping of Modern Biology</article-title><source>Bioessays</source><year>2015</year><volume>37</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1002/bies.201400152</pub-id><pub-id pub-id-type="pmid">25521633</pub-id></element-citation></ref><ref id="B98-microorganisms-11-01899"><label>98.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Kasman</surname><given-names>L.M.</given-names></name>
<name><surname>Porter</surname><given-names>L.D.</given-names></name>
</person-group><article-title>Bacteriophages</article-title><source>Brenner&#x02019;s Encyclopedia of Genetics</source><edition>2nd ed.</edition><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2022</year><fpage>280</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-374984-0.00131-5</pub-id></element-citation></ref><ref id="B99-microorganisms-11-01899"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koskella</surname><given-names>B.</given-names></name>
<name><surname>Meaden</surname><given-names>S.</given-names></name>
</person-group><article-title>Understanding Bacteriophage Specificity in Natural Microbial Communities</article-title><source>Viruses</source><year>2013</year><volume>5</volume><fpage>806</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.3390/v5030806</pub-id><pub-id pub-id-type="pmid">23478639</pub-id></element-citation></ref><ref id="B100-microorganisms-11-01899"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kortright</surname><given-names>K.E.</given-names></name>
<name><surname>Chan</surname><given-names>B.K.</given-names></name>
<name><surname>Turner</surname><given-names>P.E.</given-names></name>
</person-group><article-title>High-Throughput Discovery of Phage Receptors Using Transposon Insertion Sequencing of Bacteria</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2020</year><volume>117</volume><fpage>18670</fpage><lpage>18679</lpage><pub-id pub-id-type="doi">10.1073/pnas.2001888117</pub-id><pub-id pub-id-type="pmid">32675236</pub-id></element-citation></ref><ref id="B101-microorganisms-11-01899"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dunne</surname><given-names>M.</given-names></name>
<name><surname>Prokhorov</surname><given-names>N.S.</given-names></name>
<name><surname>Loessner</surname><given-names>M.J.</given-names></name>
<name><surname>Leiman</surname><given-names>P.G.</given-names></name>
</person-group><article-title>Reprogramming Bacteriophage Host Range: Design Principles and Strategies for Engineering Receptor Binding Proteins This Review Comes from a Themed Issue on Nanobiotechnology-Phage Therapy</article-title><source>Curr. Opin. Biotechnol.</source><year>2021</year><volume>68</volume><fpage>272</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2021.02.006</pub-id><pub-id pub-id-type="pmid">33744824</pub-id></element-citation></ref><ref id="B102-microorganisms-11-01899"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Batra</surname><given-names>H.</given-names></name>
<name><surname>Dong</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Rao</surname><given-names>V.B.</given-names></name>
<name><surname>Tao</surname><given-names>P.</given-names></name>
</person-group><article-title>Genetic Engineering of Bacteriophages against Infectious Diseases</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>954</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.00954</pub-id><pub-id pub-id-type="pmid">31130936</pub-id></element-citation></ref><ref id="B103-microorganisms-11-01899"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yehl</surname><given-names>K.</given-names></name>
<name><surname>Lemire</surname><given-names>S.</given-names></name>
<name><surname>Yang</surname><given-names>A.C.</given-names></name>
<name><surname>Ando</surname><given-names>H.</given-names></name>
<name><surname>Mimee</surname><given-names>M.</given-names></name>
<name><surname>Torres</surname><given-names>M.D.T.</given-names></name>
<name><surname>de la Fuente-Nunez</surname><given-names>C.</given-names></name>
<name><surname>Lu</surname><given-names>T.K.</given-names></name>
</person-group><article-title>Engineering Phage Host-Range and Suppressing Bacterial Resistance through Phage Tail Fiber Mutagenesis</article-title><source>Cell</source><year>2019</year><volume>179</volume><fpage>459</fpage><lpage>469.e9</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.09.015</pub-id><pub-id pub-id-type="pmid">31585083</pub-id></element-citation></ref><ref id="B104-microorganisms-11-01899"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Little</surname><given-names>J.S.</given-names></name>
<name><surname>Dedrick</surname><given-names>R.M.</given-names></name>
<name><surname>Freeman</surname><given-names>K.G.</given-names></name>
<name><surname>Cristinziano</surname><given-names>M.</given-names></name>
<name><surname>Smith</surname><given-names>B.E.</given-names></name>
<name><surname>Benson</surname><given-names>C.A.</given-names></name>
<name><surname>Jhaveri</surname><given-names>T.A.</given-names></name>
<name><surname>Baden</surname><given-names>L.R.</given-names></name>
<name><surname>Solomon</surname><given-names>D.A.</given-names></name>
<name><surname>Hatfull</surname><given-names>G.F.</given-names></name>
</person-group><article-title>Bacteriophage Treatment of Disseminated Cutaneous <italic toggle="yes">Mycobacterium chelonae</italic> Infection</article-title><source>Nat. Commun.</source><year>2022</year><volume>13</volume><fpage>2313</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-29689-4</pub-id><pub-id pub-id-type="pmid">35504908</pub-id></element-citation></ref><ref id="B105-microorganisms-11-01899"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Meng</surname><given-names>W.</given-names></name>
<name><surname>Zhang</surname><given-names>K.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Lu</surname><given-names>B.</given-names></name>
<name><surname>Wang</surname><given-names>R.</given-names></name>
<name><surname>Jia</surname><given-names>K.</given-names></name>
</person-group><article-title>Topically Applied Bacteriophage to Control Multi-Drug Resistant Pseudomonas aeruginosa-Infected Wounds in a New Zealand Rabbit Model</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><fpage>4171</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.1031101</pub-id></element-citation></ref><ref id="B106-microorganisms-11-01899"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Golembo</surname><given-names>M.</given-names></name>
<name><surname>Puttagunta</surname><given-names>S.</given-names></name>
<name><surname>Rappo</surname><given-names>U.</given-names></name>
<name><surname>Weinstock</surname><given-names>E.</given-names></name>
<name><surname>Engelstein</surname><given-names>R.</given-names></name>
<name><surname>Gahali-Sass</surname><given-names>I.</given-names></name>
<name><surname>Moses</surname><given-names>A.</given-names></name>
<name><surname>Kario</surname><given-names>E.</given-names></name>
<name><surname>Ben-Dor Cohen</surname><given-names>E.</given-names></name>
<name><surname>Nicenboim</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Development of a Topical Bacteriophage Gel Targeting <italic toggle="yes">Cutibacterium acnes</italic> for Acne Prone Skin and Results of a Phase 1 Cosmetic Randomized Clinical Trial</article-title><source>Ski. Health Dis.</source><year>2022</year><volume>2</volume><fpage>e93</fpage><pub-id pub-id-type="doi">10.1002/ski2.93</pub-id><?supplied-pmid 35677920?><pub-id pub-id-type="pmid">35677920</pub-id></element-citation></ref><ref id="B107-microorganisms-11-01899"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valente</surname><given-names>L.G.</given-names></name>
<name><surname>Pitton</surname><given-names>M.</given-names></name>
<name><surname>Urholz</surname><given-names>M.F.</given-names></name>
<name><surname>Oberhaensli</surname><given-names>S.</given-names></name>
<name><surname>Bruggmann</surname><given-names>R.</given-names></name>
<name><surname>Leib</surname><given-names>S.L.</given-names></name>
<name><surname>Jakob</surname><given-names>S.M.</given-names></name>
<name><surname>Resch</surname><given-names>G.</given-names></name>
<name><surname>Que</surname><given-names>Y.-A.</given-names></name>
<name><surname>Cameron</surname><given-names>D.R.</given-names></name>
</person-group><article-title>Isolation and Characterization of Bacteriophages from the Human Skin Microbiome That Infect <italic toggle="yes">Staphylococcus epidermidis</italic></article-title><source>FEMS Microbes</source><year>2022</year><volume>2</volume><fpage>xtab003</fpage><pub-id pub-id-type="doi">10.1093/femsmc/xtab003</pub-id><?supplied-pmid 37334235?><pub-id pub-id-type="pmid">37334235</pub-id></element-citation></ref><ref id="B108-microorganisms-11-01899"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shimamori</surname><given-names>Y.</given-names></name>
<name><surname>Mitsunaka</surname><given-names>S.</given-names></name>
<name><surname>Yamashita</surname><given-names>H.</given-names></name>
<name><surname>Suzuki</surname><given-names>T.</given-names></name>
<name><surname>Kitao</surname><given-names>T.</given-names></name>
<name><surname>Kubori</surname><given-names>T.</given-names></name>
<name><surname>Nagai</surname><given-names>H.</given-names></name>
<name><surname>Takeda</surname><given-names>S.</given-names></name>
<name><surname>Ando</surname><given-names>H.</given-names></name>
</person-group><article-title>Staphylococcal Phage in Combination with <italic toggle="yes">Staphylococcus epidermidis</italic> as a Potential Treatment for <italic toggle="yes">Staphylococcus aureus</italic>-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants</article-title><source>Viruses</source><year>2020</year><volume>13</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.3390/v13010007</pub-id><pub-id pub-id-type="pmid">33375201</pub-id></element-citation></ref><ref id="B109-microorganisms-11-01899"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Metsemakers</surname><given-names>W.-J.</given-names></name>
<name><surname>Onsea</surname><given-names>J.</given-names></name>
<name><surname>Fintan Moriarty</surname><given-names>T.</given-names></name>
<name><surname>Pruidze</surname><given-names>N.</given-names></name>
<name><surname>Nadareishvili</surname><given-names>L.</given-names></name>
<name><surname>Dadiani</surname><given-names>M.</given-names></name>
<name><surname>Kutateladze</surname><given-names>M.</given-names></name>
<name><surname>Eliava</surname><given-names>G.</given-names></name>
</person-group><article-title>Bacteriophage Therapy for Human Musculoskeletal and Skin/Soft Tissue Infections</article-title><source>Clin. Microbiol. Infect.</source><year>2023</year><volume>29</volume><fpage>695</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2023.01.011</pub-id><pub-id pub-id-type="pmid">36669559</pub-id></element-citation></ref><ref id="B110-microorganisms-11-01899"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stacey</surname><given-names>H.J.</given-names></name>
<name><surname>De Soir</surname><given-names>S.</given-names></name>
<name><surname>Jones</surname><given-names>J.D.</given-names></name>
</person-group><article-title>The Safety and Efficacy of Phage Therapy: A Systematic Review of Clinical and Safety Trials</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1340</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11101340</pub-id><?supplied-pmid 36289998?><pub-id pub-id-type="pmid">36289998</pub-id></element-citation></ref><ref id="B111-microorganisms-11-01899"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Azevedo</surname><given-names>M.M.</given-names></name>
<name><surname>Pina-Vaz</surname><given-names>C.</given-names></name>
<name><surname>Rodrigues</surname><given-names>A.G.</given-names></name>
</person-group><article-title>The Role of Phage Therapy in Burn Wound Infections Management: Advantages and Pitfalls</article-title><source>J. Burn. Care Res.</source><year>2022</year><volume>43</volume><fpage>336</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1093/jbcr/irab175</pub-id><pub-id pub-id-type="pmid">34523679</pub-id></element-citation></ref><ref id="B112-microorganisms-11-01899"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mayslich</surname><given-names>C.</given-names></name>
<name><surname>Grange</surname><given-names>P.A.</given-names></name>
<name><surname>Dupin</surname><given-names>N.</given-names></name>
</person-group><article-title><italic toggle="yes">Cutibacterium acnes</italic> as an Opportunistic Pathogen: An Update of Its Virulence-Associated Factors</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>303</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9020303</pub-id><pub-id pub-id-type="pmid">33540667</pub-id></element-citation></ref><ref id="B113-microorganisms-11-01899"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verbanic</surname><given-names>S.</given-names></name>
<name><surname>Deacon</surname><given-names>J.M.</given-names></name>
<name><surname>Chen</surname><given-names>I.A.</given-names></name>
</person-group><article-title>The Chronic Wound Virome: Phage Diversity and Associations with Wounds and Healing Outcomes</article-title><source>medRxiv</source><year>2022</year><pub-id pub-id-type="doi">10.1101/2022.01.05.22268807</pub-id></element-citation></ref><ref id="B114-microorganisms-11-01899"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khullar</surname><given-names>L.</given-names></name>
<name><surname>Harjai</surname><given-names>K.</given-names></name>
<name><surname>Chhibber</surname><given-names>S.</given-names></name>
</person-group><article-title>Therapeutic and Pro-Healing Potential of Advanced Wound Dressings Loaded with Bioactive Agents</article-title><source>Future Microbiol.</source><year>2023</year><volume>18</volume><fpage>43</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.2217/fmb-2022-0162</pub-id><?supplied-pmid 36537228?><pub-id pub-id-type="pmid">36537228</pub-id></element-citation></ref><ref id="B115-microorganisms-11-01899"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Natarelli</surname><given-names>N.</given-names></name>
<name><surname>Gahoonia</surname><given-names>N.</given-names></name>
<name><surname>Sivamani</surname><given-names>R.K.</given-names></name>
</person-group><article-title>Bacteriophages and the Microbiome in Dermatology: The Role of the Phageome and a Potential Therapeutic Strategy</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>2695</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24032695</pub-id><pub-id pub-id-type="pmid">36769020</pub-id></element-citation></ref><ref id="B116-microorganisms-11-01899"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Souza</surname><given-names>C.M.</given-names></name>
<name><surname>Tanir</surname><given-names>T.</given-names></name>
<name><surname>Orellana</surname><given-names>M.</given-names></name>
<name><surname>Escalante</surname><given-names>A.</given-names></name>
<name><surname>Koeris</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations</article-title><source>Pharmaceuticals</source><year>2021</year><volume>14</volume><elocation-id>895</elocation-id><pub-id pub-id-type="doi">10.3390/ph14090895</pub-id><pub-id pub-id-type="pmid">34577595</pub-id></element-citation></ref><ref id="B117-microorganisms-11-01899"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>T.</given-names></name>
<name><surname>Yu</surname><given-names>M.</given-names></name>
<name><surname>Chen</surname><given-names>Y.L.</given-names></name>
<name><surname>Jin</surname><given-names>M.</given-names></name>
</person-group><article-title>The Life Cycle Transitions of Temperate Phages: Regulating Factors and Potential Ecological Implications</article-title><source>Viruses</source><year>2022</year><volume>14</volume><elocation-id>1904</elocation-id><pub-id pub-id-type="doi">10.3390/v14091904</pub-id><?supplied-pmid 36146712?><pub-id pub-id-type="pmid">36146712</pub-id></element-citation></ref><ref id="B118-microorganisms-11-01899"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hobbs</surname><given-names>Z.</given-names></name>
<name><surname>Abedon</surname><given-names>S.T.</given-names></name>
</person-group><article-title>Diversity of Phage Infection Types and Associated Terminology: The Problem with &#x02018;Lytic or Lysogenic&#x02019;</article-title><source>FEMS Microbiol. Lett.</source><year>2016</year><volume>363</volume><fpage>47</fpage><pub-id pub-id-type="doi">10.1093/femsle/fnw047</pub-id></element-citation></ref><ref id="B119-microorganisms-11-01899"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Venturini</surname><given-names>C.</given-names></name>
<name><surname>Fabijan</surname><given-names>A.P.</given-names></name>
<name><surname>Lubian</surname><given-names>A.F.</given-names></name>
<name><surname>Barbirz</surname><given-names>S.</given-names></name>
<name><surname>Iredell</surname><given-names>J.</given-names></name>
</person-group><article-title>Biological Foundations of Successful Bacteriophage Therapy</article-title><source>EMBO Mol. Med.</source><year>2022</year><volume>14</volume><fpage>e12435</fpage><pub-id pub-id-type="doi">10.15252/emmm.202012435</pub-id><?supplied-pmid 35620963?><pub-id pub-id-type="pmid">35620963</pub-id></element-citation></ref><ref id="B120-microorganisms-11-01899"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fillol-Salom</surname><given-names>A.</given-names></name>
<name><surname>Rost&#x000f8;l</surname><given-names>J.T.</given-names></name>
<name><surname>Ojiogu</surname><given-names>A.D.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Douce</surname><given-names>G.</given-names></name>
<name><surname>Humphrey</surname><given-names>S.</given-names></name>
<name><surname>Penad&#x000e9;s</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Bacteriophages Benefit from Mobilizing Pathogenicity Islands Encoding Immune Systems against Competitors</article-title><source>Cell</source><year>2022</year><volume>185</volume><fpage>3248</fpage><lpage>3262.e20</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.07.014</pub-id><?supplied-pmid 35985290?><pub-id pub-id-type="pmid">35985290</pub-id></element-citation></ref><ref id="B121-microorganisms-11-01899"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fern&#x000e1;ndez</surname><given-names>L.</given-names></name>
<name><surname>Gonz&#x000e1;lez</surname><given-names>S.</given-names></name>
<name><surname>Quiles-Puchalt</surname><given-names>N.</given-names></name>
<name><surname>Guti&#x000e9;rrez</surname><given-names>D.</given-names></name>
<name><surname>Penad&#x000e9;s</surname><given-names>J.R.</given-names></name>
<name><surname>Garc&#x000ed;a</surname><given-names>P.</given-names></name>
<name><surname>Rodr&#x000ed;guez</surname><given-names>A.</given-names></name>
</person-group><article-title>Lysogenization of <italic toggle="yes">Staphylococcus aureus</italic> RN450 by Phages &#x003a6;11 and &#x003a6;80&#x003b1; Leads to the Activation of the SigB Regulon</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>12662</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-31107-z</pub-id><pub-id pub-id-type="pmid">30139986</pub-id></element-citation></ref><ref id="B122-microorganisms-11-01899"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guo</surname><given-names>D.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Zhao</surname><given-names>X.</given-names></name>
<name><surname>Luo</surname><given-names>Y.</given-names></name>
<name><surname>Jin</surname><given-names>M.</given-names></name>
<name><surname>Fan</surname><given-names>F.</given-names></name>
<name><surname>Park</surname><given-names>C.</given-names></name>
<name><surname>Yang</surname><given-names>X.</given-names></name>
<name><surname>Sun</surname><given-names>C.</given-names></name>
<name><surname>Yan</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Genetic and Chemical Engineering of Phages for Controlling Multidrug-Resistant Bacteria</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><elocation-id>202</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10020202</pub-id><?supplied-pmid 33669513?><pub-id pub-id-type="pmid">33669513</pub-id></element-citation></ref><ref id="B123-microorganisms-11-01899"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Bacteriophage-Derived Endolysins Applied as Potent Biocontrol Agents to Enhance Food Safety</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>724</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8050724</pub-id><?supplied-pmid 32413991?><pub-id pub-id-type="pmid">32413991</pub-id></element-citation></ref><ref id="B124-microorganisms-11-01899"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moreau</surname><given-names>M.</given-names></name>
<name><surname>Seit&#x000e9;</surname><given-names>S.</given-names></name>
<name><surname>Aguilar</surname><given-names>L.</given-names></name>
<name><surname>Da Cruz</surname><given-names>O.</given-names></name>
<name><surname>Puech</surname><given-names>J.</given-names></name>
<name><surname>Frieling</surname><given-names>J.</given-names></name>
<name><surname>Demessant</surname><given-names>A.L.</given-names></name>
</person-group><article-title>Topical <italic toggle="yes">S. aureus</italic>-Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals with Atopic Dermatitis</article-title><source>J. Drugs Dermatol.</source><year>2021</year><volume>20</volume><fpage>1323</fpage><lpage>1328</lpage><pub-id pub-id-type="doi">10.36849/JDD.6363</pub-id><pub-id pub-id-type="pmid">34898160</pub-id></element-citation></ref><ref id="B125-microorganisms-11-01899"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Townsend</surname><given-names>E.C.</given-names></name>
<name><surname>Kalan</surname><given-names>L.R.</given-names></name>
</person-group><article-title>The Dynamic Balance of the Skin Microbiome across the Lifespan</article-title><source>Biochem. Soc. Trans.</source><year>2023</year><volume>51</volume><fpage>71</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1042/BST20220216</pub-id><?supplied-pmid 36606709?><pub-id pub-id-type="pmid">36606709</pub-id></element-citation></ref><ref id="B126-microorganisms-11-01899"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bomar</surname><given-names>L.</given-names></name>
<name><surname>Brugger</surname><given-names>S.D.</given-names></name>
<name><surname>Yost</surname><given-names>B.H.</given-names></name>
<name><surname>Davies</surname><given-names>S.S.</given-names></name>
<name><surname>Lemon</surname><given-names>K.P.</given-names></name>
</person-group><article-title><italic toggle="yes">Corynebacterium accolens</italic> Releases Antipneumococcal Free Fatty Acids from Human Nostril and Skin Surface Triacylglycerols</article-title><source>mBio</source><year>2016</year><volume>7</volume><fpage>e01725-15</fpage><pub-id pub-id-type="doi">10.1128/mBio.01725-15</pub-id><?supplied-pmid 26733066?><pub-id pub-id-type="pmid">26733066</pub-id></element-citation></ref><ref id="B127-microorganisms-11-01899"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Zhao</surname><given-names>Q.</given-names></name>
<name><surname>Zhong</surname><given-names>Q.</given-names></name>
<name><surname>Cheng</surname><given-names>D.</given-names></name>
<name><surname>Krutmann</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Xia</surname><given-names>J.</given-names></name>
</person-group><article-title>Skin Microbiome, Metabolome and Skin Phenome, from the Perspectives of Skin as an Ecosystem</article-title><source>Phenomics</source><year>2022</year><volume>2</volume><fpage>363</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1007/s43657-022-00073-y</pub-id><?supplied-pmid 36939800?><pub-id pub-id-type="pmid">36939800</pub-id></element-citation></ref><ref id="B128-microorganisms-11-01899"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>I.</given-names></name>
<name><surname>Ichimura</surname><given-names>A.</given-names></name>
<name><surname>Ohue-Kitano</surname><given-names>R.</given-names></name>
<name><surname>Igarashi</surname><given-names>M.</given-names></name>
</person-group><article-title>Free Fatty Acid Receptors in Health and Disease</article-title><source>Physiol. Rev.</source><year>2020</year><volume>100</volume><fpage>171</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1152/physrev.00041.2018</pub-id><?supplied-pmid 31487233?><pub-id pub-id-type="pmid">31487233</pub-id></element-citation></ref><ref id="B129-microorganisms-11-01899"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rawlings</surname><given-names>A.</given-names></name>
<name><surname>Sabin</surname><given-names>R.</given-names></name>
<name><surname>Harding</surname><given-names>C.</given-names></name>
<name><surname>Watkinson</surname><given-names>A.</given-names></name>
<name><surname>Banks</surname><given-names>J.</given-names></name>
<name><surname>Ackerman</surname><given-names>C.</given-names></name>
</person-group><article-title>The Effect of Glycerol and Humidity on Desmosome Degradation in Stratum Corneum</article-title><source>Arch. Dermatol. Res.</source><year>1995</year><volume>287</volume><fpage>457</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1007/BF00373429</pub-id><pub-id pub-id-type="pmid">7625857</pub-id></element-citation></ref><ref id="B130-microorganisms-11-01899"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Atrux-Tallau</surname><given-names>N.</given-names></name>
<name><surname>Romagny</surname><given-names>C.</given-names></name>
<name><surname>Padois</surname><given-names>K.</given-names></name>
<name><surname>Denis</surname><given-names>A.</given-names></name>
<name><surname>Haftek</surname><given-names>M.</given-names></name>
<name><surname>Falson</surname><given-names>F.</given-names></name>
<name><surname>Pirot</surname><given-names>F.</given-names></name>
<name><surname>Maibach</surname><given-names>H.I.</given-names></name>
</person-group><article-title>Effects of Glycerol on Human Skin Damaged by Acute Sodium Lauryl Sulphate Treatment</article-title><source>Arch. Dermatol. Res.</source><year>2010</year><volume>302</volume><fpage>435</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1007/s00403-009-1021-z</pub-id><pub-id pub-id-type="pmid">20043170</pub-id></element-citation></ref><ref id="B131-microorganisms-11-01899"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salgaonkar</surname><given-names>N.</given-names></name>
<name><surname>Kadamkode</surname><given-names>V.</given-names></name>
<name><surname>Kumaran</surname><given-names>S.</given-names></name>
<name><surname>Mallemala</surname><given-names>P.</given-names></name>
<name><surname>Christy</surname><given-names>E.</given-names></name>
<name><surname>Appavoo</surname><given-names>S.</given-names></name>
<name><surname>Majumdar</surname><given-names>A.</given-names></name>
<name><surname>Mitra</surname><given-names>R.</given-names></name>
<name><surname>Dasgupta</surname><given-names>A.</given-names></name>
</person-group><article-title>Glycerol Fermentation by Skin Bacteria Generates Lactic Acid and Upregulates the Expression Levels of Genes Associated with the Skin Barrier Function</article-title><source>Exp. Dermatol.</source><year>2022</year><volume>31</volume><fpage>1364</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1111/exd.14604</pub-id><pub-id pub-id-type="pmid">35535416</pub-id></element-citation></ref><ref id="B132-microorganisms-11-01899"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Moran</surname><given-names>J.C.</given-names></name>
<name><surname>Campbell-Lee</surname><given-names>S.</given-names></name>
<name><surname>Horsburgh</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Transcriptomic Responses and Survival Mechanisms of Staphylococci to the Antimicrobial Skin Lipid Sphingosine</article-title><source>Antimicrob. Agents Chemother.</source><year>2022</year><volume>66</volume><fpage>e00569-21</fpage><pub-id pub-id-type="doi">10.1128/aac.00569-21</pub-id><?supplied-pmid 34902269?><pub-id pub-id-type="pmid">34902269</pub-id></element-citation></ref><ref id="B133-microorganisms-11-01899"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Araki</surname><given-names>H.</given-names></name>
<name><surname>Hajime</surname><given-names>M.</given-names></name>
<name><surname>Tamura</surname><given-names>E.</given-names></name>
<name><surname>Hagihara</surname><given-names>H.</given-names></name>
<name><surname>Takigawa</surname><given-names>H.</given-names></name>
<name><surname>Araki</surname><given-names>H.</given-names></name>
<name><surname>Hajime</surname><given-names>M.</given-names></name>
<name><surname>Tamura</surname><given-names>E.</given-names></name>
<name><surname>Hagihara</surname><given-names>H.</given-names></name>
<name><surname>Takigawa</surname><given-names>H.</given-names></name>
</person-group><article-title>Human Sebaceous Cis-6-Hexadecenoic Acid: Possible Application of an Innate Antimicrobial Substance to Cosmetic Products for Mucous Membrane</article-title><source>J. Cosmet. Dermatol. Sci. Appl.</source><year>2017</year><volume>7</volume><fpage>133</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.4236/jcdsa.2017.72012</pub-id></element-citation></ref><ref id="B134-microorganisms-11-01899"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brandwein</surname><given-names>M.</given-names></name>
<name><surname>Steinberg</surname><given-names>D.</given-names></name>
<name><surname>Meshner</surname><given-names>S.</given-names></name>
</person-group><article-title>Microbial Biofilms and the Human Skin Microbiome</article-title><source>npj Biofilms Microbiomes</source><year>2016</year><volume>2</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/s41522-016-0004-z</pub-id><?supplied-pmid 28649397?><pub-id pub-id-type="pmid">28649395</pub-id></element-citation></ref><ref id="B135-microorganisms-11-01899"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Domenico</surname><given-names>E.G.D.</given-names></name>
<name><surname>Cavallo</surname><given-names>I.</given-names></name>
<name><surname>Capitanio</surname><given-names>B.</given-names></name>
<name><surname>Ascenzioni</surname><given-names>F.</given-names></name>
<name><surname>Pimpinelli</surname><given-names>F.</given-names></name>
<name><surname>Morrone</surname><given-names>A.</given-names></name>
<name><surname>Ensoli</surname><given-names>F.</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> and the Cutaneous Microbiota Biofilms in the Pathogenesis of Atopic Dermatitis</article-title><source>Microorganisms</source><year>2019</year><volume>7</volume><elocation-id>301</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms7090301</pub-id><?supplied-pmid 31470558?><pub-id pub-id-type="pmid">31470558</pub-id></element-citation></ref><ref id="B136-microorganisms-11-01899"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vestby</surname><given-names>L.K.</given-names></name>
<name><surname>Gr&#x000f8;nseth</surname><given-names>T.</given-names></name>
<name><surname>Simm</surname><given-names>R.</given-names></name>
<name><surname>Nesse</surname><given-names>L.L.</given-names></name>
</person-group><article-title>Bacterial Biofilm and Its Role in the Pathogenesis of Disease</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9020059</pub-id><?supplied-pmid 32028684?><pub-id pub-id-type="pmid">32028684</pub-id></element-citation></ref><ref id="B137-microorganisms-11-01899"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gonzalez</surname><given-names>T.</given-names></name>
<name><surname>Stevens</surname><given-names>M.L.</given-names></name>
<name><surname>Baatyrbek</surname><given-names>A.K.</given-names></name>
<name><surname>Alarcon</surname><given-names>R.</given-names></name>
<name><surname>He</surname><given-names>H.</given-names></name>
<name><surname>Kroner</surname><given-names>J.W.</given-names></name>
<name><surname>Spagna</surname><given-names>D.</given-names></name>
<name><surname>Grashel</surname><given-names>B.</given-names></name>
<name><surname>Sidler</surname><given-names>E.</given-names></name>
<name><surname>Martin</surname><given-names>L.J.</given-names></name>
<etal/>
</person-group><article-title>Biofilm Propensity of <italic toggle="yes">Staphylococcus aureus</italic> Skin Isolates Is Associated with Increased Atopic Dermatitis Severity and Barrier Dysfunction in the MPAACH Pediatric Cohort</article-title><source>Allergy</source><year>2021</year><volume>76</volume><fpage>302</fpage><pub-id pub-id-type="doi">10.1111/all.14489</pub-id><pub-id pub-id-type="pmid">32640045</pub-id></element-citation></ref><ref id="B138-microorganisms-11-01899"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kuehnast</surname><given-names>T.</given-names></name>
<name><surname>Cakar</surname><given-names>F.</given-names></name>
<name><surname>Weinh&#x000e4;upl</surname><given-names>T.</given-names></name>
<name><surname>Pilz</surname><given-names>A.</given-names></name>
<name><surname>Selak</surname><given-names>S.</given-names></name>
<name><surname>Schmidt</surname><given-names>M.A.</given-names></name>
<name><surname>R&#x000fc;ter</surname><given-names>C.</given-names></name>
<name><surname>Schild</surname><given-names>S.</given-names></name>
</person-group><article-title>Comparative Analyses of Biofilm Formation among Different <italic toggle="yes">Cutibacterium acnes</italic> Isolates</article-title><source>Int. J. Med. Microbiol.</source><year>2018</year><volume>308</volume><fpage>1027</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2018.09.005</pub-id><pub-id pub-id-type="pmid">30268774</pub-id></element-citation></ref><ref id="B139-microorganisms-11-01899"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>Y.</given-names></name>
<name><surname>Cai</surname><given-names>W.J.</given-names></name>
<name><surname>Ren</surname><given-names>Z.</given-names></name>
<name><surname>Han</surname><given-names>P.</given-names></name>
</person-group><article-title>The Role of Staphylococcal Biofilm on the Surface of Implants in Orthopedic Infection</article-title><source>Microorganisms</source><year>2022</year><volume>10</volume><elocation-id>1909</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms10101909</pub-id><pub-id pub-id-type="pmid">36296183</pub-id></element-citation></ref><ref id="B140-microorganisms-11-01899"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garcia</surname><given-names>D.</given-names></name>
<name><surname>Mayfield</surname><given-names>C.K.</given-names></name>
<name><surname>Leong</surname><given-names>J.</given-names></name>
<name><surname>Deckey</surname><given-names>D.G.</given-names></name>
<name><surname>Zega</surname><given-names>A.</given-names></name>
<name><surname>Glasser</surname><given-names>J.</given-names></name>
<name><surname>Daniels</surname><given-names>A.H.</given-names></name>
<name><surname>Eberson</surname><given-names>C.</given-names></name>
<name><surname>Green</surname><given-names>A.</given-names></name>
<name><surname>Born</surname><given-names>C.</given-names></name>
</person-group><article-title>Early Adherence and Biofilm Formation of <italic toggle="yes">Cutibacterium acnes</italic> (Formerly <italic toggle="yes">Propionibacterium acnes</italic>) on Spinal Implant Materials</article-title><source>Spine J.</source><year>2020</year><volume>20</volume><fpage>981</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1016/j.spinee.2020.01.001</pub-id><pub-id pub-id-type="pmid">31972305</pub-id></element-citation></ref><ref id="B141-microorganisms-11-01899"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nowrouzian</surname><given-names>F.L.</given-names></name>
<name><surname>Ljung</surname><given-names>A.</given-names></name>
<name><surname>Hesselmar</surname><given-names>B.</given-names></name>
<name><surname>Nilsson</surname><given-names>S.</given-names></name>
<name><surname>Adlerberth</surname><given-names>I.</given-names></name>
<name><surname>Wolda</surname><given-names>A.E.</given-names></name>
</person-group><article-title>Bacterial Carriage of Genes Encoding Fibronectin-Binding Proteins Is Associated with Long-Term Persistence of <italic toggle="yes">Staphylococcus aureus</italic> in the Nasal and Gut Microbiota of Infants</article-title><source>Appl. Environ. Microbiol.</source><year>2021</year><volume>87</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1128/AEM.00671-21</pub-id></element-citation></ref><ref id="B142-microorganisms-11-01899"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sugimoto</surname><given-names>S.</given-names></name>
<name><surname>Iwamoto</surname><given-names>T.</given-names></name>
<name><surname>Takada</surname><given-names>K.</given-names></name>
<name><surname>Okuda</surname><given-names>K.I.</given-names></name>
<name><surname>Tajima</surname><given-names>A.</given-names></name>
<name><surname>Iwase</surname><given-names>T.</given-names></name>
<name><surname>Mizunoe</surname><given-names>Y.</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus epidermidis</italic> Esp Degrades Specific Proteins Associated with <italic toggle="yes">Staphylococcus aureus</italic> Biofilm Formation and Host-Pathogen Interaction</article-title><source>J. Bacteriol.</source><year>2013</year><volume>195</volume><fpage>1645</fpage><lpage>1655</lpage><pub-id pub-id-type="doi">10.1128/JB.01672-12</pub-id><pub-id pub-id-type="pmid">23316041</pub-id></element-citation></ref><ref id="B143-microorganisms-11-01899"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iwase</surname><given-names>T.</given-names></name>
<name><surname>Uehara</surname><given-names>Y.</given-names></name>
<name><surname>Shinji</surname><given-names>H.</given-names></name>
<name><surname>Tajima</surname><given-names>A.</given-names></name>
<name><surname>Seo</surname><given-names>H.</given-names></name>
<name><surname>Takada</surname><given-names>K.</given-names></name>
<name><surname>Agata</surname><given-names>T.</given-names></name>
<name><surname>Mizunoe</surname><given-names>Y.</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus epidermidis</italic> Esp Inhibits <italic toggle="yes">Staphylococcus aureus</italic> Biofilm Formation and Nasal Colonization</article-title><source>Nature</source><year>2010</year><volume>465</volume><fpage>346</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1038/nature09074</pub-id><pub-id pub-id-type="pmid">20485435</pub-id></element-citation></ref><ref id="B144-microorganisms-11-01899"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kumari</surname><given-names>A.</given-names></name>
<name><surname>Singh</surname><given-names>R.</given-names></name>
</person-group><article-title>Antibiofilm Activity of Small Molecules Produced by <italic toggle="yes">Staphylococcus epidermidis</italic> against <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2020</year><volume>86</volume><fpage>e00627-20</fpage><pub-id pub-id-type="doi">10.1128/AEM.00627-20</pub-id><?supplied-pmid 32358008?><pub-id pub-id-type="pmid">32358008</pub-id></element-citation></ref><ref id="B145-microorganisms-11-01899"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Glatthardt</surname><given-names>T.</given-names></name>
<name><surname>Curityba de Mello Campos</surname><given-names>J.</given-names></name>
<name><surname>Chamon</surname><given-names>R.C.</given-names></name>
<name><surname>Freitas de S&#x000e1; Coimbra</surname><given-names>T.</given-names></name>
<name><surname>de Almeida Rocha</surname><given-names>G.</given-names></name>
<name><surname>Figueira de Melo</surname><given-names>M.A.</given-names></name>
<name><surname>Parente</surname><given-names>T.E.</given-names></name>
<name><surname>Lobo</surname><given-names>L.A.</given-names></name>
<name><surname>Antunes</surname><given-names>L.C.M.</given-names></name>
<name><surname>dos Santos</surname><given-names>K.R.N.</given-names></name>
<etal/>
</person-group><article-title>Small Molecules Produced by Commensal <italic toggle="yes">Staphylococcus epidermidis</italic> Disrupt Formation of Biofilms by <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2020</year><volume>86</volume><fpage>e02539-19</fpage><pub-id pub-id-type="doi">10.1128/AEM.02539-19</pub-id><pub-id pub-id-type="pmid">31862721</pub-id></element-citation></ref><ref id="B146-microorganisms-11-01899"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brooks</surname><given-names>J.L.</given-names></name>
<name><surname>Jefferson</surname><given-names>K.K.</given-names></name>
</person-group><article-title>Phase Variation of Poly-N-Acetylglucosamine Expression in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>PLoS Pathog.</source><year>2014</year><volume>10</volume><elocation-id>e1004292</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004292</pub-id><pub-id pub-id-type="pmid">25077798</pub-id></element-citation></ref><ref id="B147-microorganisms-11-01899"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.J.</given-names></name>
<name><surname>Lee</surname><given-names>B.J.</given-names></name>
<name><surname>Kwon</surname><given-names>A.R.</given-names></name>
</person-group><article-title>The Grease Trap: Uncovering the Mechanism of the Hydrophobic Lid in <italic toggle="yes">Cutibacterium acnes</italic> Lipase</article-title><source>J. Lipid Res.</source><year>2020</year><volume>61</volume><fpage>722</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1194/jlr.RA119000279</pub-id><pub-id pub-id-type="pmid">32165394</pub-id></element-citation></ref><ref id="B148-microorganisms-11-01899"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Br&#x000fc;ggemann</surname><given-names>H.</given-names></name>
<name><surname>Salar-Vidal</surname><given-names>L.</given-names></name>
<name><surname>Gollnick</surname><given-names>H.P.M.</given-names></name>
<name><surname>Lood</surname><given-names>R.</given-names></name>
</person-group><article-title>A Janus-Faced Bacterium: Host-Beneficial and -Detrimental Roles of <italic toggle="yes">Cutibacterium acnes</italic></article-title><source>Front. Microbiol.</source><year>2021</year><volume>12</volume><fpage>673845</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.673845</pub-id><pub-id pub-id-type="pmid">34135880</pub-id></element-citation></ref><ref id="B149-microorganisms-11-01899"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>T.Y.</given-names></name>
<name><surname>Jiang</surname><given-names>Y.E.</given-names></name>
<name><surname>Scott</surname><given-names>D.A.</given-names></name>
</person-group><article-title>Culturable Bacteria in the Entire Acne Lesion and Short-Chain Fatty Acid Metabolites of <italic toggle="yes">Cutibacterium acnes</italic> and <italic toggle="yes">Staphylococcus epidermidis</italic> Isolates</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2022</year><volume>622</volume><fpage>45</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2022.06.068</pub-id><pub-id pub-id-type="pmid">35843093</pub-id></element-citation></ref><ref id="B150-microorganisms-11-01899"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sanford</surname><given-names>J.A.</given-names></name>
<name><surname>O&#x02019;Neill</surname><given-names>A.M.</given-names></name>
<name><surname>Zouboulis</surname><given-names>C.C.</given-names></name>
<name><surname>Gallo</surname><given-names>R.L.</given-names></name>
</person-group><article-title>Short-Chain Fatty Acids from <italic toggle="yes">Cutibacterium acnes</italic> Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes</article-title><source>J. Immunol.</source><year>2019</year><volume>202</volume><fpage>1767</fpage><lpage>1776</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1800893</pub-id><?supplied-pmid 30737272?><pub-id pub-id-type="pmid">30737272</pub-id></element-citation></ref><ref id="B151-microorganisms-11-01899"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakamura</surname><given-names>K.</given-names></name>
<name><surname>O&#x02019;Neill</surname><given-names>A.M.</given-names></name>
<name><surname>Williams</surname><given-names>M.R.</given-names></name>
<name><surname>Cau</surname><given-names>L.</given-names></name>
<name><surname>Nakatsuji</surname><given-names>T.</given-names></name>
<name><surname>Horswill</surname><given-names>A.R.</given-names></name>
<name><surname>Gallo</surname><given-names>R.L.</given-names></name>
</person-group><article-title>Short Chain Fatty Acids Produced by <italic toggle="yes">Cutibacterium acnes</italic> Inhibit Biofilm Formation by <italic toggle="yes">Staphylococcus epidermidis</italic></article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>21237</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-77790-9</pub-id><?supplied-pmid 33277548?><pub-id pub-id-type="pmid">33277548</pub-id></element-citation></ref><ref id="B152-microorganisms-11-01899"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gill</surname><given-names>P.A.</given-names></name>
<name><surname>van Zelm</surname><given-names>M.C.</given-names></name>
<name><surname>Muir</surname><given-names>J.G.</given-names></name>
<name><surname>Gibson</surname><given-names>P.R.</given-names></name>
</person-group><article-title>Review Article: Short Chain Fatty Acids as Potential Therapeutic Agents in Human Gastrointestinal and Inflammatory Disorders</article-title><source>Aliment. Pharmacol. Ther.</source><year>2018</year><volume>48</volume><fpage>15</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1111/APT.14689</pub-id><?supplied-pmid 29722430?><pub-id pub-id-type="pmid">29722430</pub-id></element-citation></ref><ref id="B153-microorganisms-11-01899"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keshari</surname><given-names>S.</given-names></name>
<name><surname>Balasubramaniam</surname><given-names>A.</given-names></name>
<name><surname>Myagmardoloonjin</surname><given-names>B.</given-names></name>
<name><surname>Herr</surname><given-names>D.R.</given-names></name>
<name><surname>Negari</surname><given-names>I.P.</given-names></name>
<name><surname>Huang</surname><given-names>C.M.</given-names></name>
</person-group><article-title>Butyric Acid from Probiotic <italic toggle="yes">Staphylococcus epidermidis</italic> in the Skin Microbiome Down-Regulates the Ultraviolet-Induced Pro-Inflammatory IL-6 Cytokine via Short-Chain Fatty Acid Receptor</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>4477</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20184477</pub-id><pub-id pub-id-type="pmid">31514281</pub-id></element-citation></ref><ref id="B154-microorganisms-11-01899"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xiao</surname><given-names>X.</given-names></name>
<name><surname>Hu</surname><given-names>X.</given-names></name>
<name><surname>Yao</surname><given-names>J.</given-names></name>
<name><surname>Cao</surname><given-names>W.</given-names></name>
<name><surname>Zou</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Qin</surname><given-names>H.</given-names></name>
<name><surname>Zhong</surname><given-names>D.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Xue</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>The Role of Short-Chain Fatty Acids in Inflammatory Skin Diseases</article-title><source>Front. Microbiol.</source><year>2023</year><volume>13</volume><fpage>5417</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.1083432</pub-id><?supplied-pmid 36817115?><pub-id pub-id-type="pmid">36817115</pub-id></element-citation></ref><ref id="B155-microorganisms-11-01899"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scheuerl</surname><given-names>T.</given-names></name>
<name><surname>Hopkins</surname><given-names>M.</given-names></name>
<name><surname>Nowell</surname><given-names>R.W.</given-names></name>
<name><surname>Rivett</surname><given-names>D.W.</given-names></name>
<name><surname>Barraclough</surname><given-names>T.G.</given-names></name>
<name><surname>Bell</surname><given-names>T.</given-names></name>
</person-group><article-title>Bacterial Adaptation Is Constrained in Complex Communities</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>754</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-14570-z</pub-id><?supplied-pmid 32029713?><pub-id pub-id-type="pmid">32029713</pub-id></element-citation></ref><ref id="B156-microorganisms-11-01899"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abisado</surname><given-names>R.G.</given-names></name>
<name><surname>Benomar</surname><given-names>S.</given-names></name>
<name><surname>Klaus</surname><given-names>J.R.</given-names></name>
<name><surname>Dandekar</surname><given-names>A.A.</given-names></name>
<name><surname>Chandler</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Bacterial Quorum Sensing and Microbial Community Interactions</article-title><source>mBio</source><year>2018</year><volume>9</volume><fpage>e02331-17</fpage><pub-id pub-id-type="doi">10.1128/mBio.02331-17</pub-id><?supplied-pmid 29789364?><pub-id pub-id-type="pmid">29789364</pub-id></element-citation></ref><ref id="B157-microorganisms-11-01899"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>M.B.</given-names></name>
<name><surname>Bassler</surname><given-names>B.L.</given-names></name>
</person-group><article-title>Quorum Sensing in Bacteria</article-title><source>Annu. Rev. Microbiol.</source><year>2001</year><volume>55</volume><fpage>165</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.55.1.165</pub-id><pub-id pub-id-type="pmid">11544353</pub-id></element-citation></ref><ref id="B158-microorganisms-11-01899"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abbamondi</surname><given-names>G.R.</given-names></name>
<name><surname>Tommonaro</surname><given-names>G.</given-names></name>
</person-group><article-title>Research Progress and Hopeful Strategies of Application of Quorum Sensing in Food, Agriculture and Nanomedicine</article-title><source>Microorganisms</source><year>2022</year><volume>10</volume><elocation-id>1192</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms10061192</pub-id><pub-id pub-id-type="pmid">35744710</pub-id></element-citation></ref><ref id="B159-microorganisms-11-01899"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haque</surname><given-names>S.</given-names></name>
<name><surname>Yadav</surname><given-names>D.K.</given-names></name>
<name><surname>Bisht</surname><given-names>S.C.</given-names></name>
<name><surname>Yadav</surname><given-names>N.</given-names></name>
<name><surname>Singh</surname><given-names>V.</given-names></name>
<name><surname>Dubey</surname><given-names>K.K.</given-names></name>
<name><surname>Jawed</surname><given-names>A.</given-names></name>
<name><surname>Wahid</surname><given-names>M.</given-names></name>
<name><surname>Dar</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Quorum Sensing Pathways in Gram-Positive and -Negative Bacteria: Potential of Their Interruption in Abating Drug Resistance</article-title><source>J. Chem.</source><year>2019</year><volume>31</volume><fpage>161</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1080/1120009X.2019.1599175</pub-id></element-citation></ref><ref id="B160-microorganisms-11-01899"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rutherford</surname><given-names>S.T.</given-names></name>
<name><surname>Bassler</surname><given-names>B.L.</given-names></name>
</person-group><article-title>Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control</article-title><source>Cold Spring Harb. Perspect. Med.</source><year>2012</year><volume>2</volume><fpage>a012427</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a012427</pub-id><pub-id pub-id-type="pmid">23125205</pub-id></element-citation></ref><ref id="B161-microorganisms-11-01899"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>L.</given-names></name>
<name><surname>Ku</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
</person-group><article-title>Editorial: Frontiers in Bacterial Quorum Sensing Research</article-title><source>Front. Cell Infect. Microbiol.</source><year>2022</year><volume>12</volume><fpage>1293</fpage><pub-id pub-id-type="doi">10.3389/FCIMB.2022.999388</pub-id></element-citation></ref><ref id="B162-microorganisms-11-01899"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grando</surname><given-names>K.</given-names></name>
<name><surname>Nicastro</surname><given-names>L.K.</given-names></name>
<name><surname>Tursi</surname><given-names>S.A.</given-names></name>
<name><surname>De Anda</surname><given-names>J.</given-names></name>
<name><surname>Lee</surname><given-names>E.Y.</given-names></name>
<name><surname>Wong</surname><given-names>G.C.L.</given-names></name>
<name><surname>T&#x000fc;kel</surname><given-names>&#x000c7;.</given-names></name>
</person-group><article-title>Phenol-Soluble Modulins from <italic toggle="yes">Staphylococcus aureus</italic> Biofilms Form Complexes with DNA to Drive Autoimmunity</article-title><source>Front. Cell Infect. Microbiol.</source><year>2022</year><volume>12</volume><fpage>517</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2022.884065</pub-id></element-citation></ref><ref id="B163-microorganisms-11-01899"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Erez</surname><given-names>Z.</given-names></name>
<name><surname>Steinberger-Levy</surname><given-names>I.</given-names></name>
<name><surname>Shamir</surname><given-names>M.</given-names></name>
<name><surname>Doron</surname><given-names>S.</given-names></name>
<name><surname>Stokar-Avihail</surname><given-names>A.</given-names></name>
<name><surname>Peleg</surname><given-names>Y.</given-names></name>
<name><surname>Melamed</surname><given-names>S.</given-names></name>
<name><surname>Leavitt</surname><given-names>A.</given-names></name>
<name><surname>Savidor</surname><given-names>A.</given-names></name>
<name><surname>Albeck</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Communication between Viruses Guides Lysis&#x02013;Lysogeny Decisions</article-title><source>Nature</source><year>2017</year><volume>541</volume><fpage>488</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1038/nature21049</pub-id><pub-id pub-id-type="pmid">28099413</pub-id></element-citation></ref><ref id="B164-microorganisms-11-01899"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Whiteley</surname><given-names>M.</given-names></name>
<name><surname>Diggle</surname><given-names>S.P.</given-names></name>
<name><surname>Greenberg</surname><given-names>E.P.</given-names></name>
</person-group><article-title>Progress in and Promise of Bacterial Quorum Sensing Research</article-title><source>Nature</source><year>2017</year><volume>551</volume><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1038/nature24624</pub-id><?supplied-pmid 29144467?><pub-id pub-id-type="pmid">29144467</pub-id></element-citation></ref><ref id="B165-microorganisms-11-01899"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parlet</surname><given-names>C.P.</given-names></name>
<name><surname>Brown</surname><given-names>M.M.</given-names></name>
<name><surname>Horswill</surname><given-names>A.R.</given-names></name>
</person-group><article-title>Commensal Staphylococci Influence <italic toggle="yes">Staphylococcus aureus</italic> Skin Colonization and Disease</article-title><source>Trends Microbiol.</source><year>2019</year><volume>27</volume><fpage>497</fpage><pub-id pub-id-type="doi">10.1016/j.tim.2019.01.008</pub-id><?supplied-pmid 30846311?><pub-id pub-id-type="pmid">30846311</pub-id></element-citation></ref><ref id="B166-microorganisms-11-01899"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brown</surname><given-names>M.M.</given-names></name>
<name><surname>Kwiecinski</surname><given-names>J.M.</given-names></name>
<name><surname>Cruz</surname><given-names>L.M.</given-names></name>
<name><surname>Shahbandi</surname><given-names>A.</given-names></name>
<name><surname>Todd</surname><given-names>D.A.</given-names></name>
<name><surname>Cech</surname><given-names>N.B.</given-names></name>
<name><surname>Horswill</surname><given-names>A.R.</given-names></name>
</person-group><article-title>Novel Peptide from Commensal <italic toggle="yes">Staphylococcus simulans</italic> Blocks Methicillin-Resistant <italic toggle="yes">Staphylococcus aureus</italic> Quorum Sensing and Protects Host Skin from Damage</article-title><source>Antimicrob. Agents Chemother.</source><year>2020</year><volume>64</volume><fpage>e00172-20</fpage><pub-id pub-id-type="doi">10.1128/AAC.00172-20</pub-id><?supplied-pmid 32253213?><pub-id pub-id-type="pmid">32253213</pub-id></element-citation></ref><ref id="B167-microorganisms-11-01899"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Severn</surname><given-names>M.M.</given-names></name>
<name><surname>Williams</surname><given-names>M.R.</given-names></name>
<name><surname>Shahbandi</surname><given-names>A.</given-names></name>
<name><surname>Bunch</surname><given-names>Z.L.</given-names></name>
<name><surname>Lyon</surname><given-names>L.M.</given-names></name>
<name><surname>Nguyen</surname><given-names>A.</given-names></name>
<name><surname>Zaramela</surname><given-names>L.S.</given-names></name>
<name><surname>Todd</surname><given-names>D.A.</given-names></name>
<name><surname>Zengler</surname><given-names>K.</given-names></name>
<name><surname>Cech</surname><given-names>N.B.</given-names></name>
<etal/>
</person-group><article-title>The Ubiquitous Human Skin Commensal <italic toggle="yes">Staphylococcus hominis</italic> Protects against Opportunistic Pathogens</article-title><source>mBio</source><year>2022</year><volume>13</volume><fpage>e00930-22</fpage><pub-id pub-id-type="doi">10.1128/mbio.00930-22</pub-id><pub-id pub-id-type="pmid">35608301</pub-id></element-citation></ref><ref id="B168-microorganisms-11-01899"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Severn</surname><given-names>M.M.</given-names></name>
<name><surname>Cho</surname><given-names>Y.S.K.</given-names></name>
<name><surname>Manzer</surname><given-names>H.S.</given-names></name>
<name><surname>Bunch</surname><given-names>Z.L.</given-names></name>
<name><surname>Shahbandi</surname><given-names>A.</given-names></name>
<name><surname>Todd</surname><given-names>D.A.</given-names></name>
<name><surname>Cech</surname><given-names>N.B.</given-names></name>
<name><surname>Horswill</surname><given-names>A.R.</given-names></name>
</person-group><article-title>The Commensal <italic toggle="yes">Staphylococcus warneri</italic> Makes Peptide Inhibitors of MRSA Quorum Sensing That Protect Skin from Atopic or Necrotic Damage</article-title><source>J. Investig. Dermatol.</source><year>2022</year><volume>142</volume><fpage>3349</fpage><lpage>3352.e5</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2022.05.1092</pub-id><?supplied-pmid 35803321?><pub-id pub-id-type="pmid">35803321</pub-id></element-citation></ref><ref id="B169-microorganisms-11-01899"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pena</surname><given-names>R.T.</given-names></name>
<name><surname>Blasco</surname><given-names>L.</given-names></name>
<name><surname>Ambroa</surname><given-names>A.</given-names></name>
<name><surname>Gonz&#x000e1;lez-Pedrajo</surname><given-names>B.</given-names></name>
<name><surname>Fern&#x000e1;ndez-Garc&#x000ed;a</surname><given-names>L.</given-names></name>
<name><surname>L&#x000f3;pez</surname><given-names>M.</given-names></name>
<name><surname>Bleriot</surname><given-names>I.</given-names></name>
<name><surname>Bou</surname><given-names>G.</given-names></name>
<name><surname>Garc&#x000ed;a-Contreras</surname><given-names>R.</given-names></name>
<name><surname>Wood</surname><given-names>T.K.</given-names></name>
<etal/>
</person-group><article-title>Relationship between Quorum Sensing and Secretion Systems</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>1100</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.01100</pub-id><pub-id pub-id-type="pmid">31231316</pub-id></element-citation></ref><ref id="B170-microorganisms-11-01899"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghosh</surname><given-names>A.</given-names></name>
<name><surname>Jayaraman</surname><given-names>N.</given-names></name>
<name><surname>Chatterji</surname><given-names>D.</given-names></name>
</person-group><article-title>Small-Molecule Inhibition of Bacterial Biofilm</article-title><source>ACS Omega</source><year>2020</year><volume>5</volume><fpage>3108</fpage><lpage>3115</lpage><pub-id pub-id-type="doi">10.1021/acsomega.9b03695</pub-id><pub-id pub-id-type="pmid">32118127</pub-id></element-citation></ref><ref id="B171-microorganisms-11-01899"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balaban</surname><given-names>N.</given-names></name>
<name><surname>Goldkorn</surname><given-names>T.</given-names></name>
<name><surname>Gov</surname><given-names>Y.</given-names></name>
<name><surname>Hirshberg</surname><given-names>M.</given-names></name>
<name><surname>Koyfman</surname><given-names>N.</given-names></name>
<name><surname>Matthews</surname><given-names>H.R.</given-names></name>
<name><surname>Nhan</surname><given-names>R.T.</given-names></name>
<name><surname>Singh</surname><given-names>B.</given-names></name>
<name><surname>Uziel</surname><given-names>O.</given-names></name>
</person-group><article-title>Regulation of <italic toggle="yes">Staphylococcus aureus</italic> Pathogenesis via Target of RNAIII-Activating Protein (TRAP)</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>2658</fpage><lpage>2667</lpage><pub-id pub-id-type="doi">10.1074/jbc.M005446200</pub-id><pub-id pub-id-type="pmid">11160124</pub-id></element-citation></ref><ref id="B172-microorganisms-11-01899"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ciulla</surname><given-names>M.</given-names></name>
<name><surname>Di Stefano</surname><given-names>A.</given-names></name>
<name><surname>Marinelli</surname><given-names>L.</given-names></name>
<name><surname>Cacciatore</surname><given-names>I.</given-names></name>
<name><surname>Di Biase</surname><given-names>G.</given-names></name>
</person-group><article-title>RNAIII Inhibiting Peptide (RIP) and Derivatives as Potential Tools for the Treatment of <italic toggle="yes">S. aureus</italic> Biofilm Infections</article-title><source>Curr. Top. Med. Chem.</source><year>2018</year><volume>18</volume><fpage>2068</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.2174/1568026618666181022120711</pub-id><pub-id pub-id-type="pmid">30345922</pub-id></element-citation></ref><ref id="B173-microorganisms-11-01899"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ye</surname><given-names>H.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Han</surname><given-names>J.</given-names></name>
</person-group><article-title>The Use of RNAIII Inhibitory Peptide in the Treatment of Elderly Patients with <italic toggle="yes">Staphylococcus aureus</italic> Infection and Construction of Fuzzy Mathematical Model for Curative Effect Evaluation</article-title><source>Results Phys.</source><year>2021</year><volume>25</volume><fpage>104323</fpage><pub-id pub-id-type="doi">10.1016/j.rinp.2021.104323</pub-id></element-citation></ref><ref id="B174-microorganisms-11-01899"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Simonetti</surname><given-names>O.</given-names></name>
<name><surname>Cirioni</surname><given-names>O.</given-names></name>
<name><surname>Ghiselli</surname><given-names>R.</given-names></name>
<name><surname>Goteri</surname><given-names>G.</given-names></name>
<name><surname>Scalise</surname><given-names>A.</given-names></name>
<name><surname>Orlando</surname><given-names>F.</given-names></name>
<name><surname>Silvestri</surname><given-names>C.</given-names></name>
<name><surname>Riva</surname><given-names>A.</given-names></name>
<name><surname>Saba</surname><given-names>V.</given-names></name>
<name><surname>Madanahally</surname><given-names>K.D.</given-names></name>
<etal/>
</person-group><article-title>RNAIII-Inhibiting Peptide Enhances Healing of Wounds Infected with Methicillin-Resistant <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Antimicrob. Agents Chemother.</source><year>2008</year><volume>52</volume><fpage>2205</fpage><lpage>2211</lpage><pub-id pub-id-type="doi">10.1128/AAC.01340-07</pub-id><?supplied-pmid 18391046?><pub-id pub-id-type="pmid">18391046</pub-id></element-citation></ref><ref id="B175-microorganisms-11-01899"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grimshaw</surname><given-names>S.G.</given-names></name>
<name><surname>Smith</surname><given-names>A.M.</given-names></name>
<name><surname>Arnold</surname><given-names>D.S.</given-names></name>
<name><surname>Xu</surname><given-names>E.</given-names></name>
<name><surname>Hoptroff</surname><given-names>M.</given-names></name>
<name><surname>Murphy</surname><given-names>B.</given-names></name>
</person-group><article-title>The Diversity and Abundance of Fungi and Bacteria on the Healthy and Dandruff Affected Human Scalp</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0225796</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0225796</pub-id><?supplied-pmid 31851674?><pub-id pub-id-type="pmid">31851674</pub-id></element-citation></ref><ref id="B176-microorganisms-11-01899"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leong</surname><given-names>C.</given-names></name>
<name><surname>Schmid</surname><given-names>B.</given-names></name>
<name><surname>Buttafuoco</surname><given-names>A.</given-names></name>
<name><surname>Glatz</surname><given-names>M.</given-names></name>
<name><surname>Bosshard</surname><given-names>P.P.</given-names></name>
</person-group><article-title>In Vitro Efficacy of Antifungal Agents Alone and in Shampoo Formulation against Dandruff-Associated <italic toggle="yes">Malassezia</italic> spp. and <italic toggle="yes">Staphylococcus</italic> spp.</article-title><source>Int. J. Cosmet. Sci.</source><year>2019</year><volume>41</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1111/ics.12525</pub-id><?supplied-pmid 30851208?><pub-id pub-id-type="pmid">30851208</pub-id></element-citation></ref><ref id="B177-microorganisms-11-01899"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>U.T.</given-names></name>
<name><surname>Kalan</surname><given-names>L.R.</given-names></name>
</person-group><article-title>Forgotten Fungi: The Importance of the Skin Mycobiome</article-title><source>Curr. Opin. Microbiol.</source><year>2022</year><volume>70</volume><fpage>102235</fpage><pub-id pub-id-type="doi">10.1016/J.MIB.2022.102235</pub-id><?supplied-pmid 36372041?><pub-id pub-id-type="pmid">36372041</pub-id></element-citation></ref><ref id="B178-microorganisms-11-01899"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Denissen</surname><given-names>J.</given-names></name>
<name><surname>Reyneke</surname><given-names>B.</given-names></name>
<name><surname>Waso-Reyneke</surname><given-names>M.</given-names></name>
<name><surname>Havenga</surname><given-names>B.</given-names></name>
<name><surname>Barnard</surname><given-names>T.</given-names></name>
<name><surname>Khan</surname><given-names>S.</given-names></name>
<name><surname>Khan</surname><given-names>W.</given-names></name>
</person-group><article-title>Prevalence of ESKAPE Pathogens in the Environment: Antibiotic Resistance Status, Community-Acquired Infection and Risk to Human Health</article-title><source>Int. J. Hyg. Environ. Health</source><year>2022</year><volume>244</volume><fpage>114006</fpage><pub-id pub-id-type="doi">10.1016/j.ijheh.2022.114006</pub-id><pub-id pub-id-type="pmid">35841823</pub-id></element-citation></ref><ref id="B179-microorganisms-11-01899"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ka-Wai Hui</surname><given-names>E.</given-names></name>
</person-group><article-title>Reasons for the Increase in Emerging and Re-Emerging Viral Infectious Diseases</article-title><source>Microbes Infect.</source><year>2006</year><volume>8</volume><fpage>905</fpage><pub-id pub-id-type="doi">10.1016/j.micinf.2005.06.032</pub-id><?supplied-pmid 16448839?><pub-id pub-id-type="pmid">16448839</pub-id></element-citation></ref><ref id="B180-microorganisms-11-01899"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fisher</surname><given-names>M.C.</given-names></name>
<name><surname>Alastruey-Izquierdo</surname><given-names>A.</given-names></name>
<name><surname>Berman</surname><given-names>J.</given-names></name>
<name><surname>Bicanic</surname><given-names>T.</given-names></name>
<name><surname>Bignell</surname><given-names>E.M.</given-names></name>
<name><surname>Bowyer</surname><given-names>P.</given-names></name>
<name><surname>Bromley</surname><given-names>M.</given-names></name>
<name><surname>Br&#x000fc;ggemann</surname><given-names>R.</given-names></name>
<name><surname>Garber</surname><given-names>G.</given-names></name>
<name><surname>Cornely</surname><given-names>O.A.</given-names></name>
<etal/>
</person-group><article-title>Tackling the Emerging Threat of Antifungal Resistance to Human Health</article-title><source>Nat. Rev. Microbiol.</source><year>2022</year><volume>20</volume><fpage>557</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1038/s41579-022-00720-1</pub-id><?supplied-pmid 35352028?><pub-id pub-id-type="pmid">35352028</pub-id></element-citation></ref><ref id="B181-microorganisms-11-01899"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fisher</surname><given-names>M.C.</given-names></name>
<name><surname>Hawkins</surname><given-names>N.J.</given-names></name>
<name><surname>Sanglard</surname><given-names>D.</given-names></name>
<name><surname>Gurr</surname><given-names>S.J.</given-names></name>
</person-group><article-title>Worldwide Emergence of Resistance to Antifungal Drugs Challenges Human Health and Food Security</article-title><source>Science</source><year>2018</year><volume>360</volume><fpage>739</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1126/science.aap7999</pub-id><pub-id pub-id-type="pmid">29773744</pub-id></element-citation></ref><ref id="B182-microorganisms-11-01899"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saheb Kashaf</surname><given-names>S.</given-names></name>
<name><surname>Proctor</surname><given-names>D.M.</given-names></name>
<name><surname>Deming</surname><given-names>C.</given-names></name>
<name><surname>Saary</surname><given-names>P.</given-names></name>
<name><surname>H&#x000f6;lzer</surname><given-names>M.</given-names></name>
<name><surname>Mullikin</surname><given-names>J.</given-names></name>
<name><surname>Thomas</surname><given-names>J.</given-names></name>
<name><surname>Young</surname><given-names>A.</given-names></name>
<name><surname>Bouffard</surname><given-names>G.</given-names></name>
<name><surname>Barnabas</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Integrating Cultivation and Metagenomics for a Multi-Kingdom View of Skin Microbiome Diversity and Functions</article-title><source>Nat. Microbiol.</source><year>2021</year><volume>7</volume><fpage>169</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/s41564-021-01011-w</pub-id><pub-id pub-id-type="pmid">34952941</pub-id></element-citation></ref><ref id="B183-microorganisms-11-01899"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vijaya Chandra</surname><given-names>S.H.</given-names></name>
<name><surname>Srinivas</surname><given-names>R.</given-names></name>
<name><surname>Dawson</surname><given-names>T.L.</given-names></name>
<name><surname>Common</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Cutaneous <italic toggle="yes">Malassezia</italic>: Commensal, Pathogen, or Protector?</article-title><source>Front. Cell Infect. Microbiol.</source><year>2020</year><volume>10</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2020.614446</pub-id><pub-id pub-id-type="pmid">32083019</pub-id></element-citation></ref><ref id="B184-microorganisms-11-01899"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gaitanis</surname><given-names>G.</given-names></name>
<name><surname>Magiatis</surname><given-names>P.</given-names></name>
<name><surname>Mexia</surname><given-names>N.</given-names></name>
<name><surname>Melliou</surname><given-names>E.</given-names></name>
<name><surname>Efstratiou</surname><given-names>M.A.</given-names></name>
<name><surname>Bassukas</surname><given-names>I.D.</given-names></name>
<name><surname>Velegraki</surname><given-names>A.</given-names></name>
</person-group><article-title>Antifungal Activity of Selected <italic toggle="yes">Malassezia</italic> Indolic Compounds Detected in Culture</article-title><source>Mycoses</source><year>2019</year><volume>62</volume><fpage>597</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1111/myc.12893</pub-id><?supplied-pmid 30636018?><pub-id pub-id-type="pmid">30636018</pub-id></element-citation></ref><ref id="B185-microorganisms-11-01899"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sparber</surname><given-names>F.</given-names></name>
<name><surname>LeibundGut-Landmann</surname><given-names>S.</given-names></name>
</person-group><article-title>Host Responses to <italic toggle="yes">Malassezia</italic> spp. in the Mammalian Skin</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>1614</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.01614</pub-id><?supplied-pmid 29213272?><pub-id pub-id-type="pmid">29213272</pub-id></element-citation></ref><ref id="B186-microorganisms-11-01899"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sparber</surname><given-names>F.</given-names></name>
<name><surname>De Gregorio</surname><given-names>C.</given-names></name>
<name><surname>Steckholzer</surname><given-names>S.</given-names></name>
<name><surname>Ferreira</surname><given-names>F.M.</given-names></name>
<name><surname>Dolowschiak</surname><given-names>T.</given-names></name>
<name><surname>Ruchti</surname><given-names>F.</given-names></name>
<name><surname>Kirchner</surname><given-names>F.R.</given-names></name>
<name><surname>Mertens</surname><given-names>S.</given-names></name>
<name><surname>Prinz</surname><given-names>I.</given-names></name>
<name><surname>Joller</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>The Skin Commensal Yeast <italic toggle="yes">Malassezia</italic> Triggers a Type 17 Response That Coordinates Anti-Fungal Immunity and Exacerbates Skin Inflammation</article-title><source>Cell Host Microbe</source><year>2019</year><volume>25</volume><fpage>389</fpage><lpage>403.e6</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2019.02.002</pub-id><pub-id pub-id-type="pmid">30870621</pub-id></element-citation></ref><ref id="B187-microorganisms-11-01899"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naik</surname><given-names>S.</given-names></name>
<name><surname>Bouladoux</surname><given-names>N.</given-names></name>
<name><surname>Linehan</surname><given-names>J.L.</given-names></name>
<name><surname>Han</surname><given-names>S.J.</given-names></name>
<name><surname>Harrison</surname><given-names>O.J.</given-names></name>
<name><surname>Wilhelm</surname><given-names>C.</given-names></name>
<name><surname>Conlan</surname><given-names>S.</given-names></name>
<name><surname>Himmelfarb</surname><given-names>S.</given-names></name>
<name><surname>Byrd</surname><given-names>A.L.</given-names></name>
<name><surname>Deming</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Commensal&#x02013;Dendritic-Cell Interaction Specifies a Unique Protective Skin Immune Signature</article-title><source>Nature</source><year>2015</year><volume>520</volume><fpage>104</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1038/nature14052</pub-id><pub-id pub-id-type="pmid">25539086</pub-id></element-citation></ref><ref id="B188-microorganisms-11-01899"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wanke</surname><given-names>I.</given-names></name>
<name><surname>Steffen</surname><given-names>H.</given-names></name>
<name><surname>Christ</surname><given-names>C.</given-names></name>
<name><surname>Krismer</surname><given-names>B.</given-names></name>
<name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>
<name><surname>Peschel</surname><given-names>A.</given-names></name>
<name><surname>Schaller</surname><given-names>M.</given-names></name>
<name><surname>Schittek</surname><given-names>B.</given-names></name>
</person-group><article-title>Skin Commensals Amplify the Innate Immune Response to Pathogens by Activation of Distinct Signaling Pathways</article-title><source>J. Investig. Dermatol.</source><year>2011</year><volume>131</volume><fpage>382</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1038/jid.2010.328</pub-id><pub-id pub-id-type="pmid">21048787</pub-id></element-citation></ref><ref id="B189-microorganisms-11-01899"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>H&#x000f6;fs</surname><given-names>S.</given-names></name>
<name><surname>Mogavero</surname><given-names>S.</given-names></name>
<name><surname>Hube</surname><given-names>B.</given-names></name>
</person-group><article-title>Interaction of Candida Albicans with Host Cells: Virulence Factors, Host Defense, Escape Strategies, and the Microbiota</article-title><source>J. Microbiol.</source><year>2016</year><volume>54</volume><fpage>149</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1007/s12275-016-5514-0</pub-id><?supplied-pmid 26920876?><pub-id pub-id-type="pmid">26920876</pub-id></element-citation></ref><ref id="B190-microorganisms-11-01899"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Desai</surname><given-names>J.V.</given-names></name>
</person-group><article-title>Candida Albicans Hyphae: From Growth Initiation to Invasion</article-title><source>J. Fungi</source><year>2018</year><volume>4</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.3390/jof4010010</pub-id><?supplied-pmid 29371503?><pub-id pub-id-type="pmid">29371503</pub-id></element-citation></ref><ref id="B191-microorganisms-11-01899"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lacroix</surname><given-names>G.</given-names></name>
<name><surname>Gouyer</surname><given-names>V.</given-names></name>
<name><surname>Gottrand</surname><given-names>F.</given-names></name>
<name><surname>Desseyn</surname><given-names>J.L.</given-names></name>
</person-group><article-title>The Cervicovaginal Mucus Barrier</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>8266</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21218266</pub-id><?supplied-pmid 33158227?><pub-id pub-id-type="pmid">33158227</pub-id></element-citation></ref><ref id="B192-microorganisms-11-01899"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Hu</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>C.</given-names></name>
<name><surname>Gu</surname><given-names>F.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Probiotics: Potential Novel Therapeutics Against Fungal Infections</article-title><source>Front. Cell Infect. Microbiol.</source><year>2021</year><volume>11</volume><fpage>793419</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2021.793419</pub-id><pub-id pub-id-type="pmid">35127557</pub-id></element-citation></ref><ref id="B193-microorganisms-11-01899"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mattiuzzi</surname><given-names>C.</given-names></name>
<name><surname>Lippi</surname><given-names>G.</given-names></name>
</person-group><article-title>Current Cancer Epidemiology</article-title><source>J. Epidemiol. Glob. Health</source><year>2019</year><volume>9</volume><fpage>217</fpage><pub-id pub-id-type="doi">10.2991/jegh.k.191008.001</pub-id><?supplied-pmid 31854162?><pub-id pub-id-type="pmid">31854162</pub-id></element-citation></ref><ref id="B194-microorganisms-11-01899"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sung</surname><given-names>H.</given-names></name>
<name><surname>Ferlay</surname><given-names>J.</given-names></name>
<name><surname>Siegel</surname><given-names>R.L.</given-names></name>
<name><surname>Laversanne</surname><given-names>M.</given-names></name>
<name><surname>Soerjomataram</surname><given-names>I.</given-names></name>
<name><surname>Jemal</surname><given-names>A.</given-names></name>
<name><surname>Bray</surname><given-names>F.</given-names></name>
</person-group><article-title>Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries</article-title><source>CA Cancer J. Clin.</source><year>2021</year><volume>71</volume><fpage>209</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.3322/caac.21660</pub-id><?supplied-pmid 33538338?><pub-id pub-id-type="pmid">33538338</pub-id></element-citation></ref><ref id="B195-microorganisms-11-01899"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Woo</surname><given-names>Y.R.</given-names></name>
<name><surname>Cho</surname><given-names>S.H.</given-names></name>
<name><surname>Lee</surname><given-names>J.D.</given-names></name>
<name><surname>Kim</surname><given-names>H.S.</given-names></name>
</person-group><article-title>The Human Microbiota and Skin Cancer</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>1813</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23031813</pub-id><?supplied-pmid 35163734?><pub-id pub-id-type="pmid">35163734</pub-id></element-citation></ref><ref id="B196-microorganisms-11-01899"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Qureshi</surname><given-names>A.A.</given-names></name>
<name><surname>Fortner</surname><given-names>R.T.</given-names></name>
<name><surname>Hankinson</surname><given-names>S.E.</given-names></name>
<name><surname>Wei</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>L.E.</given-names></name>
<name><surname>Eliassen</surname><given-names>A.H.</given-names></name>
<name><surname>Willett</surname><given-names>W.C.</given-names></name>
<name><surname>Hunter</surname><given-names>D.J.</given-names></name>
<name><surname>Han</surname><given-names>J.</given-names></name>
</person-group><article-title>Teenage Acne and Cancer Risk in US Women: A Prospective Cohort Study</article-title><source>Cancer</source><year>2015</year><volume>121</volume><fpage>1681</fpage><lpage>1687</lpage><pub-id pub-id-type="doi">10.1002/cncr.29216</pub-id><pub-id pub-id-type="pmid">25572604</pub-id></element-citation></ref><ref id="B197-microorganisms-11-01899"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>He</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>Zhou</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Zhou</surname><given-names>H.</given-names></name>
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
</person-group><article-title>Atopic Dermatitis and Skin Cancer Risk: A Systematic Review</article-title><source>Dermatol. Ther.</source><year>2022</year><volume>12</volume><fpage>1167</fpage><pub-id pub-id-type="doi">10.1007/s13555-022-00720-2</pub-id><?supplied-pmid 35430723?><pub-id pub-id-type="pmid">35430723</pub-id></element-citation></ref><ref id="B198-microorganisms-11-01899"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Butr&#x000f3;n-Bris</surname><given-names>B.</given-names></name>
<name><surname>Daud&#x000e9;n</surname><given-names>E.</given-names></name>
<name><surname>Rodr&#x000ed;guez-Jim&#x000e9;nez</surname><given-names>P.</given-names></name>
</person-group><article-title>Psoriasis Therapy and Skin Cancer: A Review</article-title><source>Life</source><year>2021</year><volume>11</volume><elocation-id>1109</elocation-id><pub-id pub-id-type="doi">10.3390/life11101109</pub-id><pub-id pub-id-type="pmid">34685480</pub-id></element-citation></ref><ref id="B199-microorganisms-11-01899"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>W.Q.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Danby</surname><given-names>F.W.</given-names></name>
<name><surname>Han</surname><given-names>J.</given-names></name>
<name><surname>Qureshi</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Personal History of Rosacea and Risk of Incident Cancer among Women in the US</article-title><source>Br. J. Cancer</source><year>2015</year><volume>113</volume><fpage>520</fpage><pub-id pub-id-type="doi">10.1038/bjc.2015.217</pub-id><pub-id pub-id-type="pmid">26103573</pub-id></element-citation></ref><ref id="B200-microorganisms-11-01899"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mercier-Parot</surname><given-names>L.T.-D.H.</given-names></name>
</person-group><article-title>Skeletal Malformations in Rats Produced by 6-Hydroxylaminopurine. Attempts at Prevention</article-title><source>C. R. Seances Soc. Biol. Fil.</source><year>1973</year><volume>167</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">4804699</pub-id></element-citation></ref><ref id="B201-microorganisms-11-01899"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stepchenkova</surname><given-names>E.I.</given-names></name>
<name><surname>Kozmin</surname><given-names>S.G.</given-names></name>
<name><surname>Alenin</surname><given-names>V.V.</given-names></name>
<name><surname>Pavlov</surname><given-names>Y.I.</given-names></name>
</person-group><article-title>Genome-Wide Screening for Genes Whose Deletions Confer Sensitivity to Mutagenic Purine Base Analogs in Yeast</article-title><source>BMC Genet.</source><year>2005</year><volume>6</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2156-6-31</pub-id><pub-id pub-id-type="pmid">15932646</pub-id></element-citation></ref><ref id="B202-microorganisms-11-01899"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakatsuji</surname><given-names>T.</given-names></name>
<name><surname>Chen</surname><given-names>T.H.</given-names></name>
<name><surname>Butcher</surname><given-names>A.M.</given-names></name>
<name><surname>Trzoss</surname><given-names>L.L.</given-names></name>
<name><surname>Nam</surname><given-names>S.J.</given-names></name>
<name><surname>Shirakawa</surname><given-names>K.T.</given-names></name>
<name><surname>Zhou</surname><given-names>W.</given-names></name>
<name><surname>Oh</surname><given-names>J.</given-names></name>
<name><surname>Otto</surname><given-names>M.</given-names></name>
<name><surname>Fenical</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>A Commensal Strain of <italic toggle="yes">Staphylococcus epidermidis</italic> Protects against Skin Neoplasia</article-title><source>Sci. Adv.</source><year>2018</year><volume>4</volume><fpage>eaao4502</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aao4502</pub-id><pub-id pub-id-type="pmid">29507878</pub-id></element-citation></ref><ref id="B203-microorganisms-11-01899"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakatsuji</surname><given-names>T.</given-names></name>
<name><surname>Fenical</surname><given-names>W.</given-names></name>
<name><surname>Gallo</surname><given-names>R.L.</given-names></name>
</person-group><article-title>Response to Comment on &#x0201c;A Commensal Strain of <italic toggle="yes">Staphylococcus epidermidis</italic> Protects against Skin Neoplasia&#x0201d; by Nakatsuji et Al</article-title><source>Sci. Adv.</source><year>2019</year><volume>5</volume><fpage>5611</fpage><lpage>5622</lpage><pub-id pub-id-type="doi">10.1126/sciadv.aay5611</pub-id></element-citation></ref><ref id="B204-microorganisms-11-01899"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kozmin</surname><given-names>S.G.</given-names></name>
<name><surname>Rogozin</surname><given-names>I.B.</given-names></name>
<name><surname>Moore</surname><given-names>E.A.</given-names></name>
<name><surname>Abney</surname><given-names>M.</given-names></name>
<name><surname>Schaaper</surname><given-names>R.M.</given-names></name>
<name><surname>Pavlov</surname><given-names>Y.I.</given-names></name>
</person-group><article-title>Comment on &#x0201c;A Commensal Strain of <italic toggle="yes">Staphylococcus epidermidis</italic> Protects against Skin Neoplasia&#x0201d; by Nakatsuji et Al</article-title><source>Sci. Adv.</source><year>2019</year><volume>5</volume><fpage>3915</fpage><lpage>3926</lpage><pub-id pub-id-type="doi">10.1126/sciadv.aaw3915</pub-id><?supplied-pmid 31535021?><pub-id pub-id-type="pmid">31535021</pub-id></element-citation></ref><ref id="B205-microorganisms-11-01899"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ding</surname><given-names>L.</given-names></name>
<name><surname>Cao</surname><given-names>J.</given-names></name>
<name><surname>Lin</surname><given-names>W.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Xiong</surname><given-names>X.</given-names></name>
<name><surname>Ao</surname><given-names>H.</given-names></name>
<name><surname>Yu</surname><given-names>M.</given-names></name>
<name><surname>Lin</surname><given-names>J.</given-names></name>
<name><surname>Cui</surname><given-names>Q.</given-names></name>
</person-group><article-title>The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>1960</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21061960</pub-id><?supplied-pmid 32183020?><pub-id pub-id-type="pmid">32183020</pub-id></element-citation></ref><ref id="B206-microorganisms-11-01899"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Huang</surname><given-names>W.</given-names></name>
<name><surname>Rao</surname><given-names>X.</given-names></name>
<name><surname>Lai</surname><given-names>Y.</given-names></name>
</person-group><article-title>Pharmacological Properties of Indirubin and Its Derivatives</article-title><source>Biomed. Pharmacother.</source><year>2022</year><volume>151</volume><fpage>113112</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2022.113112</pub-id><?supplied-pmid 35598366?><pub-id pub-id-type="pmid">35598366</pub-id></element-citation></ref><ref id="B207-microorganisms-11-01899"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saunte</surname><given-names>D.M.L.</given-names></name>
<name><surname>Gaitanis</surname><given-names>G.</given-names></name>
<name><surname>Hay</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment</article-title><source>Front. Cell Infect. Microbiol.</source><year>2020</year><volume>10</volume><fpage>112</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2020.00112</pub-id><?supplied-pmid 32266163?><pub-id pub-id-type="pmid">32266163</pub-id></element-citation></ref><ref id="B208-microorganisms-11-01899"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Molujin</surname><given-names>A.M.</given-names></name>
<name><surname>Abbasiliasi</surname><given-names>S.</given-names></name>
<name><surname>Nurdin</surname><given-names>A.</given-names></name>
<name><surname>Lee</surname><given-names>P.C.</given-names></name>
<name><surname>Gansau</surname><given-names>J.A.</given-names></name>
<name><surname>Jawan</surname><given-names>R.</given-names></name>
</person-group><article-title>Bacteriocins as Potential Therapeutic Approaches in the Treatment of Various Cancers: A Review of In Vitro Studies</article-title><source>Cancers</source><year>2022</year><volume>14</volume><elocation-id>4758</elocation-id><pub-id pub-id-type="doi">10.3390/cancers14194758</pub-id><?supplied-pmid 36230679?><pub-id pub-id-type="pmid">36230679</pub-id></element-citation></ref><ref id="B209-microorganisms-11-01899"><label>209.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>P.</given-names></name>
<name><surname>Tiwari</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Bacteriocins of Probiotics as Potent Anticancer Agents</article-title><source>Probiotic Research in Therapeutics</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2021</year><volume>Volume 1</volume><fpage>231</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1007/978-981-15-8214-1_11</pub-id></element-citation></ref><ref id="B210-microorganisms-11-01899"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tran</surname><given-names>N.B.V.</given-names></name>
<name><surname>Truong</surname><given-names>Q.M.</given-names></name>
<name><surname>Nguyen</surname><given-names>L.Q.A.</given-names></name>
<name><surname>Nguyen</surname><given-names>N.M.H.</given-names></name>
<name><surname>Tran</surname><given-names>Q.H.</given-names></name>
<name><surname>Dinh</surname><given-names>T.T.P.</given-names></name>
<name><surname>Hua</surname><given-names>V.S.</given-names></name>
<name><surname>Nguyen</surname><given-names>V.D.</given-names></name>
<name><surname>Lambert</surname><given-names>P.A.</given-names></name>
<name><surname>Nguyen</surname><given-names>T.T.H.</given-names></name>
</person-group><article-title>Prevalence and Virulence of Commensal <italic toggle="yes">Pseudomonas aeruginosa</italic> Isolates from Healthy Individuals in Southern Vietnam (2018&#x02013;2020)</article-title><source>Biomedicines</source><year>2022</year><volume>11</volume><elocation-id>54</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines11010054</pub-id><pub-id pub-id-type="pmid">36672562</pub-id></element-citation></ref><ref id="B211-microorganisms-11-01899"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zgheib</surname><given-names>H.</given-names></name>
<name><surname>Drider</surname><given-names>D.</given-names></name>
<name><surname>Belguesmia</surname><given-names>Y.</given-names></name>
</person-group><article-title>Broadening and Enhancing Bacteriocins Activities by Association with Bioactive Substances</article-title><source>Int. J. Environ. Res. Public Health</source><year>2020</year><volume>17</volume><elocation-id>7835</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph17217835</pub-id><pub-id pub-id-type="pmid">33114656</pub-id></element-citation></ref><ref id="B212-microorganisms-11-01899"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Natural Products in Cosmetics</article-title><source>Nat. Prod. Bioprospect.</source><year>2022</year><volume>12</volume><fpage>40</fpage><pub-id pub-id-type="doi">10.1007/s13659-022-00363-y</pub-id><pub-id pub-id-type="pmid">36437391</pub-id></element-citation></ref><ref id="B213-microorganisms-11-01899"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>B.</given-names></name>
<name><surname>Grimshaw</surname><given-names>S.</given-names></name>
<name><surname>Hoptroff</surname><given-names>M.</given-names></name>
<name><surname>Paterson</surname><given-names>S.</given-names></name>
<name><surname>Arnold</surname><given-names>D.</given-names></name>
<name><surname>Cawley</surname><given-names>A.</given-names></name>
<name><surname>Adams</surname><given-names>S.E.</given-names></name>
<name><surname>Falciani</surname><given-names>F.</given-names></name>
<name><surname>Dadd</surname><given-names>T.</given-names></name>
<name><surname>Eccles</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Alteration of Barrier Properties, Stratum Corneum Ceramides and Microbiome Composition in Response to Lotion Application on Cosmetic Dry Skin</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><fpage>5223</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-09231-8</pub-id><pub-id pub-id-type="pmid">35340018</pub-id></element-citation></ref><ref id="B214-microorganisms-11-01899"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mukherjee</surname><given-names>S.</given-names></name>
<name><surname>Mitra</surname><given-names>R.</given-names></name>
<name><surname>Maitra</surname><given-names>A.</given-names></name>
<name><surname>Gupta</surname><given-names>S.</given-names></name>
<name><surname>Kumaran</surname><given-names>S.</given-names></name>
<name><surname>Chakrabortty</surname><given-names>A.</given-names></name>
<name><surname>Majumder</surname><given-names>P.P.</given-names></name>
</person-group><article-title>Sebum and Hydration Levels in Specific Regions of Human Face Significantly Predict the Nature and Diversity of Facial Skin Microbiome</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>36062</fpage><pub-id pub-id-type="doi">10.1038/srep36062</pub-id><pub-id pub-id-type="pmid">27786295</pub-id></element-citation></ref><ref id="B215-microorganisms-11-01899"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roux</surname><given-names>P.F.</given-names></name>
<name><surname>Oddos</surname><given-names>T.</given-names></name>
<name><surname>Stamatas</surname><given-names>G.</given-names></name>
</person-group><article-title>Deciphering the Role of Skin Surface Microbiome in Skin Health: An Integrative Multiomics Approach Reveals Three Distinct Metabolite&#x02013;Microbe Clusters</article-title><source>J. Investig. Dermatol.</source><year>2022</year><volume>142</volume><fpage>469</fpage><lpage>479.e5</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2021.07.159</pub-id><?supplied-pmid 34343557?><pub-id pub-id-type="pmid">34343557</pub-id></element-citation></ref><ref id="B216-microorganisms-11-01899"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>H.J.</given-names></name>
<name><surname>Kim</surname><given-names>M.</given-names></name>
</person-group><article-title>Skin Barrier Function and the Microbiome</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>13071</elocation-id><pub-id pub-id-type="doi">10.3390/ijms232113071</pub-id><?supplied-pmid 36361857?><pub-id pub-id-type="pmid">36361857</pub-id></element-citation></ref><ref id="B217-microorganisms-11-01899"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Habeebuddin</surname><given-names>M.</given-names></name>
<name><surname>Karnati</surname><given-names>R.K.</given-names></name>
<name><surname>Shiroorkar</surname><given-names>P.N.</given-names></name>
<name><surname>Nagaraja</surname><given-names>S.</given-names></name>
<name><surname>Asdaq</surname><given-names>S.M.B.</given-names></name>
<name><surname>Anwer</surname><given-names>M.K.</given-names></name>
<name><surname>Fattepur</surname><given-names>S.</given-names></name>
</person-group><article-title>Topical Probiotics: More Than a Skin Deep</article-title><source>Pharmaceutics</source><year>2022</year><volume>14</volume><elocation-id>557</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics14030557</pub-id><pub-id pub-id-type="pmid">35335933</pub-id></element-citation></ref><ref id="B218-microorganisms-11-01899"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ellis</surname><given-names>S.R.</given-names></name>
<name><surname>Nguyen</surname><given-names>M.</given-names></name>
<name><surname>Vaughn</surname><given-names>A.R.</given-names></name>
<name><surname>Notay</surname><given-names>M.</given-names></name>
<name><surname>Burney</surname><given-names>W.A.</given-names></name>
<name><surname>Sandhu</surname><given-names>S.</given-names></name>
<name><surname>Sivamani</surname><given-names>R.K.</given-names></name>
</person-group><article-title>The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions</article-title><source>Microorganisms</source><year>2019</year><volume>7</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms7110550</pub-id><?supplied-pmid 31717915?><pub-id pub-id-type="pmid">31717915</pub-id></element-citation></ref><ref id="B219-microorganisms-11-01899"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leung</surname><given-names>A.K.C.</given-names></name>
<name><surname>Barankin</surname><given-names>B.</given-names></name>
<name><surname>Lam</surname><given-names>J.M.</given-names></name>
<name><surname>Leong</surname><given-names>K.F.</given-names></name>
<name><surname>Hon</surname><given-names>K.L.</given-names></name>
</person-group><article-title>Dermatology: How to Manage <italic toggle="yes">Acne vulgaris</italic></article-title><source>Drugs Context</source><year>2021</year><volume>10</volume><pub-id pub-id-type="doi">10.7573/dic.2021-8-6</pub-id><?supplied-pmid 34691199?><pub-id pub-id-type="pmid">34691199</pub-id></element-citation></ref><ref id="B220-microorganisms-11-01899"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mavranezouli</surname><given-names>I.</given-names></name>
<name><surname>Welton</surname><given-names>N.J.</given-names></name>
<name><surname>Daly</surname><given-names>C.H.</given-names></name>
<name><surname>Wilcock</surname><given-names>J.</given-names></name>
<name><surname>Bromham</surname><given-names>N.</given-names></name>
<name><surname>Berg</surname><given-names>L.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Wood</surname><given-names>D.</given-names></name>
<name><surname>Ravenscroft</surname><given-names>J.C.</given-names></name>
<name><surname>Dworzynski</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Cost-effectiveness of Topical Pharmacological, Oral Pharmacological, Physical and Combined Treatments for <italic toggle="yes">Acne vulgaris</italic></article-title><source>Clin. Exp. Dermatol.</source><year>2022</year><volume>47</volume><fpage>2176</fpage><lpage>2187</lpage><pub-id pub-id-type="doi">10.1111/ced.15356</pub-id><?supplied-pmid 36258288?><pub-id pub-id-type="pmid">36258288</pub-id></element-citation></ref><ref id="B221-microorganisms-11-01899"><label>221.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Sutaria</surname><given-names>A.H.</given-names></name>
<name><surname>Masood</surname><given-names>S.</given-names></name>
<name><surname>Schlessinger</surname><given-names>J.</given-names></name>
</person-group><source>Acne Vulgari</source><publisher-name>StatePearls Publishing</publisher-name><publisher-loc>Treasure Island, FL USA</publisher-loc><year>2023</year><comment>Available online: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK459173/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK459173/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-06-19">(accessed on 19 June 2023)</date-in-citation></element-citation></ref><ref id="B222-microorganisms-11-01899"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goodarzi</surname><given-names>A.</given-names></name>
<name><surname>Mozafarpoor</surname><given-names>S.</given-names></name>
<name><surname>Bodaghabadi</surname><given-names>M.</given-names></name>
<name><surname>Mohamadi</surname><given-names>M.</given-names></name>
</person-group><article-title>The Potential of Probiotics for Treating <italic toggle="yes">Acne vulgaris</italic>: A Review of Literature on Acne and Microbiota</article-title><source>Dermatol. Ther.</source><year>2020</year><volume>33</volume><fpage>e13279</fpage><pub-id pub-id-type="doi">10.1111/dth.13279</pub-id><?supplied-pmid 32266790?><pub-id pub-id-type="pmid">32266790</pub-id></element-citation></ref><ref id="B223-microorganisms-11-01899"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kang</surname><given-names>B.S.</given-names></name>
<name><surname>Seo</surname><given-names>J.G.</given-names></name>
<name><surname>Lee</surname><given-names>G.S.</given-names></name>
<name><surname>Kim</surname><given-names>J.H.</given-names></name>
<name><surname>Kim</surname><given-names>S.Y.</given-names></name>
<name><surname>Han</surname><given-names>Y.W.</given-names></name>
<name><surname>Kang</surname><given-names>H.</given-names></name>
<name><surname>Kim</surname><given-names>H.O.</given-names></name>
<name><surname>Rhee</surname><given-names>J.H.</given-names></name>
<name><surname>Chung</surname><given-names>M.J.</given-names></name>
<etal/>
</person-group><article-title>Antimicrobial Activity of Enterocins from <italic toggle="yes">Enterococcus faecalis</italic> SL-5 against <italic toggle="yes">Propionibacterium acnes</italic>, the Causative Agent in <italic toggle="yes">Acne vulgaris</italic>, and Its Therapeutic Effect</article-title><source>J. Microbiol.</source><year>2009</year><volume>47</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1007/s12275-008-0179-y</pub-id><pub-id pub-id-type="pmid">19229497</pub-id></element-citation></ref><ref id="B224-microorganisms-11-01899"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Muizzuddin</surname><given-names>N.</given-names></name>
<name><surname>Maher</surname><given-names>W.</given-names></name>
<name><surname>Sullivan</surname><given-names>M.</given-names></name>
<name><surname>Schnittger</surname><given-names>S.</given-names></name>
<name><surname>Mammone</surname><given-names>T.</given-names></name>
</person-group><article-title>Physiological Effect of a Probiotic on Skin</article-title><source>J. Cosmet. Sci.</source><year>2012</year><volume>63</volume><fpage>385</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">23286870</pub-id></element-citation></ref><ref id="B225-microorganisms-11-01899"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lebeer</surname><given-names>S.</given-names></name>
<name><surname>Oerlemans</surname><given-names>E.F.M.</given-names></name>
<name><surname>Claes</surname><given-names>I.</given-names></name>
<name><surname>Henkens</surname><given-names>T.</given-names></name>
<name><surname>Delanghe</surname><given-names>L.</given-names></name>
<name><surname>Wuyts</surname><given-names>S.</given-names></name>
<name><surname>Spacova</surname><given-names>I.</given-names></name>
<name><surname>van den Broek</surname><given-names>M.F.L.</given-names></name>
<name><surname>Tuyaerts</surname><given-names>I.</given-names></name>
<name><surname>Wittouck</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Selective Targeting of Skin Pathobionts and Inflammation with Topically Applied Lactobacilli</article-title><source>Cell Rep. Med.</source><year>2022</year><volume>3</volume><fpage>100521</fpage><pub-id pub-id-type="doi">10.1016/j.xcrm.2022.100521</pub-id><pub-id pub-id-type="pmid">35243421</pub-id></element-citation></ref><ref id="B226-microorganisms-11-01899"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Frazier</surname><given-names>W.</given-names></name>
<name><surname>Bhardwaj</surname><given-names>N.</given-names></name>
</person-group><article-title>Atopic Dermatitis: Diagnosis and Treatment</article-title><source>Am. Fam. Physician</source><year>2020</year><volume>101</volume><fpage>590</fpage><lpage>598</lpage><?supplied-pmid 32412211?><pub-id pub-id-type="pmid">32412211</pub-id></element-citation></ref><ref id="B227-microorganisms-11-01899"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wollenberg</surname><given-names>A.</given-names></name>
<name><surname>Thomsen</surname><given-names>S.F.</given-names></name>
<name><surname>Lacour</surname><given-names>J.P.</given-names></name>
<name><surname>Jaumont</surname><given-names>X.</given-names></name>
<name><surname>Lazarewicz</surname><given-names>S.</given-names></name>
</person-group><article-title>Targeting Immunoglobulin E in Atopic Dermatitis: A Review of the Existing Evidence</article-title><source>World Allergy Organ. J.</source><year>2021</year><volume>14</volume><fpage>100519</fpage><pub-id pub-id-type="doi">10.1016/j.waojou.2021.100519</pub-id><?supplied-pmid 33815652?><pub-id pub-id-type="pmid">33815652</pub-id></element-citation></ref><ref id="B228-microorganisms-11-01899"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakatsuji</surname><given-names>T.</given-names></name>
<name><surname>Chen</surname><given-names>T.H.</given-names></name>
<name><surname>Narala</surname><given-names>S.</given-names></name>
<name><surname>Chun</surname><given-names>K.A.</given-names></name>
<name><surname>Two</surname><given-names>A.M.</given-names></name>
<name><surname>Yun</surname><given-names>T.</given-names></name>
<name><surname>Shafiq</surname><given-names>F.</given-names></name>
<name><surname>Kotol</surname><given-names>P.F.</given-names></name>
<name><surname>Bouslimani</surname><given-names>A.</given-names></name>
<name><surname>Melnik</surname><given-names>A.V.</given-names></name>
<etal/>
</person-group><article-title>Antimicrobials from Human Skin Commensal Bacteria Protect against <italic toggle="yes">Staphylococcus aureus</italic> and Are Deficient in Atopic Dermatitis</article-title><source>Sci. Transl. Med.</source><year>2017</year><volume>9</volume><fpage>eaah4680</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aah4680</pub-id><?supplied-pmid 28228596?><pub-id pub-id-type="pmid">28228596</pub-id></element-citation></ref><ref id="B229-microorganisms-11-01899"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bjerre</surname><given-names>R.D.</given-names></name>
<name><surname>Holm</surname><given-names>J.B.</given-names></name>
<name><surname>Palleja</surname><given-names>A.</given-names></name>
<name><surname>S&#x000f8;lberg</surname><given-names>J.</given-names></name>
<name><surname>Skov</surname><given-names>L.</given-names></name>
<name><surname>Johansen</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Skin Dysbiosis in the Microbiome in Atopic Dermatitis Is Site-Specific and Involves Bacteria, Fungus and Virus</article-title><source>BMC Microbiol.</source><year>2021</year><volume>21</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1186/s12866-021-02302-2</pub-id><?supplied-pmid 34551705?><pub-id pub-id-type="pmid">33386072</pub-id></element-citation></ref><ref id="B230-microorganisms-11-01899"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koh</surname><given-names>L.F.</given-names></name>
<name><surname>Ong</surname><given-names>R.Y.</given-names></name>
<name><surname>Common</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Skin Microbiome of Atopic Dermatitis</article-title><source>Allergol. Int.</source><year>2022</year><volume>71</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.alit.2021.11.001</pub-id><pub-id pub-id-type="pmid">34838450</pub-id></element-citation></ref><ref id="B231-microorganisms-11-01899"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Knackstedt</surname><given-names>R.</given-names></name>
<name><surname>Knackstedt</surname><given-names>T.</given-names></name>
<name><surname>Gatherwright</surname><given-names>J.</given-names></name>
</person-group><article-title>The Role of Topical Probiotics in Skin Conditions: A Systematic Review of Animal and Human Studies and Implications for Future Therapies</article-title><source>Exp. Dermatol.</source><year>2020</year><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1111/exd.14032</pub-id><pub-id pub-id-type="pmid">31494971</pub-id></element-citation></ref><ref id="B232-microorganisms-11-01899"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>L&#x000f3;pez-Ot&#x000ed;n</surname><given-names>C.</given-names></name>
<name><surname>Blasco</surname><given-names>M.A.</given-names></name>
<name><surname>Partridge</surname><given-names>L.</given-names></name>
<name><surname>Serrano</surname><given-names>M.</given-names></name>
<name><surname>Kroemer</surname><given-names>G.</given-names></name>
</person-group><article-title>Hallmarks of Aging: An Expanding Universe</article-title><source>Cell</source><year>2023</year><volume>186</volume><fpage>243</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.11.001</pub-id><pub-id pub-id-type="pmid">36599349</pub-id></element-citation></ref><ref id="B233-microorganisms-11-01899"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Duan</surname><given-names>E.</given-names></name>
</person-group><article-title>Fighting against Skin Aging: The Way from Bench to Bedside</article-title><source>Cell Transpl.</source><year>2018</year><volume>27</volume><fpage>729</fpage><pub-id pub-id-type="doi">10.1177/0963689717725755</pub-id></element-citation></ref><ref id="B234-microorganisms-11-01899"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>W.</given-names></name>
<name><surname>Fleming</surname><given-names>E.</given-names></name>
<name><surname>Legendre</surname><given-names>G.</given-names></name>
<name><surname>Roux</surname><given-names>L.</given-names></name>
<name><surname>Latreille</surname><given-names>J.</given-names></name>
<name><surname>Gendronneau</surname><given-names>G.</given-names></name>
<name><surname>Forestier</surname><given-names>S.</given-names></name>
<name><surname>Oh</surname><given-names>J.</given-names></name>
</person-group><article-title>Skin Microbiome Attributes Associate with Biophysical Skin Aging</article-title><source>bioRxiv</source><year>2023</year><pub-id pub-id-type="doi">10.1101/2023.01.30.526239</pub-id></element-citation></ref><ref id="B235-microorganisms-11-01899"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>B.</given-names></name>
<name><surname>Hoptroff</surname><given-names>M.</given-names></name>
<name><surname>Arnold</surname><given-names>D.</given-names></name>
<name><surname>Cawley</surname><given-names>A.</given-names></name>
<name><surname>Smith</surname><given-names>E.</given-names></name>
<name><surname>Adams</surname><given-names>S.E.</given-names></name>
<name><surname>Mitchell</surname><given-names>A.</given-names></name>
<name><surname>Horsburgh</surname><given-names>M.J.</given-names></name>
<name><surname>Hunt</surname><given-names>J.</given-names></name>
<name><surname>Dasgupta</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Compositional Variations between Adult and Infant Skin Microbiome: An Update</article-title><source>Microorganisms</source><year>2023</year><volume>11</volume><elocation-id>1484</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms11061484</pub-id><pub-id pub-id-type="pmid">37374986</pub-id></element-citation></ref><ref id="B236-microorganisms-11-01899"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andersson</surname><given-names>T.</given-names></name>
<name><surname>Ert&#x000fc;rk Bergdahl</surname><given-names>G.</given-names></name>
<name><surname>Saleh</surname><given-names>K.</given-names></name>
<name><surname>Magn&#x000fa;sd&#x000f3;ttir</surname><given-names>H.</given-names></name>
<name><surname>St&#x000f8;dkilde</surname><given-names>K.</given-names></name>
<name><surname>Andersen</surname><given-names>C.B.F.</given-names></name>
<name><surname>Lundqvist</surname><given-names>K.</given-names></name>
<name><surname>Jensen</surname><given-names>A.</given-names></name>
<name><surname>Br&#x000fc;ggemann</surname><given-names>H.</given-names></name>
<name><surname>Lood</surname><given-names>R.</given-names></name>
</person-group><article-title>Common Skin Bacteria Protect Their Host from Oxidative Stress through Secreted Antioxidant RoxP</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>3596</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-40471-3</pub-id><pub-id pub-id-type="pmid">30837648</pub-id></element-citation></ref><ref id="B237-microorganisms-11-01899"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>G.</given-names></name>
<name><surname>Kim</surname><given-names>M.</given-names></name>
<name><surname>Kim</surname><given-names>M.</given-names></name>
<name><surname>Park</surname><given-names>C.</given-names></name>
<name><surname>Yoon</surname><given-names>Y.</given-names></name>
<name><surname>Lim</surname><given-names>D.H.</given-names></name>
<name><surname>Yeo</surname><given-names>H.</given-names></name>
<name><surname>Kang</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>Y.G.</given-names></name>
<name><surname>Beak</surname><given-names>N.I.</given-names></name>
<etal/>
</person-group><article-title>Spermidine-Induced Recovery of Human Dermal Structure and Barrier Function by Skin Microbiome</article-title><source>Commun. Biol.</source><year>2021</year><volume>4</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s42003-020-01566-0</pub-id><?supplied-pmid 33398033?><pub-id pub-id-type="pmid">33398033</pub-id></element-citation></ref><ref id="B238-microorganisms-11-01899"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Madeo</surname><given-names>F.</given-names></name>
<name><surname>Carmona-Gutierrez</surname><given-names>D.</given-names></name>
<name><surname>Kepp</surname><given-names>O.</given-names></name>
<name><surname>Kroemer</surname><given-names>G.</given-names></name>
</person-group><article-title>Spermidine Delays Aging in Humans</article-title><source>Aging</source><year>2018</year><volume>10</volume><fpage>2209</fpage><pub-id pub-id-type="doi">10.18632/aging.101517</pub-id><pub-id pub-id-type="pmid">30082504</pub-id></element-citation></ref><ref id="B239-microorganisms-11-01899"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Madeo</surname><given-names>F.</given-names></name>
<name><surname>Eisenberg</surname><given-names>T.</given-names></name>
<name><surname>Pietrocola</surname><given-names>F.</given-names></name>
<name><surname>Kroemer</surname><given-names>G.</given-names></name>
</person-group><article-title>Spermidine in Health and Disease</article-title><source>Science</source><year>2018</year><volume>359</volume><fpage>eaan2788</fpage><pub-id pub-id-type="doi">10.1126/science.aan2788</pub-id><pub-id pub-id-type="pmid">29371440</pub-id></element-citation></ref><ref id="B240-microorganisms-11-01899"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Madeo</surname><given-names>F.</given-names></name>
<name><surname>Bauer</surname><given-names>M.A.</given-names></name>
<name><surname>Carmona-Gutierrez</surname><given-names>D.</given-names></name>
<name><surname>Kroemer</surname><given-names>G.</given-names></name>
</person-group><article-title>Spermidine: A Physiological Autophagy Inducer Acting as an Anti-Aging Vitamin in Humans?</article-title><source>Autophagy</source><year>2018</year><volume>15</volume><fpage>165</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1080/15548627.2018.1530929</pub-id><pub-id pub-id-type="pmid">30306826</pub-id></element-citation></ref><ref id="B241-microorganisms-11-01899"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>St&#x000f8;dkilde</surname><given-names>K.</given-names></name>
<name><surname>Nielsen</surname><given-names>J.T.</given-names></name>
<name><surname>Petersen</surname><given-names>S.V.</given-names></name>
<name><surname>Paetzold</surname><given-names>B.</given-names></name>
<name><surname>Br&#x000fc;ggemann</surname><given-names>H.</given-names></name>
<name><surname>Mulder</surname><given-names>F.A.A.</given-names></name>
<name><surname>Andersen</surname><given-names>C.B.F.</given-names></name>
</person-group><article-title>Solution Structure of the <italic toggle="yes">Cutibacterium acnes</italic>-Specific Protein RoxP and Insights Into Its Antioxidant Activity</article-title><source>Front. Cell Infect. Microbiol.</source><year>2022</year><volume>12</volume><fpage>100</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2022.803004</pub-id><?supplied-pmid 35223541?><pub-id pub-id-type="pmid">35223541</pub-id></element-citation></ref><ref id="B242-microorganisms-11-01899"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allhorn</surname><given-names>M.</given-names></name>
<name><surname>Arve</surname><given-names>S.</given-names></name>
<name><surname>Br&#x000fc;ggemann</surname><given-names>H.</given-names></name>
<name><surname>Lood</surname><given-names>R.</given-names></name>
</person-group><article-title>A Novel Enzyme with Antioxidant Capacity Produced by the Ubiquitous Skin Colonizer <italic toggle="yes">Propionibacterium acnes</italic></article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>36412</fpage><pub-id pub-id-type="doi">10.1038/srep36412</pub-id><pub-id pub-id-type="pmid">27805044</pub-id></element-citation></ref><ref id="B243-microorganisms-11-01899"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Teichmann</surname><given-names>P.</given-names></name>
<name><surname>Both</surname><given-names>A.</given-names></name>
<name><surname>Wolz</surname><given-names>C.</given-names></name>
<name><surname>Hornef</surname><given-names>M.W.</given-names></name>
<name><surname>Rohde</surname><given-names>H.</given-names></name>
<name><surname>Yazdi</surname><given-names>A.S.</given-names></name>
<name><surname>Burian</surname><given-names>M.</given-names></name>
</person-group><article-title>The <italic toggle="yes">Staphylococcus epidermidis</italic> Transcriptional Profile During Carriage</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><fpage>1537</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.896311</pub-id><?supplied-pmid 35558117?><pub-id pub-id-type="pmid">35558117</pub-id></element-citation></ref><ref id="B244-microorganisms-11-01899"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>Y.</given-names></name>
<name><surname>Hunt</surname><given-names>R.L.</given-names></name>
<name><surname>Villaruz</surname><given-names>A.E.</given-names></name>
<name><surname>Fisher</surname><given-names>E.L.</given-names></name>
<name><surname>Liu</surname><given-names>R.</given-names></name>
<name><surname>Liu</surname><given-names>Q.</given-names></name>
<name><surname>Cheung</surname><given-names>G.Y.C.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Otto</surname><given-names>M.</given-names></name>
</person-group><article-title>Commensal <italic toggle="yes">Staphylococcus epidermidis</italic> Contributes to Skin Barrier Homeostasis by Generating Protective Ceramides</article-title><source>Cell Host Microbe</source><year>2022</year><volume>30</volume><fpage>301</fpage><lpage>313.e9</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2022.01.004</pub-id><pub-id pub-id-type="pmid">35123653</pub-id></element-citation></ref><ref id="B245-microorganisms-11-01899"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Q.</given-names></name>
<name><surname>Fang</surname><given-names>H.</given-names></name>
<name><surname>Dang</surname><given-names>E.</given-names></name>
<name><surname>Wang</surname><given-names>G.</given-names></name>
</person-group><article-title>The Role of Ceramides in Skin Homeostasis and Inflammatory Skin Diseases</article-title><source>J. Dermatol. Sci.</source><year>2020</year><volume>97</volume><fpage>2</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2019.12.002</pub-id><pub-id pub-id-type="pmid">31866207</pub-id></element-citation></ref><ref id="B246-microorganisms-11-01899"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di Marzio</surname><given-names>L.</given-names></name>
<name><surname>Cinque</surname><given-names>B.</given-names></name>
<name><surname>De Simone</surname><given-names>C.</given-names></name>
<name><surname>Cifone</surname><given-names>M.G.</given-names></name>
</person-group><article-title>Effect of the Lactic Acid Bacterium <italic toggle="yes">Streptococcus thermophilus</italic> on Ceramide Levels in Human KeratinocytesIn Vitro and Stratum Corneum In Vivo</article-title><source>J. Investig. Dermatol.</source><year>1999</year><volume>113</volume><fpage>98</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1747.1999.00633.x</pub-id><pub-id pub-id-type="pmid">10417626</pub-id></element-citation></ref><ref id="B247-microorganisms-11-01899"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di Marzio</surname><given-names>L.</given-names></name>
<name><surname>Cinque</surname><given-names>B.</given-names></name>
<name><surname>Cupelli</surname><given-names>F.</given-names></name>
<name><surname>De Simone</surname><given-names>C.</given-names></name>
<name><surname>Cifone</surname><given-names>M.G.</given-names></name>
<name><surname>Giuliani</surname><given-names>M.</given-names></name>
</person-group><article-title>Increase of Skin-Ceramide Levels in Aged Subjects Following a Short-Term Topical Application of Bacterial Sphingomyelinase from <italic toggle="yes">Streptococcus thermophilus</italic></article-title><source>Int. J. Immunopathol. Pharmacol.</source><year>2008</year><volume>21</volume><fpage>137</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1177/039463200802100115</pub-id><?supplied-pmid 18336739?><pub-id pub-id-type="pmid">18336739</pub-id></element-citation></ref><ref id="B248-microorganisms-11-01899"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Izawa</surname><given-names>N.</given-names></name>
<name><surname>Hanamizu</surname><given-names>T.</given-names></name>
<name><surname>Iizuka</surname><given-names>R.</given-names></name>
<name><surname>Sone</surname><given-names>T.</given-names></name>
<name><surname>Mizukoshi</surname><given-names>H.</given-names></name>
<name><surname>Kimura</surname><given-names>K.</given-names></name>
<name><surname>Chiba</surname><given-names>K.</given-names></name>
</person-group><article-title><italic toggle="yes">Streptococcus thermophilus</italic> Produces Exopolysaccharides Including Hyaluronic Acid</article-title><source>J. Biosci. Bioeng.</source><year>2009</year><volume>107</volume><fpage>119</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.jbiosc.2008.11.007</pub-id><?supplied-pmid 19217548?><pub-id pub-id-type="pmid">19217548</pub-id></element-citation></ref><ref id="B249-microorganisms-11-01899"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Swaney</surname><given-names>M.H.</given-names></name>
<name><surname>Kalan</surname><given-names>L.R.</given-names></name>
</person-group><article-title>Two-for-One: Dual Host-Microbe Functions of <italic toggle="yes">S. epidermidis</italic> Sph</article-title><source>Cell Host Microbe</source><year>2022</year><volume>30</volume><fpage>279</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2022.02.011</pub-id><?supplied-pmid 35271798?><pub-id pub-id-type="pmid">35271798</pub-id></element-citation></ref><ref id="B250-microorganisms-11-01899"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boer</surname><given-names>D.E.C.</given-names></name>
<name><surname>van Smeden</surname><given-names>J.</given-names></name>
<name><surname>Al-Khakany</surname><given-names>H.</given-names></name>
<name><surname>Melnik</surname><given-names>E.</given-names></name>
<name><surname>van Dijk</surname><given-names>R.</given-names></name>
<name><surname>Absalah</surname><given-names>S.</given-names></name>
<name><surname>Vreeken</surname><given-names>R.J.</given-names></name>
<name><surname>Haenen</surname><given-names>C.C.P.</given-names></name>
<name><surname>Lavrijsen</surname><given-names>A.P.M.</given-names></name>
<name><surname>Overkleeft</surname><given-names>H.S.</given-names></name>
<etal/>
</person-group><article-title>Skin of Atopic Dermatitis Patients Shows Disturbed &#x003b2;-Glucocerebrosidase and Acid Sphingomyelinase Activity That Relates to Changes in Stratum Corneum Lipid Composition</article-title><source>Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids</source><year>2020</year><volume>1865</volume><fpage>158673</fpage><pub-id pub-id-type="doi">10.1016/J.BBALIP.2020.158673</pub-id></element-citation></ref><ref id="B251-microorganisms-11-01899"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Delanghe</surname><given-names>L.</given-names></name>
<name><surname>Spacova</surname><given-names>I.</given-names></name>
<name><surname>Van Malderen</surname><given-names>J.</given-names></name>
<name><surname>Oerlemans</surname><given-names>E.</given-names></name>
<name><surname>Claes</surname><given-names>I.</given-names></name>
<name><surname>Lebeer</surname><given-names>S.</given-names></name>
</person-group><article-title>The Role of Lactobacilli in Inhibiting Skin Pathogens</article-title><source>Biochem. Soc. Trans.</source><year>2021</year><volume>49</volume><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1042/BST20200329</pub-id><pub-id pub-id-type="pmid">33704415</pub-id></element-citation></ref><ref id="B252-microorganisms-11-01899"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohammedsaeed</surname><given-names>W.</given-names></name>
<name><surname>Cruickshank</surname><given-names>S.</given-names></name>
<name><surname>McBain</surname><given-names>A.J.</given-names></name>
<name><surname>O&#x02019;Neill</surname><given-names>C.A.</given-names></name>
</person-group><article-title><italic toggle="yes">Lactobacillus rhamnosus</italic> GG Lysate Increases Re-Epithelialization of Keratinocyte Scratch Assays by Promoting Migration</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>16147</fpage><pub-id pub-id-type="doi">10.1038/srep16147</pub-id><pub-id pub-id-type="pmid">26537246</pub-id></element-citation></ref><ref id="B253-microorganisms-11-01899"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Draelos</surname><given-names>Z.D.</given-names></name>
</person-group><article-title>The Science behind Skin Care: Moisturizers</article-title><source>J. Cosmet. Dermatol.</source><year>2018</year><volume>17</volume><fpage>138</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1111/jocd.12490</pub-id><?supplied-pmid 29319217?><pub-id pub-id-type="pmid">29319217</pub-id></element-citation></ref><ref id="B254-microorganisms-11-01899"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>H.J.</given-names></name>
<name><surname>Lee</surname><given-names>P.Y.</given-names></name>
<name><surname>Chen</surname><given-names>C.Y.</given-names></name>
<name><surname>Huang</surname><given-names>S.L.</given-names></name>
<name><surname>Huang</surname><given-names>B.W.</given-names></name>
<name><surname>Dai</surname><given-names>F.J.</given-names></name>
<name><surname>Chau</surname><given-names>C.F.</given-names></name>
<name><surname>Chen</surname><given-names>C.S.</given-names></name>
<name><surname>Lin</surname><given-names>Y.S.</given-names></name>
</person-group><article-title>Moisture Retention of Glycerin Solutions with Various Concentrations: A Comparative Study</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><fpage>10232</fpage><pub-id pub-id-type="doi">10.1038/S41598-022-13452-2</pub-id><pub-id pub-id-type="pmid">35715536</pub-id></element-citation></ref><ref id="B255-microorganisms-11-01899"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iglesia</surname><given-names>S.</given-names></name>
<name><surname>Kononov</surname><given-names>T.</given-names></name>
<name><surname>Zahr</surname><given-names>A.S.</given-names></name>
</person-group><article-title>A Multi-functional Anti-aging Moisturizer Maintains a Diverse and Balanced Facial Skin Microbiome</article-title><source>J. Appl. Microbiol.</source><year>2022</year><volume>133</volume><fpage>1791</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.1111/jam.15663</pub-id><pub-id pub-id-type="pmid">35698733</pub-id></element-citation></ref><ref id="B256-microorganisms-11-01899"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jung</surname><given-names>Y.O.</given-names></name>
<name><surname>Jeong</surname><given-names>H.</given-names></name>
<name><surname>Cho</surname><given-names>Y.</given-names></name>
<name><surname>Lee</surname><given-names>E.O.</given-names></name>
<name><surname>Jang</surname><given-names>H.W.</given-names></name>
<name><surname>Kim</surname><given-names>J.</given-names></name>
<name><surname>Nam</surname><given-names>K.T.</given-names></name>
<name><surname>Lim</surname><given-names>K.M.</given-names></name>
</person-group><article-title>Lysates of a Probiotic, <italic toggle="yes">Lactobacillus rhamnosus</italic>, Can Improve Skin Barrier Function in a Reconstructed Human Epidermis Model</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>4289</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20174289</pub-id><?supplied-pmid 31480681?><pub-id pub-id-type="pmid">31480681</pub-id></element-citation></ref><ref id="B257-microorganisms-11-01899"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chandan</surname><given-names>N.</given-names></name>
<name><surname>Rajkumar</surname><given-names>J.R.</given-names></name>
<name><surname>Shi</surname><given-names>V.Y.</given-names></name>
<name><surname>Lio</surname><given-names>P.A.</given-names></name>
</person-group><article-title>A New Era of Moisturizers</article-title><source>J. Cosmet. Dermatol.</source><year>2021</year><volume>20</volume><fpage>2425</fpage><lpage>2430</lpage><pub-id pub-id-type="doi">10.1111/jocd.14217</pub-id><pub-id pub-id-type="pmid">33977643</pub-id></element-citation></ref><ref id="B258-microorganisms-11-01899"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bamford</surname><given-names>J.T.M.</given-names></name>
<name><surname>Flores-Genuino</surname><given-names>R.N.S.</given-names></name>
<name><surname>Ray</surname><given-names>S.</given-names></name>
<name><surname>Bigby</surname><given-names>M.</given-names></name>
<name><surname>Morales-S&#x000e1;nchez</surname><given-names>M.A.</given-names></name>
<name><surname>Arkoncel</surname><given-names>M.</given-names></name>
<name><surname>Realubit-Serrano</surname><given-names>M.A.C.</given-names></name>
</person-group><article-title>Interventions for the Treatment of Pityriasis Versicolor</article-title><source>Cochrane Database Syst. Rev.</source><year>2018</year><volume>2018</volume><fpage>CD011208</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD011208.pub2</pub-id></element-citation></ref><ref id="B259-microorganisms-11-01899"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gaitanis</surname><given-names>G.</given-names></name>
<name><surname>Magiatis</surname><given-names>P.</given-names></name>
<name><surname>Stathopoulou</surname><given-names>K.</given-names></name>
<name><surname>Bassukas</surname><given-names>I.D.</given-names></name>
<name><surname>Alexopoulos</surname><given-names>E.C.</given-names></name>
<name><surname>Velegraki</surname><given-names>A.</given-names></name>
<name><surname>Skaltsounis</surname><given-names>A.L.</given-names></name>
</person-group><article-title>AhR Ligands, Malassezin, and Indolo[3,2-b]Carbazole Are Selectively Produced by <italic toggle="yes">Malassezia furfur</italic> Strains Isolated from Seborrheic Dermatitis</article-title><source>J. Investig. Dermatol.</source><year>2008</year><volume>128</volume><fpage>1620</fpage><lpage>1625</lpage><pub-id pub-id-type="doi">10.1038/sj.jid.5701252</pub-id><?supplied-pmid 18219281?><pub-id pub-id-type="pmid">18219281</pub-id></element-citation></ref><ref id="B260-microorganisms-11-01899"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van den Bogaard</surname><given-names>E.H.</given-names></name>
<name><surname>Esser</surname><given-names>C.</given-names></name>
<name><surname>Perdew</surname><given-names>G.H.</given-names></name>
</person-group><article-title>The Aryl Hydrocarbon Receptor at the Forefront of Host-Microbe Interactions in the Skin: A Perspective on Current Knowledge Gaps and Directions for Future Research and Therapeutic Applications</article-title><source>Exp. Dermatol.</source><year>2021</year><volume>30</volume><fpage>1477</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.1111/exd.14409</pub-id><?supplied-pmid 34105853?><pub-id pub-id-type="pmid">34105853</pub-id></element-citation></ref><ref id="B261-microorganisms-11-01899"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grimes</surname><given-names>P.</given-names></name>
<name><surname>Bhawan</surname><given-names>J.</given-names></name>
<name><surname>Howell</surname><given-names>M.</given-names></name>
<name><surname>Desai</surname><given-names>S.</given-names></name>
<name><surname>Coryell</surname><given-names>E.</given-names></name>
<name><surname>Einziger</surname><given-names>M.</given-names></name>
<name><surname>Simpson</surname><given-names>A.</given-names></name>
<name><surname>Yaroshinsky</surname><given-names>A.</given-names></name>
<name><surname>McCraw</surname><given-names>T.</given-names></name>
</person-group><article-title>Histopathological Changes Induced by Malassezin: A Novel Natural Microbiome Indole for Treatment of Facial Hyperpigmentation</article-title><source>J. Drugs Dermatol.</source><year>2022</year><volume>21</volume><fpage>141</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.36849/JDD.6596</pub-id><?supplied-pmid 35133118?><pub-id pub-id-type="pmid">35133118</pub-id></element-citation></ref><ref id="B262-microorganisms-11-01899"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kurniadi</surname><given-names>I.</given-names></name>
<name><surname>Wijaya</surname><given-names>W.H.</given-names></name>
<name><surname>Timotius</surname><given-names>K.H.</given-names></name>
</person-group><article-title><italic toggle="yes">Malassezia</italic> Virulence Factors and Their Role in Dermatological Disorders</article-title><source>Acta Dermatovenerol. Alp. Pannonica Adriat.</source><year>2022</year><volume>31</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.15570/ACTAAPA.2022.8</pub-id><?supplied-pmid 35751534?><pub-id pub-id-type="pmid">35751534</pub-id></element-citation></ref><ref id="B263-microorganisms-11-01899"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grimes</surname><given-names>P.E.</given-names></name>
<name><surname>Bhawan</surname><given-names>J.</given-names></name>
<name><surname>Howell</surname><given-names>M.D.</given-names></name>
<name><surname>Desai</surname><given-names>S.</given-names></name>
<name><surname>Coryell</surname><given-names>E.</given-names></name>
<name><surname>Nashawati</surname><given-names>R.</given-names></name>
<name><surname>Einziger</surname><given-names>M.</given-names></name>
<name><surname>Simpson</surname><given-names>A.M.</given-names></name>
<name><surname>Yaroshinsky</surname><given-names>A.</given-names></name>
<name><surname>Mc Craw</surname><given-names>T.</given-names></name>
</person-group><article-title>A Novel Proof-of-Concept Study Assessing the Lightening Effects and Safety of Malassezin for Treatment of Facial Hyperpigmentation</article-title><source>J. Am. Acad. Dermatol.</source><year>2022</year><volume>87</volume><fpage>456</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2021.10.008</pub-id><pub-id pub-id-type="pmid">34678236</pub-id></element-citation></ref><ref id="B264-microorganisms-11-01899"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fortuna</surname><given-names>M.C.</given-names></name>
<name><surname>Garelli</surname><given-names>V.</given-names></name>
<name><surname>Pranteda</surname><given-names>G.</given-names></name>
<name><surname>Romaniello</surname><given-names>F.</given-names></name>
<name><surname>Cardone</surname><given-names>M.</given-names></name>
<name><surname>Carlesimo</surname><given-names>M.</given-names></name>
<name><surname>Rossi</surname><given-names>A.</given-names></name>
</person-group><article-title>A Case of Scalp Rosacea Treated with Low Dose Doxycycline and Probiotic Therapy and Literature Review on Therapeutic Options</article-title><source>Dermatol. Ther.</source><year>2016</year><volume>29</volume><fpage>249</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1111/dth.12355</pub-id><pub-id pub-id-type="pmid">27087407</pub-id></element-citation></ref><ref id="B265-microorganisms-11-01899"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smythe</surname><given-names>P.</given-names></name>
<name><surname>Wilkinson</surname><given-names>H.N.</given-names></name>
</person-group><article-title>The Skin Microbiome: Current Landscape and Future Opportunities</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>3950</elocation-id><pub-id pub-id-type="doi">10.3390/IJMS24043950</pub-id><pub-id pub-id-type="pmid">36835363</pub-id></element-citation></ref><ref id="B266-microorganisms-11-01899"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Larson</surname><given-names>P.J.</given-names></name>
<name><surname>Chong</surname><given-names>D.</given-names></name>
<name><surname>Fleming</surname><given-names>E.</given-names></name>
<name><surname>Oh</surname><given-names>J.</given-names></name>
</person-group><article-title>Challenges Developing a Human Model System for Skin Microbiome Research</article-title><source>J. Investig. Dermatol.</source><year>2021</year><volume>141</volume><fpage>228</fpage><pub-id pub-id-type="doi">10.1016/j.jid.2020.05.096</pub-id><?supplied-pmid 32522484?><pub-id pub-id-type="pmid">32522484</pub-id></element-citation></ref><ref id="B267-microorganisms-11-01899"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shen</surname><given-names>J.</given-names></name>
<name><surname>McFarland</surname><given-names>A.G.</given-names></name>
<name><surname>Blaustein</surname><given-names>R.A.</given-names></name>
<name><surname>Rose</surname><given-names>L.J.</given-names></name>
<name><surname>Perry-Dow</surname><given-names>K.A.</given-names></name>
<name><surname>Moghadam</surname><given-names>A.A.</given-names></name>
<name><surname>Hayden</surname><given-names>M.K.</given-names></name>
<name><surname>Young</surname><given-names>V.B.</given-names></name>
<name><surname>Hartmann</surname><given-names>E.M.</given-names></name>
</person-group><article-title>An Improved Workflow for Accurate and Robust Healthcare Environmental Surveillance Using Metagenomics</article-title><source>Microbiome</source><year>2022</year><volume>10</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1186/s40168-022-01412-x</pub-id><?supplied-pmid 36457108?><pub-id pub-id-type="pmid">34980280</pub-id></element-citation></ref><ref id="B268-microorganisms-11-01899"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shute</surname><given-names>A.</given-names></name>
<name><surname>Bihan</surname><given-names>D.G.</given-names></name>
<name><surname>Lewis</surname><given-names>I.A.</given-names></name>
<name><surname>Nasser</surname><given-names>Y.</given-names></name>
</person-group><article-title>Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission</article-title><source>Front. Neurosci.</source><year>2022</year><volume>16</volume><fpage>937</fpage><pub-id pub-id-type="doi">10.3389/fnins.2022.917197</pub-id><?supplied-pmid 35812241?><pub-id pub-id-type="pmid">35812241</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="microorganisms-11-01899-f002"><label>Figure 2</label><caption><p>Drivers structuring the human skin microbiome structure. Intrinsic intrapersonal factors are associated with the differing physiological conditions across different microenvironments on the body. Extrinsic intrapersonal factors relate to environmentally derived variations, such as observations of cultural practices. Intrinsic interpersonal drivers are associated with the biological variation between individuals, such as hormonal differences between genders leading to altered skin physiology [<xref rid="B45-microorganisms-11-01899" ref-type="bibr">45</xref>]. Created with <uri xlink:href="www.BioRender.com">www.BioRender.com</uri>.</p></caption><graphic xlink:href="microorganisms-11-01899-g002" position="float"/></fig></floats-group></article>